Risteys ·

OMOP concept ID	Test name	Measurement unit (harmonized unit)	N people	N records	Missing measurement value	Harmonized value distribution	Test outcome NA N A AA L LL H HH
3026285	s-antitry	g/l (g/l)	5114	5501	0.04%
3026285	s-antitry	— (—)	576	607	100.00%	Distribution not available

LabWAS

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

Chronic hepatitis, not elsewhere classified

218

30.11

318.93

1.2

1.1

1.57

1.49

g/l

1.29

194

Diseases of liver

2082

1127

21.16

307.65

1.1

1.56

1.47

g/l

7.84

1842

1033

Cirrhosis of liver, NAS

470

165

38.58

307.65

1.2

1.1

1.64

1.53

g/l

2.70

429

153

Any gastric operation

1239

1520

4.15

307.65

1.1

1.0

1.51

1.42

g/l

8.25

1129

1380

Other diseases of liver

1141

545

24.49

307.65

1.1

1.48

1.49

g/l

0.21

996

503

Fibrosis and cirrhosis of liver

604

192

40.08

307.65

1.2

1.1

1.62

1.50

g/l

3.80

545

178

Nonalcoholic fatty liver disease

713

397

22.08

307.65

1.1

1.43

1.49

g/l

1.97

632

356

Cirrhosis, broad definition used in the article https://doi.org/10.1101/594523

916

515

21.01

307.65

1.2

1.1

1.65

1.51

g/l

9.56

822

465

Oesophageal varices

321

155

26.28

307.65

1.3

1.1

1.62

1.54

g/l

1.37

299

142

GASTRO-related operations

1239

1520

4.15

307.65

1.1

1.0

1.51

1.42

g/l

8.25

1129

1380

Ascites

315

239

14.73

307.65

1.2

1.1

1.73

1.50

g/l

9.47

286

220

Alcoholic liver disease

514

287

20.51

307.65

1.1

1.69

1.52

g/l

6.43

447

263

Abnormal findings on examination of blood, without diagnosis

873

2047

4.11

302.73

1.1

1.49

1.55

g/l

3.39

806

1835

Abnormal serum enzyme levels

650

1350

4.95

287.32

1.1

1.47

1.55

g/l

5.14

600

1213

Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)

261

196

14.84

282.20

1.3

1.1

1.68

1.54

g/l

3.35

246

168

ILD medications

1704

3444

2.76

272.46

1.1

1.53

1.48

g/l

3.45

1572

3094

First line medication for Crohn's disease

1654

3331

2.75

262.58

1.1

1.53

1.48

g/l

4.21

1529

2984

Hepatocellular carcinoma, excluding all cancers (controls excluding all cancers)

179

29.36

258.78

1.4

1.0

1.64

1.57

g/l

0.71

174

ILD medications: prednisolone, methylprednisolone, prednisone

1609

3385

2.72

254.49

1.1

1.53

1.48

g/l

3.08

1481

3040

Inflammatory bowel disease treatment related agents

1680

3648

2.65

253.29

1.1

1.51

1.49

g/l

1.11

1553

3279

Hepatic failure, not elsewhere classified

176

22.22

230.95

1.2

1.1

1.67

1.48

g/l

3.82

160

Asthma, excluding more controls

1162

2032

3.10

224.32

1.1

1.45

1.49

g/l

1.63

1065

1830

Cholangitis (primary sclerosing, PSC)

233

220

11.63

217.64

1.2

1.1

1.63

1.47

g/l

4.20

218

197

Oral corticosteroids

1490

3543

2.58

217.04

1.1

1.52

1.50

g/l

1.03

1366

3182

Asthma

1175

2144

2.98

214.25

1.1

1.45

1.50

g/l

2.44

1077

1934

Gastrointestinal diseases

792

1018

3.95

210.94

1.1

1.0

1.50

1.43

g/l

3.70

711

946

Asthma (only as main-diagnosis), excluding more controls

1038

2032

3.09

207.79

1.1

1.44

1.49

g/l

2.33

948

1830

Other inflammatory liver diseases

212

194

11.83

201.71

1.1

1.60

1.48

g/l

2.47

194

177

ILD medications: immunosuppressive drugs

927

3015

3.00

201.55

1.1

1.54

1.48

g/l

4.13

865

2712

Abnormal findings on diagnostic imaging and in function studies, without diagnosis

924

2896

3.01

200.37

1.1

1.51

1.53

g/l

0.71

834

2602

Chronic lower respiratory diseases

1660

3805

2.39

200.02

1.1

1.47

1.51

g/l

2.38

1517

3432

Asthma (only as main-diagnosis)

1045

2144

2.98

198.44

1.1

1.45

1.50

g/l

3.05

955

1934

Alcohol use disorder, Swedish definition

881

2748

3.04

193.49

1.1

1.64

1.49

g/l

19.13

771

2514

Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder

180

144

13.88

187.39

1.3

1.1

1.69

1.59

g/l

1.24

171

131

Disorders of gallbladder, biliary tract and pancreas

1340

3506

2.50

186.17

1.1

1.52

1.50

g/l

0.83

1217

3169

COPD

657

1536

3.61

184.01

1.1

1.54

1.56

g/l

0.42

600

1369

Diseases of oesophagus, stomach and duodenum

1435

3676

2.40

180.91

1.1

1.54

1.49

g/l

3.54

1302

3337

894

2886

2.90

180.50

1.1

1.64

1.48

g/l

19.68

782

2642

Abnormal results of function studies

264

371

7.63

179.76

1.1

1.47

1.51

g/l

0.60

215

334

924

2973

2.83

178.14

1.1

1.63

1.48

g/l

20.09

810

2719

Malignant neoplasm of liver and intrahepatic bile ducts

151

17.56

177.49

1.3

1.1

1.68

1.57

g/l

1.22

143

Emphysema

208

226

9.86

174.95

1.1

1.52

1.56

g/l

0.58

192

202

Asthma (mode)

1077

2176

2.75

172.77

1.1

1.45

1.50

g/l

3.31

991

1959

Autoimmune diseases related-to ILD

1156

4175

2.47

169.30

1.1

1.53

1.49

g/l

2.08

1066

3766

Asthma, unspecified (mode), excluding more controls

724

1808

3.20

166.80

1.1

1.46

1.49

g/l

1.08

660

1627

Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism

1275

3947

2.34

159.28

1.1

1.58

1.48

g/l

12.90

1161

3577

Asthma, unspecified (mode)

726

1901

3.07

157.44

1.1

1.46

1.50

g/l

1.55

662

1715

Autoimmune diseases excluding thyroid diseases

1387

3371

2.31

156.80

1.1

1.53

1.48

g/l

3.99

1273

3051

Autoimmune diseases excluding thyroid diseases, strict definition

1362

3299

2.33

156.72

1.1

1.54

1.48

g/l

4.30

1247

2985

Early onset COPD, excluding more controls

364

790

4.74

155.27

1.1

1.53

g/l

0.09

332

706

Anaemias

414

591

4.77

154.21

1.1

1.60

1.39

g/l

14.57

375

546

Cholangitis (primary sclerosing, PSC), with reimbursement 202

124

19.56

150.34

1.2

1.1

1.57

1.43

g/l

2.59

114

Heart failure, not strict

984

2676

2.57

148.07

1.1

1.64

1.49

g/l

19.06

904

2402

Abnormalities of breathing

1194

3019

2.38

146.77

1.1

1.48

1.49

g/l

0.37

1085

2729

Inflammatory bowel disease

551

1697

3.33

143.37

1.1

1.50

1.49

g/l

0.14

519

1531

Transplanted organ and tissue status

256

443

6.12

142.28

1.3

1.1

1.57

1.47

g/l

2.48

247

395

Noninfective enteritis and colitis

707

2519

2.86

141.89

1.1

1.50

1.49

g/l

0.52

662

2271

Asthma (diagnoses ohter than nonallergic)

1121

4193

2.31

141.69

1.1

1.45

1.51

g/l

4.26

1031

3783

Asthma-related infections

773

2847

2.71

140.58

1.1

1.48

1.51

g/l

1.22

710

2574

Asthma, hospital admission 2, infections

773

2847

2.71

140.58

1.1

1.48

1.51

g/l

1.22

710

2574

Asthma, hospital admissions , main diagnosis only

1081

4200

2.33

140.57

1.1

1.44

1.51

g/l

5.59

991

3791

Other diseases of biliary tract

203

281

7.63

139.69

1.2

1.1

1.63

1.51

g/l

2.81

192

251

IBD patients in KELA-register

438

1220

3.69

133.58

1.1

1.48

1.49

g/l

0.21

411

1100

Other chronic obstructive pulmonary disease

560

1472

3.22

132.70

1.1

1.55

1.56

g/l

0.13

505

1308

5-aminosalicylic acid

385

987

4.01

132.24

1.1

1.49

1.48

g/l

0.04

358

885

Primary biliary cholangitis (PBC)

108

19.08

132.00

1.1

1.54

1.48

g/l

0.68

Asthma, including avohilmo

1461

4113

2.08

131.00

1.1

1.45

1.52

g/l

8.05

1341

3711

Any reimbursement code in KELA

759

1326

2.90

129.72

1.1

1.49

1.42

g/l

4.71

701

1176

Inflammatory bowel disease, strict (require KELA)

438

1252

3.60

128.49

1.1

1.48

1.49

g/l

0.27

411

1130

Symptoms and signs involving the digestive system and abdomen

1286

2945

2.21

127.88

1.1

1.53

1.48

g/l

3.11

1161

2678

Tramadol

1029

2831

2.36

127.82

1.1

1.55

1.47

g/l

7.25

932

2564

L04AD Calcineurin inhibitors

264

525

5.29

126.03

1.3

1.1

1.55

1.49

g/l

1.35

254

471

Autoimmune diseases

1377

3394

2.09

120.40

1.1

1.51

1.48

g/l

1.67

1258

3071

Ulcerative colitis

426

1270

3.44

116.99

1.1

1.49

1.50

g/l

0.20

399

1144

COPD (mode)

408

902

3.66

116.07

1.1

1.57

1.53

g/l

0.80

366

801

Malignant neoplasm of digestive organs, excluding all cancers (controls excluding all cancers)

579

1565

2.94

115.44

1.2

1.1

1.65

1.51

g/l

9.66

543

1393

ILD medications: azathioprine

276

612

4.65

115.02

1.1

1.54

1.49

g/l

1.39

261

545

Dyspnoea

1066

3800

2.17

113.37

1.1

1.50

1.51

g/l

0.42

981

3433

Colitis, primary sclerosing

18.57

113.19

1.2

1.0

1.55

1.38

g/l

2.78

Azathioprine

276

620

4.59

113.17

1.1

1.54

1.48

g/l

1.60

261

553

597

2176

2.77

113.09

1.1

1.46

1.50

g/l

1.90

551

1966

Asthma/COPD (KELA code 203)

1129

3788

2.12

111.19

1.1

1.46

1.51

g/l

3.84

1032

3416

Examination and observation for other reasons

767

1846

2.56

110.66

1.1

1.50

1.51

g/l

0.25

709

1685

Malignant neoplasm of digestive organs

466

1490

3.14

110.34

1.2

1.1

1.66

1.53

g/l

7.00

438

1314

Unspecified jaundice

134

152

9.37

109.00

1.1

1.0

1.69

1.48

g/l

5.19

124

140

Used for control exclusion in common control thyroid runs

1287

3191

2.06

108.58

1.1

1.51

1.48

g/l

1.61

1181

2884

Other chronic obstructive pulmonary disease, including avohilmo

647

2081

2.63

106.52

1.1

1.54

g/l

0.01

585

1875

COPD, hospital admissions

560

1707

2.82

106.31

1.1

1.55

g/l

0.17

506

1523

Hernia of abdominal wall, postoperative

221

436

5.18

105.55

1.1

1.52

1.45

g/l

1.36

197

393

COPD, early/later onset

562

1719

2.81

105.44

1.1

1.55

g/l

0.17

507

1534

Early onset COPD

364

1067

3.50

102.81

1.1

1.53

1.52

g/l

0.18

332

963

Type 2 diabetes, wide definition

927

2726

2.24

102.51

1.1

1.55

1.50

g/l

2.53

841

2462

Asthma-related pneumonia or sepsis

451

1503

3.05

102.27

1.1

1.51

1.53

g/l

0.52

415

1344

Asthma, hospital admissions 3, pneumonia

451

1503

3.05

102.27

1.1

1.51

1.53

g/l

0.52

415

1344

Asthma-related pneumonia

449

1499

3.04

101.51

1.1

1.51

1.53

g/l

0.52

413

1340

Budesonide

240

530

4.67

100.61

1.1

1.51

1.48

g/l

0.58

219

469

Non-allergic asthma (mode), excluding more controls

282

695

4.11

100.59

1.1

1.47

1.50

g/l

0.67

261

617

COPD, hospital admissions 1, only main diagnosis

429

1174

3.17

99.85

1.1

1.55

g/l

0.03

382

1057

Mucosal proctocolitis

260

619

4.35

99.20

1.1

1.49

g/l

0.06

244

552

Symptoms and signs involving the circulatory and respiratory systems

1219

3033

2.03

98.67

1.1

1.49

g/l

0.14

1113

2742

Ulcerative colitis (strict definition, require KELA, min 2 HDR)

308

833

3.81

98.40

1.1

1.47

1.50

g/l

0.74

288

749

Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified

455

687

3.36

98.11

1.1

1.0

1.49

1.44

g/l

1.41

414

622

Other bacterial diseases

1109

3803

2.04

97.72

1.1

1.62

1.48

g/l

19.26

1027

3426

Abnormal findings on diagnostic imaging of lung

554

2069

2.65

96.13

1.1

1.52

1.54

g/l

0.40

516

1865

Cholelithiasis, broad definition with cholecystitis

969

3147

2.13

96.09

1.1

1.50

1.51

g/l

0.08

887

2841

Ulcerative colitis (strict definition, require KELA)

312

867

3.71

95.76

1.1

1.47

1.50

g/l

0.68

291

779

Non-allergic asthma (mode)

282

723

3.95

95.30

1.1

1.47

1.51

g/l

0.95

261

645

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified (FINNGEN)

633

1568

2.60

95.21

1.2

1.1

1.57

1.43

g/l

10.24

590

1419

Cholelithiasis

935

3092

2.14

94.42

1.1

1.50

1.51

g/l

0.22

855

2789

Ulcerative colitis, NAS

264

663

4.11

93.70

1.1

1.47

1.51

g/l

0.72

243

594

General symptoms and signs

1315

3426

1.94

93.65

1.1

1.53

1.48

g/l

4.02

1199

3086

UC patients in KELA-register ( KELA 208 prior to 1994, or ICD K51)

324

940

3.54

93.11

1.1

1.47

1.50

g/l

0.51

302

846

Other diseases of intestines

1259

3828

1.93

91.60

1.1

1.51

1.49

g/l

1.30

1141

3490

Crohn disease

251

618

4.20

91.56

1.1

1.51

1.49

g/l

0.23

239

551

Implicit bacterial Sepsis

454

1470

2.88

91.18

1.1

1.65

1.51

g/l

8.51

414

1312

Dental caries

395

1294

3.09

91.07

1.2

1.1

1.58

1.49

g/l

3.32

364

1178

Other gastritis (incl. Duodenitis)

316

914

3.53

90.99

1.1

1.58

1.51

g/l

1.73

280

817

Bacterial Sepsis

513

1718

2.70

90.57

1.1

1.65

1.50

g/l

10.01

470

1530

Septicaemia

472

1660

2.78

89.70

1.1

1.64

1.49

g/l

8.63

437

1480

Diseases of the digestive system

550

2180

2.55

89.24

1.1

1.58

1.51

g/l

3.10

501

1962

Fever of other and unknown origin

650

2578

2.37

88.23

1.1

1.60

1.48

g/l

9.61

613

2316

Implicit Sepsis

814

2955

2.16

86.32

1.1

1.62

1.49

g/l

11.73

727

2665

Gastro-oesophageal reflux disease

765

3135

2.19

85.34

1.1

1.51

1.50

g/l

0.51

684

2844

Endocrine, nutritional and metabolic diseases

988

2443

2.08

85.03

1.1

1.49

1.47

g/l

0.53

898

2238

Other pulmonary diagnosis

918

2167

2.14

84.98

1.1

1.50

g/l

0.08

840

1956

Excluding asthma or asthma-COPD overlap

917

2167

2.14

84.66

1.1

1.50

g/l

0.14

836

1956

Diabetes, insuline treatment (Kela reimbursement), excluding more controls

1104

3490

1.95

83.92

1.1

1.53

1.49

g/l

3.05

1010

3157

Renal failure

487

1704

2.65

83.75

1.1

1.69

1.52

g/l

11.04

452

1519

Diabetes, varying definitions

1163

3663

1.91

83.36

1.1

1.52

1.48

g/l

2.81

1056

3318

Insulin medication

688

2627

2.27

83.17

1.1

1.61

1.50

g/l

7.22

618

2383

Other septicaemia

420

1484

2.82

82.68

1.1

1.65

1.50

g/l

8.13

391

1316

Iron deficiency anaemia

481

1840

2.63

82.65

1.1

1.64

1.51

g/l

8.37

430

1656

Type 2 diabetes

1117

3463

1.93

82.24

1.1

1.52

1.49

g/l

2.00

1014

3132

Explicit Sepsis

484

1796

2.62

82.23

1.1

1.64

1.49

g/l

9.17

448

1608

Abdominal and pelvic pain

1132

2944

1.95

81.91

1.1

1.51

1.48

g/l

1.03

1032

2677

Medical observation and evaluation for suspected diseases and conditions

799

1857

2.22

81.64

1.1

1.49

1.51

g/l

0.59

707

1696

Acute renal failure

281

809

3.56

81.63

1.1

1.72

1.51

g/l

8.80

259

721

Opioids

1144

3136

1.93

81.60

1.1

1.52

1.46

g/l

5.63

1046

2844

Nutritional anaemias

540

2154

2.47

81.49

1.1

1.63

1.51

g/l

8.34

484

1946

Diabetes mellitus

1162

3682

1.90

81.48

1.1

1.52

1.48

g/l

2.75

1056

3334

Condition for Implicit Sepsis (Organ dysfunction codes)

943

3459

2.00

80.08

1.1

1.61

1.48

g/l

13.34

845

3123

Obesity related asthma

438

1645

2.71

80.00

1.1

1.46

1.52

g/l

2.79

398

1480

Dentinal caries

341

1122

3.09

78.85

1.2

1.1

1.58

1.49

g/l

2.84

312

1025

1014

3282

1.95

78.07

1.1

1.57

1.48

g/l

7.01

935

2962

COPD/asthma/ILD related pneumonia or pneumonia derived septicaemia

1014

3282

1.95

78.07

1.1

1.57

1.48

g/l

7.01

935

2962

Bronchiectasis

143

252

5.91

77.86

1.1

1.47

1.56

g/l

1.67

134

228

Metabolic disorders

1079

3538

1.91

77.83

1.1

1.52

1.50

g/l

0.66

971

3209

COPD differential diagnosis

897

2176

2.08

77.56

1.1

1.50

g/l

0.09

821

1959

ILD differential diagnosis

897

2176

2.08

77.55

1.1

1.50

g/l

0.09

821

1959

Substance abuse, excluding more controls

685

2757

2.20

77.50

1.1

1.61

1.50

g/l

8.92

590

2522

Dialysis, with operation codes

224

574

4.04

77.48

1.3

1.1

1.63

1.49

g/l

4.34

216

515

Respiratory diseases principally affecting the interstitium, IBD co-morbidites

180

261

5.21

77.23

1.1

1.57

1.51

g/l

0.99

159

243

Diabetes, insulin treatment (Kela reimbursement)

1131

3724

1.87

76.58

1.1

1.53

1.49

g/l

2.69

1034

3359

Aplastic and other anaemias

480

1817

2.54

76.35

1.1

1.66

1.52

g/l

8.32

434

1634

Second line medication for Crohn's disease

690

3235

2.16

76.31

1.1

1.53

1.49

g/l

2.00

644

2913

Type 2 diabetes, definitions combined

1047

3276

1.92

76.29

1.1

1.52

1.49

g/l

1.48

951

2959

GI-bleeding

378

1347

2.85

76.29

1.1

1.60

1.52

g/l

2.92

344

1204

Haemorrhage from respiratory passages

379

1243

2.87

76.27

1.1

1.58

1.53

g/l

0.91

342

1105

Bleeding

906

3343

1.99

76.05

1.1

1.58

1.51

g/l

4.48

814

3022

Other diseases of the digestive system

378

1350

2.85

76.00

1.2

1.1

1.60

1.52

g/l

2.55

346

1205

Other and unspecified anaemias

443

1660

2.62

75.36

1.1

1.65

1.52

g/l

6.57

400

1490

Type 2 diabetes, strict (exclude DM1)

1048

3308

1.91

74.53

1.1

1.52

1.50

g/l

1.18

952

2988

Glucagon-like peptide-1 (GLP-1) analogues

589

2117

2.32

74.49

1.1

1.60

1.52

g/l

3.88

533

1912

Cardiovascular diseases (excluding rheumatic etc)

796

2199

2.11

74.05

1.1

1.52

1.42

g/l

10.15

730

2002

Insulin, combination of fast acting with intermediate-acting or long-acting

688

2988

2.15

73.99

1.1

1.61

1.51

g/l

6.74

618

2710

Type 2 diabetes, definitions combined, including avohilmo

1050

3300

1.90

73.60

1.1

1.52

1.50

g/l

1.30

955

2980

Insulin, intermediate and long-acting

622

2782

2.22

73.52

1.1

1.60

1.51

g/l

5.57

560

2519

Bacterial infection, other or unspecified

564

2216

2.32

73.21

1.1

1.66

1.50

g/l

12.57

524

1989

Other anaemias

444

1686

2.58

73.07

1.1

1.65

1.52

g/l

6.64

401

1514

Other nutritional deficiencies

744

3562

2.06

72.92

1.1

1.51

1.49

g/l

0.43

663

3250

Secondary malignant neoplasm of respiratory and digestive organs, excluding all cancers (controls excluding all cancers)

246

701

3.60

72.73

1.1

1.65

1.53

g/l

3.52

231

612

Nephropathy related operations

218

575

3.92

72.47

1.3

1.1

1.63

1.52

g/l

2.93

210

516

COPD related to multimorbidity

421

1348

2.67

72.11

1.1

1.58

1.55

g/l

0.49

379

1206

Diabetes medication

1131

3776

1.83

71.79

1.1

1.53

1.48

g/l

2.70

1028

3418

Influenza and pneumonia

1172

4308

1.80

71.49

1.1

1.57

1.48

g/l

8.06

1080

3894

Hypertensive diseases (excluding secondary)

669

1766

2.23

70.96

1.1

1.51

1.42

g/l

5.99

604

1601

L04AA Selective immunosuppressants

323

1102

3.00

70.94

1.2

1.1

1.55

1.50

g/l

1.36

302

991

Cholecystectomy

760

3353

2.02

69.52

1.1

1.49

1.51

g/l

0.49

695

3013

COPD, hospital admission 2, with asthma infections

349

1051

2.88

69.12

1.1

1.59

1.55

g/l

0.59

315

946

Certain infectious and parasitic diseases

1122

3074

1.84

68.76

1.1

1.53

1.46

g/l

6.35

1032

2768

Mental and behavioural disorders due to psychoactive substance use

708

3287

2.05

68.22

1.1

1.60

1.49

g/l

10.06

611

3011

Pneumonias (Asthma/COPD co-morbidities)

1103

4285

1.80

67.39

1.1

1.58

1.48

g/l

9.16

1015

3878

Ulcerative colitis (strict definition, all Crohn cases excluded)

239

707

3.47

66.79

1.1

1.48

1.50

g/l

0.49

222

633

Chronic hepatitis NAS

15.84

66.76

1.2

1.1

1.62

1.46

g/l

1.64

Other special examinations and investigations of persons without complaint or reported diagnosis

760

1857

2.09

66.58

1.1

1.50

1.51

g/l

0.17

690

1696

All pneumoniae

1108

4314

1.79

66.30

1.1

1.57

1.48

g/l

8.69

1020

3902

Pain in throat and chest

900

2883

1.92

66.10

1.1

1.50

g/l

0.03

822

2607

Substance abuse

685

3229

2.05

65.73

1.1

1.61

1.49

g/l

10.52

590

2956

Heart failure and antihypertensive medication

316

694

3.06

64.80

1.1

1.66

1.49

g/l

7.50

293

625

Pneumonia, organism unspecified

992

3955

1.83

64.74

1.1

1.58

1.48

g/l

8.00

907

3571

Reimbursement for rheumatic diseases

656

3219

2.06

63.96

1.1

1.53

1.50

g/l

1.36

598

2904

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified

1031

3744

1.81

63.37

1.1

1.56

1.50

g/l

4.98

937

3384

Asthma and opportunity respiratory infection

101

156

6.83

63.03

1.1

1.44

1.58

g/l

1.84

142

Chronic gastritis

298

1041

2.91

62.51

1.1

1.55

1.52

g/l

0.68

261

932

Obesity and other hyperalimentation

694

3475

2.00

62.42

1.1

1.50

g/l

0.16

614

3174

Other (not insulin) diabetes medications

1020

3425

1.81

61.91

1.1

1.53

1.50

g/l

1.71

928

3093

Obesity

689

3463

1.99

61.45

1.1

1.50

g/l

0.22

609

3164

Pneumonia (excl. viral and due to other infectious organisms not elsewhere classified)

1063

4284

1.76

60.41

1.1

1.58

1.48

g/l

8.95

976

3873

Persons with potential health hazards related to family and personal history and certain conditions influencing health status

1026

3951

1.78

60.38

1.1

1.55

1.49

g/l

4.42

948

3565

Hypertension, essential

892

2730

1.88

60.29

1.1

1.52

1.48

g/l

1.94

798

2473

Other heart diseases

579

1777

2.17

60.19

1.1

1.54

1.42

g/l

8.46

532

1619

L04AX Other immunosuppressants

635

3163

2.03

59.84

1.1

1.54

1.49

g/l

2.22

593

2847

Other diseases of pleura

460

1774

2.33

59.78

1.1

1.60

1.54

g/l

1.93

424

1579

Oxycodone

380

1483

2.51

59.51

1.1

1.73

1.50

g/l

14.47

348

1331

Cough

439

1813

2.35

59.45

1.1

1.49

1.50

g/l

0.19

409

1626

Nausea and vomiting

287

991

2.89

59.41

1.1

1.54

1.49

g/l

1.08

266

902

Cardiovascular diseases

722

1965

2.02

59.13

1.1

1.51

1.42

g/l

7.70

666

1787

Benign neoplasm: Colon

506

1751

2.24

58.44

1.2

1.1

1.56

1.50

g/l

2.95

458

1564

Obesity due to excess calories

536

2542

2.13

57.79

1.1

1.51

1.49

g/l

0.35

478

2312

Gastroduodenal ulcer

272

942

2.92

57.70

1.1

1.63

1.53

g/l

2.81

246

841

Benign neoplasm of colon, rectum, anus and anal canal

575

1958

2.12

57.13

1.1

1.55

1.49

g/l

2.72

517

1761

Benign neoplasm of colon, rectum, anus and anal canal

607

2714

2.04

57.04

1.1

1.56

1.53

g/l

0.68

544

2442

Depression medications

370

697

2.70

56.30

1.1

1.46

1.38

g/l

2.57

334

640

Other and unspecified iron deficiency

350

1401

2.53

56.18

1.1

1.64

1.51

g/l

6.33

312

1253

Other antidepressants

1113

3387

1.73

55.87

1.1

1.52

1.50

g/l

0.48

1009

3083

Other Crohn's disease

137

313

4.54

55.41

1.1

1.48

1.45

g/l

0.47

131

281

Mental and behavioural disorders due to alcohol

583

2817

2.04

55.26

1.1

1.62

1.50

g/l

9.70

499

2589

Codeine

984

3080

1.77

54.31

1.1

1.54

1.46

g/l

7.07

888

2792

Renal tubulo-interstitial diseases

871

3756

1.79

53.92

1.1

1.62

1.49

g/l

11.71

800

3382

Neoplasms

861

2527

1.84

53.74

1.1

1.50

1.46

g/l

2.11

799

2294

Acute pancreatitis

240

813

3.01

53.44

1.1

1.58

1.50

g/l

1.69

210

740

Benign neoplasm of other and ill-defined parts of digestive system

217

696

3.18

53.18

1.1

1.53

1.50

g/l

0.53

196

609

Biguanides

978

3476

1.75

53.15

1.1

1.52

1.50

g/l

1.02

891

3139

Heart failure,strict

494

1653

2.18

52.76

1.1

1.67

1.51

g/l

12.64

460

1472

Mental and behavioural disorders due to alcohol, excluding acute intoxication

521

2528

2.08

52.76

1.1

1.63

1.50

g/l

8.51

443

2315

Infections, IBD-co-morbidities

211

461

3.39

52.69

1.1

1.59

1.49

g/l

2.05

186

429

Hypertensive diseases

894

2836

1.80

52.54

1.1

1.52

1.47

g/l

2.71

810

2572

Persons encountering health services in other circumstances, wide

1268

4048

1.64

52.13

1.1

1.51

1.49

g/l

0.53

1166

3649

Hypertension

892

2834

1.79

52.12

1.1

1.52

1.47

g/l

2.74

808

2571

Benign neoplasm: Colon

511

2423

2.09

51.98

1.2

1.1

1.56

1.54

g/l

0.76

462

2177

Viral hepatitis, IBD co-morbidity

107

210

5.27

51.84

1.1

1.68

1.45

g/l

4.38

192

Sleep disorders (combined)

1046

4079

1.69

51.52

1.1

1.48

1.51

g/l

1.36

938

3699

Other disorders of fluid, electrolyte and acid-base balance

316

1208

2.56

51.47

1.1

1.65

1.53

g/l

4.67

277

1079

ILD, hospital admissions

188

565

3.41

51.32

1.1

1.56

g/l

0.01

166

504

Other respiratory diseases principally affecting the interstitium

206

657

3.20

50.95

1.1

1.58

1.54

g/l

0.60

183

582

Other interstitial pulmonary diseases

188

568

3.39

50.88

1.1

1.56

1.55

g/l

0.07

166

506

Interstitial lung disease endpoints

188

569

3.38

50.74

1.1

1.56

1.55

g/l

0.03

166

508

Interstitial lung disease

188

569

3.38

50.74

1.1

1.56

1.55

g/l

0.03

166

508

Continuous positive airway pressure

221

625

3.10

50.19

1.1

1.55

1.44

g/l

3.14

187

585

Mood disorders, excluding more controls

988

3541

1.71

49.72

1.1

1.50

1.49

g/l

0.31

887

3230

Anxiety disorders, excluding more controls

881

3351

1.76

49.60

1.1

1.49

1.48

g/l

0.34

792

3055

Sleep apnoea

965

3889

1.70

48.18

1.1

1.47

1.51

g/l

2.98

867

3523

Chronic kidney disease

283

1101

2.59

47.81

1.1

1.66

1.52

g/l

4.61

263

983

Diseases of the skin and subcutaneous tissue

1089

3302

1.66

47.56

1.1

1.51

1.48

g/l

1.36

991

2984

6-mercaptopurine

111

7.03

47.53

1.1

1.0

1.51

1.43

g/l

0.96

Sleep apnoea, including avohilmo

1008

3947

1.67

47.07

1.1

1.46

1.51

g/l

4.00

910

3568

COPD/asthma/ILD related infections

1084

3288

1.66

47.01

1.1

1.53

1.48

g/l

2.54

989

2966

COPD/asthma related infections

1084

3288

1.66

47.01

1.1

1.53

1.48

g/l

2.54

989

2966

General examination and investigation of persons without complaint and reported diagnosis

664

1857

1.92

47.01

1.1

1.51

g/l

0.02

602

1696

Other disorders of skin and subcutaneous tissue

670

3360

1.84

46.96

1.1

1.57

1.51

g/l

3.01

603

3028

Alcohol use disorder, ICD-based

474

2334

2.05

46.36

1.1

1.63

1.51

g/l

7.10

402

2128

Later onset COPD, excluding more controls

191

464

3.26

45.91

1.0

1.1

1.61

1.55

g/l

0.80

168

405

Benign neoplasms

826

2666

1.76

45.82

1.1

1.49

1.47

g/l

0.94

760

2417

Gastric ulcer

189

612

3.14

45.54

1.1

1.62

1.53

g/l

1.89

168

543

Benign neoplasm of other and ill-defined parts of digestive system

217

769

2.88

44.68

1.1

1.53

1.52

g/l

0.15

196

688

Malaise and fatigue

470

1941

2.04

43.62

1.1

1.58

1.49

g/l

3.87

431

1728

Antihypertensive medication - note that there are other indications

663

1960

1.86

43.53

1.1

1.48

1.44

g/l

1.95

610

1781

Undetermined asthma, excluding more controls

153

448

3.48

43.44

1.1

1.39

1.53

g/l

4.52

142

395

Insulin, fast-acting

391

1837

2.15

43.30

1.1

1.59

1.50

g/l

4.32

358

1662

Depression or dysthymia

750

2368

1.78

43.13

1.1

1.49

1.50

g/l

0.41

674

2156

Oedema, not elsewhere classified

312

1332

2.36

43.06

1.1

1.57

1.50

g/l

1.97

281

1191

Complications of surgical and medical care, not elsewhere classified

961

4231

1.64

42.82

1.1

1.54

1.50

g/l

2.61

863

3836

1127

3751

1.60

42.33

1.1

1.51

1.50

g/l

0.22

1034

3386

Other ulcerative colitis

108

256

4.37

41.77

1.2

1.1

1.52

1.47

g/l

0.56

228

Undetermined asthma

153

460

3.38

41.69

1.1

1.39

1.54

g/l

5.18

142

407

Persons encountering health services for other counselling and medical advice, not elsewhere classified

1116

4038

1.58

41.45

1.1

1.50

1.49

g/l

0.17

1029

3640

Acute pancreatitis (for exclusion)

240

936

2.61

40.99

1.1

1.58

1.51

g/l

1.37

210

846

COPD-related respiratory insufficiency

142

413

3.51

40.90

1.1

1.60

1.55

g/l

0.56

126

373

Mood [affective] disorders

1044

4344

1.59

40.51

1.1

1.50

g/l

0.03

941

3940

Other soft tissue disorders, not elsewhere classified

923

3490

1.64

40.45

1.1

1.51

1.50

g/l

0.37

819

3180

Persons encountering health services for examination and investigation

670

1857

1.82

40.06

1.1

1.51

g/l

0.07

607

1696

ILD, hospital admissions 1, main diag only

162

519

3.19

39.96

1.1

1.57

1.55

g/l

0.16

144

462

Mood disorders

1043

4349

1.58

39.87

1.1

1.50

g/l

0.00

940

3945

Secondary uncertain malignant neoplasm, excluding all cancers (controls excluding all cancers)

396

1682

2.09

39.80

1.1

1.64

1.50

g/l

6.76

370

1499

Chronic pancreatitis

160

511

3.20

39.69

1.1

1.63

1.50

g/l

2.67

144

462

Iron deficiency anaemia secondary to blood loss (chronic)

182

628

2.95

39.37

1.1

1.66

1.51

g/l

4.34

165

566

Depression

978

4234

1.60

39.30

1.1

1.49

g/l

0.04

879

3841

Crohn's disease NAS

113

290

4.02

39.26

1.1

1.52

1.48

g/l

0.53

108

261

Complications of procedures, not elsewhere classified

777

4028

1.68

39.20

1.1

1.54

1.50

g/l

1.69

704

3653

Heart failure, strict

509

1922

1.92

39.05

1.1

1.67

1.52

g/l

10.50

473

1710

Hypothyroidism (congenital or acquired)

278

640

2.52

38.95

1.1

1.50

1.39

g/l

4.56

245

592

Other heart diseases, wide

957

3720

1.61

38.25

1.1

1.53

1.47

g/l

4.16

869

3369

Other noninfective gastroenteritis and colitis

268

1135

2.39

38.22

1.1

1.51

g/l

0.07

247

1014

Any mental disorder

1127

3635

1.56

38.20

1.1

1.52

1.49

g/l

1.77

1005

3316

Psychiatric diseases

1113

3583

1.56

38.07

1.1

1.52

1.49

g/l

1.85

991

3271

Diseases of pulp and periapical tissues

384

1885

2.06

38.01

1.1

1.57

1.50

g/l

2.16

331

1717

Hypothyroidism, levothyroxine purchases

274

637

2.50

37.75

1.1

1.50

1.39

g/l

4.49

242

589

Hypothyroidism and >3 levothyroxin purchases

274

637

2.50

37.75

1.1

1.50

1.39

g/l

4.49

242

589

COPD, hospital admissions 3, with asthma pneumonia sepsis

242

824

2.53

37.73

1.1

1.60

1.54

g/l

0.76

219

743

Insulin, fast-acting or short human

391

1940

2.04

37.50

1.1

1.59

1.50

g/l

4.05

358

1749

Neurotic, stress-related and somatoform disorders

914

4077

1.60

37.33

1.1

1.49

g/l

0.02

823

3701

All-cause Heart Failure

495

1884

1.91

37.26

1.1

1.67

1.52

g/l

10.30

460

1675

Other diseases of blood and blood-forming organs, wide

251

1047

2.44

37.20

1.1

1.61

1.51

g/l

2.70

229

939

Benign neoplasms

994

3521

1.58

36.88

1.1

1.50

g/l

0.07

909

3199

Anxiety disorders

918

4104

1.60

36.66

1.1

1.49

g/l

0.01

826

3727

Dermatitis and eczema

1063

4538

1.54

36.39

1.1

1.51

1.50

g/l

0.67

978

4099

Polyarthropathies

701

2748

1.71

36.38

1.1

1.55

1.51

g/l

1.80

638

2500

Sodium-glucose co-transporter 2 (SGLT2) inhibitors

275

1207

2.31

36.28

1.1

1.55

1.49

g/l

1.43

248

1096

Crohn disease (strict definition, require KELA)

113

308

3.79

36.10

1.1

1.49

1.47

g/l

0.24

107

276

Diverticular disease of intestine

667

2578

1.73

35.97

1.1

1.53

1.52

g/l

0.05

597

2339

Viral Sepsis

193

726

2.70

35.48

1.1

1.60

1.50

g/l

2.18

174

647

Pain (limb, back, neck, head abdominally)

757

2254

1.69

35.45

1.1

1.50

g/l

0.17

690

2048

Crohn's disease patients in KELA-register (KELA code 209, or 208 with ICD K50)

116

326

3.67

35.41

1.1

1.48

1.46

g/l

0.28

110

294

Constipation

830

3693

1.62

35.39

1.1

1.53

1.51

g/l

0.83

738

3352

Crohn disease (strict definition, require KELA, min 2 HDR)

111

303

3.78

35.39

1.1

1.49

1.47

g/l

0.19

105

272

Other medical care

374

1822

2.02

35.25

1.1

1.71

1.51

g/l

11.60

340

1636

Implicit viral Sepsis

192

723

2.69

35.22

1.1

1.60

1.50

g/l

2.18

173

645

Coagulation defects, purpura and other haemorrhagic conditions

218

877

2.53

34.98

1.2

1.1

1.54

1.51

g/l

0.36

209

784

Persons encountering health services for specific procedures and health care

1063

4319

1.53

34.85

1.1

1.56

1.48

g/l

7.12

958

3915

Colorectal adenocarcinoma, excluding all cancers (controls excluding all cancers)

184

686

2.72

34.41

1.1

1.61

1.54

g/l

1.40

174

602

Diseases of the respiratory system

614

1738

1.78

34.32

1.1

1.51

1.50

g/l

0.16

555

1562

Crohn's disease of small intestine

113

321

3.62

33.95

1.1

1.52

1.47

g/l

0.68

108

288

Pain in joint

576

2164

1.77

33.90

1.1

1.49

1.51

g/l

0.42

510

1963

Codeine or tramadol medication

1120

4124

1.51

33.73

1.1

1.53

1.49

g/l

2.79

1008

3735

Purpura and other haemorrhagic conditions

164

586

2.85

33.41

1.2

1.1

1.56

1.51

g/l

0.69

156

524

Disorders of mineral metabolism

109

306

3.65

33.28

1.2

1.1

1.58

1.49

g/l

1.31

101

273

Complications of medical and surgical care

677

3903

1.66

33.20

1.1

1.53

1.51

g/l

0.82

606

3531

Other acute lower respiratory infections

507

2716

1.79

33.14

1.1

1.51

1.50

g/l

0.16

459

2464

ILD, hospital admission 2, with pulmonary infections

112

321

3.57

33.09

1.1

1.59

1.53

g/l

0.61

289

Exposure to unspecified factor

930

4695

1.55

33.00

1.1

1.51

1.50

g/l

0.26

847

4252

Factors influencing health status and contact with health services

331

767

2.18

32.69

1.1

1.0

1.51

1.49

g/l

0.23

299

693

Hyperkalaemia

150

4.94

32.66

1.2

1.1

1.72

1.53

g/l

2.41

136

Persons encountering health services in other circumstances

381

1968

1.95

32.61

1.1

1.55

1.49

g/l

1.92

357

1777

Diarrhoea and gastroenteritis of presumed infectious origin

674

3728

1.65

32.52

1.1

1.53

1.49

g/l

1.88

630

3372

Other diseases of pancreas

104

288

3.71

32.44

1.1

1.56

1.50

g/l

0.72

254

Other viral hepatitis

111

322

3.56

32.36

1.1

1.70

1.44

g/l

6.43

100

295

Crohn's disease of large intestine

231

4.07

32.20

1.1

1.56

1.48

g/l

1.10

208

Thrombocytopenia, unspecified

103

287

3.69

31.87

1.2

1.1

1.58

1.51

g/l

0.63

261

Atrial fibrillation and flutter

324

1011

2.11

31.61

1.1

1.55

1.44

g/l

4.83

302

911

Other diseases of the respiratory system

194

776

2.53

31.52

1.1

1.57

1.54

g/l

0.48

177

694

Other respiratory disorders and diseases

194

776

2.53

31.52

1.1

1.57

1.54

g/l

0.48

177

694

Bronchitis

1007

4388

1.51

31.49

1.1

1.52

1.50

g/l

0.65

910

3977

Allergic asthma (mode), excluding more controls

234

1003

2.31

31.10

1.1

1.43

1.47

g/l

1.29

220

904

Cardiac arrhythmias

599

2331

1.71

31.03

1.1

1.51

1.45

g/l

2.87

545

2117

Intestinal infectious diseases

888

4520

1.54

30.84

1.1

1.54

1.49

g/l

3.39

826

4072

Malignant neoplasm, wide definition for exclusion

876

3340

1.56

30.80

1.1

1.55

1.48

g/l

5.17

820

3005

Malignant neoplasm, wide definition for exclusion, excluding all cancers (controls excluding all cancers)

876

3340

1.56

30.80

1.1

1.55

1.48

g/l

5.17

820

3005

Chronic periapical parodontitis

231

1012

2.31

30.70

1.2

1.1

1.57

1.50

g/l

1.75

202

924

Other symptoms and signs involving the digestive system and abdomen

166

624

2.70

30.63

1.1

1.51

1.49

g/l

0.17

142

565

Neurological diseases, wide definition

337

809

2.11

30.59

1.1

1.46

g/l

0.09

306

760

Follow-up examination after treatment for conditions other than malignant neoplasms

412

1428

1.90

30.32

1.1

1.50

g/l

0.06

376

1289

Viral hepatitis

119

376

3.25

30.27

1.1

1.68

1.45

g/l

5.69

108

341

Finngen Rheumatological endpoints

967

3643

1.52

30.23

1.1

1.51

1.49

g/l

1.08

868

3307

Malignant neoplasm, excluding all cancers (controls excluding all cancers)

873

3344

1.55

30.10

1.1

1.55

1.48

g/l

5.27

817

3009

Functional dyspepsia

254

1168

2.20

29.97

1.1

1.49

1.48

g/l

0.03

231

1049

Episodal and paroxysmal disorders

1092

3782

1.49

29.95

1.1

1.47

1.51

g/l

2.35

980

3420

Allergic asthma (mode)

234

1023

2.27

29.72

1.1

1.43

1.48

g/l

1.63

220

925

Irritable bowel syndrome

272

1291

2.13

29.60

1.1

1.44

1.49

g/l

1.53

242

1156

Other metabolic disorders

150

546

2.79

29.54

1.2

1.1

1.14

1.51

g/l

11.27

130

494

Dermatitis

558

3333

1.69

29.49

1.1

1.54

1.50

g/l

1.28

513

3002

Alcohol dependence

286

1396

2.07

28.95

1.1

1.65

1.50

g/l

7.03

242

1277

Soft tissue disorders

1017

3555

1.49

28.61

1.1

1.50

g/l

0.23

914

3238

Neurological diseases

892

2937

1.54

28.51

1.1

1.47

1.50

g/l

1.42

805

2662

Diseases of arteries, arterioles and capillaries (FINNGEN)

239

742

2.27

28.45

1.1

1.61

1.44

g/l

7.17

213

669

Recurrent or chronic depression

425

1692

1.83

28.23

1.1

1.49

1.48

g/l

0.28

380

1545

Acute upper respiratory infections

975

4124

1.49

28.06

1.1

1.49

1.51

g/l

0.64

896

3715

Gout

247

1046

2.17

27.96

1.1

1.63

1.55

g/l

1.53

226

935

Colorectal adenocarcinoma

184

762

2.45

27.83

1.1

1.61

1.55

g/l

0.96

174

677

Anxiety (asthma-related co-morbidities)

591

2841

1.65

27.83

1.1

1.48

1.47

g/l

0.39

530

2601

Acute bronchitis

373

1990

1.85

27.22

1.1

1.49

1.50

g/l

0.21

338

1793

Other diseases of intestine

131

466

2.86

26.99

1.1

1.54

1.52

g/l

0.25

121

415

Collagenous colitis

109

354

3.15

26.47

1.1

1.49

1.50

g/l

0.05

102

314

Gout, FINNGEN

247

1186

2.10

26.16

1.1

1.63

1.54

g/l

1.87

226

1063

Abnormalities of heart beat

292

1475

1.98

26.12

1.1

1.48

1.50

g/l

0.25

264

1327

Colorectal cancer

207

931

2.25

25.90

1.1

1.61

1.54

g/l

1.41

195

832

Atrial fibrillation and flutter with reimbursement

249

746

2.16

25.74

1.1

1.59

1.45

g/l

5.57

233

672

Chronic sinusitis

415

2376

1.76

25.68

1.1

1.43

1.52

g/l

4.55

373

2161

Selective serotonin reuptake inhibitors

950

3401

1.48

25.53

1.1

1.49

1.50

g/l

0.60

842

3097

Colon adenocarcinoma, excluding all cancers (controls excluding all cancers)

112

377

3.02

25.51

1.2

1.1

1.58

1.54

g/l

0.60

107

325

Surgical and other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

535

3279

1.64

25.28

1.1

1.54

1.51

g/l

0.68

483

2968

Polyneuropathies and other disorders of the peripheral nervous system

208

948

2.22

25.24

1.1

1.59

1.53

g/l

1.04

188

854

Disorders of lipoprotein metabolism and other lipidaemias

727

2972

1.55

25.10

1.1

1.54

1.51

g/l

0.68

664

2692

Certain disorders involving the immune mechanism

211

971

2.20

25.04

1.1

1.52

1.51

g/l

0.21

200

876

Direct fill therapy

158

644

2.49

24.85

1.3

1.1

1.58

1.50

g/l

1.33

147

577

Gout, strict definition

168

704

2.42

24.85

1.1

1.70

1.54

g/l

3.13

153

631

Erysipelas

464

2514

1.69

24.83

1.1

1.59

1.50

g/l

5.23

420

2262

Other and unspecified dermatitis

456

2708

1.70

24.78

1.1

1.53

1.50

g/l

0.79

421

2434

Systemic connective tissue disorders

310

1644

1.90

24.75

1.1

1.55

1.51

g/l

0.71

284

1481

Acute sinusitis

509

2895

1.65

24.66

1.1

1.47

1.49

g/l

0.60

474

2606

Other and unspecified polyneuropathies, also in other diseases

184

808

2.31

24.45

1.1

1.56

1.53

g/l

0.27

167

723

Hypokalaemia

119

426

2.84

24.28

1.1

1.66

1.52

g/l

2.31

101

382

Low back pain

681

3418

1.54

24.18

1.1

1.47

1.51

g/l

1.74

608

3110

Any operation in hilmo

6.91

24.14

1.0

1.1

1.43

1.41

g/l

0.09

Deposits [accretions] on teeth

100

314

3.15

24.10

1.3

1.1

1.53

1.48

g/l

0.56

284

Any event in cancer register

871

3513

1.48

24.07

1.1

1.55

1.49

g/l

3.85

811

3166

Colectomy operation

169

721

2.38

24.03

1.2

1.1

1.52

1.54

g/l

0.29

163

643

Other functional intestinal disorders

373

2007

1.78

24.03

1.1

1.51

1.50

g/l

0.26

334

1814

Non-invasive ventilation

186

772

2.28

24.00

1.1

1.58

1.45

g/l

3.87

164

716

All anxiety disorders

598

3059

1.58

23.94

1.1

1.48

1.47

g/l

0.17

536

2783

Colorectal cancer, excluding all cancers (controls excluding all cancers)

229

1067

2.10

23.94

1.1

1.60

1.53

g/l

2.13

217

937

Benzodiazepine use

913

4493

1.45

23.91

1.1

1.54

1.50

g/l

2.17

800

4094

Malignant neoplasm of colon, excluding all cancers (controls excluding all cancers)

161

674

2.42

23.83

1.2

1.1

1.59

1.54

g/l

0.76

153

594

Fall on same level

1097

4350

1.41

23.82

1.1

1.53

1.49

g/l

2.25

971

3972

Hypothyroidism, strict autoimmune

619

2612

1.58

23.61

1.1

1.48

1.49

g/l

0.20

554

2352

Respiratory insufficiency

230

3.53

23.53

1.0

1.1

1.61

1.54

g/l

0.77

201

Falls/tendency to fall

1076

3810

1.42

23.34

1.1

1.50

1.49

g/l

0.27

957

3485

Non-allergic asthma

112

397

2.88

23.33

1.1

1.42

1.52

g/l

1.78

103

355

Diaphragmatic hernia

314

1707

1.86

23.24

1.1

1.54

1.52

g/l

0.24

284

1545

Non-ischemic cardiomyopathy

247

1005

2.04

23.20

1.1

1.62

1.50

g/l

3.83

228

888

Streptococcal septicaemia

319

3.10

23.10

1.2

1.1

1.63

1.50

g/l

1.83

286

Chronic laryngitis and laryngotracheitis

152

630

2.45

23.09

1.1

1.50

1.54

g/l

0.69

130

565

Hypo-osmolality and hyponatraemia

148

605

2.47

22.94

1.1

1.65

1.54

g/l

1.82

127

534

Symptoms and signs involving the skin and subcutaneous tissue

607

3918

1.55

22.94

1.1

1.51

g/l

0.08

562

3529

Noninfectious colitis NAS

142

572

2.52

22.93

1.1

1.54

1.50

g/l

0.50

127

504

Malignant neoplasm

840

3398

1.47

22.93

1.1

1.56

1.48

g/l

4.86

778

3064

Headache

568

3018

1.58

22.84

1.1

1.45

1.47

g/l

0.65

511

2712

Substance use, excluding alcohol

212

1014

2.12

22.81

1.1

1.56

1.46

g/l

2.78

186

929

Other disorders of skin and subcutaneous tissue, not elsewhere classified

148

610

2.46

22.75

1.0

1.1

1.62

1.52

g/l

1.87

130

548

Benign neoplasm: Colon, unspecified

201

938

2.15

22.71

1.2

1.1

1.57

1.52

g/l

0.85

173

823

Parasetamol

802

2754

1.49

22.67

1.1

1.50

1.48

g/l

0.86

731

2497

Asthma and allergy, excluding more controls

134

521

2.57

22.61

1.1

1.41

1.47

g/l

1.25

129

468

Disorders of thyroid, IBD co-morbidities

170

528

2.37

22.60

1.1

1.50

1.48

g/l

0.24

156

490

Unspecified kidney failure

323

3.05

22.59

1.1

1.64

1.53

g/l

1.60

291

Acute upper respiratory infections of multiple and unspecified sites

685

3398

1.52

22.55

1.1

1.51

1.50

g/l

0.31

622

3067

Later onset COPD

198

719

2.18

22.11

1.0

1.1

1.60

1.58

g/l

0.24

175

637

Other diseases of stomach and duodenum

207

3.60

22.08

1.1

1.55

1.51

g/l

0.34

188

Explicit bacterial Sepsis

109

393

2.82

21.99

1.2

1.1

1.63

1.47

g/l

2.82

100

347

Gout, idiopatic and unspecified

209

1009

2.09

21.95

1.1

1.65

1.54

g/l

2.21

191

904

Diagnoses used for exclusion with ILD

233

1170

2.01

21.95

1.1

1.57

1.52

g/l

0.87

216

1048

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

492

3077

1.61

21.81

1.1

1.54

1.51

g/l

1.05

444

2777

Fungal Sepsis

133

4.35

21.77

1.1

1.51

1.49

g/l

0.08

120

Asthma and allergy

134

531

2.52

21.75

1.1

1.41

1.48

g/l

1.43

129

478

Other skin changes

162

710

2.31

21.70

1.1

1.51

1.53

g/l

0.39

148

631

Pain in limb

687

3315

1.51

21.69

1.1

1.52

1.50

g/l

0.49

612

3022

Pulmonary heart disease, diseases of pulmonary circulation

261

1371

1.92

21.52

1.1

1.55

1.53

g/l

0.26

246

1224

Valvular heart disease excluding rheumatic fever

400

1718

1.71

21.50

1.1

1.60

1.51

g/l

3.39

362

1547

Dorsalgia

928

3531

1.43

21.28

1.1

1.48

1.50

g/l

0.93

835

3214

ILD-related respiratory insufficiency

103

4.83

21.19

1.0

1.1

1.61

1.57

g/l

0.23

Cholecystitis

126

498

2.56

21.18

1.1

1.59

1.52

g/l

0.86

116

447

Symptoms and signs concerning food and fluid intake

106

384

2.80

21.16

1.1

1.56

1.49

g/l

0.80

336

Mycoses

250

1305

1.94

21.08

1.1

1.54

1.51

g/l

0.46

223

1168

Chronic rhinitis, nasopharyngitis and pharyngitis

307

1711

1.81

21.02

1.1

1.44

1.51

g/l

2.33

269

1554

Covid-19 confirmed case

263

1397

1.90

21.01

1.1

1.52

1.51

g/l

0.12

239

1266

Colon adenocarcinoma

112

420

2.71

20.98

1.2

1.1

1.58

1.56

g/l

0.26

107

369

Biological medication for rheuma

175

805

2.20

20.89

1.1

1.44

1.49

g/l

0.95

159

726

Other diseases of upper respiratory tract

1009

3761

1.40

20.84

1.1

1.47

1.52

g/l

3.54

906

3417

Other specific joint derangements/joint disorders

689

3104

1.50

20.79

1.1

1.48

1.49

g/l

0.24

612

2831

Smoking dependency

109

406

2.74

20.77

1.1

1.53

1.50

g/l

0.25

364

Other reaction to severe stress, and adjustment disorders

357

2085

1.73

20.77

1.1

1.51

1.48

g/l

0.85

329

1901

Gout, unspecified

176

815

2.19

20.64

1.1

1.65

1.54

g/l

2.06

159

726

Non-rheumatic valve diseases

394

1704

1.70

20.60

1.1

1.60

1.51

g/l

3.24

356

1534

Implicit fungal Sepsis

122

4.41

20.56

1.1

1.49

g/l

0.04

112

Other disorders of teeth and supporting structures

205

1008

2.06

20.53

1.2

1.1

1.59

1.51

g/l

2.16

188

908

Lower back pain or/and sciatica

916

4523

1.41

20.47

1.1

1.48

1.51

g/l

1.26

822

4101

Mental and behavioural disorders due to tobacco

109

410

2.72

20.39

1.1

1.53

1.50

g/l

0.31

367

Use of hypnotics and sedatives

979

4060

1.40

20.29

1.1

1.52

1.50

g/l

1.06

875

3689

Chronic viral hepatitis

260

3.20

20.23

1.1

1.71

1.43

g/l

5.73

234

Acute peritonitis

265

3.17

20.22

1.2

1.1

1.64

1.53

g/l

0.89

242

Obesity, other/unspecified

313

1778

1.78

20.12

1.1

1.49

g/l

0.00

279

1621

Fibromyalgia

346

2.85

20.03

1.1

1.47

1.49

g/l

0.21

317

Childhood asthma (age<16), excluding more controls

135

439

2.46

19.98

1.1

1.42

1.44

g/l

0.17

124

394

Nerve, nerve root and plexus disorders

940

4236

1.40

19.78

1.1

1.50

1.51

g/l

0.37

845

3836

Myalgia

219

1119

1.98

19.70

1.1

1.50

g/l

0.06

192

1008

ILD, hospital admissions 3, with pneumonia sepsis

274

3.08

19.70

1.1

1.66

1.54

g/l

1.32

250

Pleural effusion

135

571

2.39

19.66

1.1

1.66

1.52

g/l

2.59

122

509

Vocal cord dysfunction

119

439

2.54

19.52

1.1

1.48

1.46

g/l

0.23

109

404

Pure hypercholesterolaemia

603

2682

1.52

19.46

1.1

1.56

1.52

g/l

1.36

545

2425

Heart failure and bmi 25plus

299

1146

1.81

19.36

1.1

1.66

1.52

g/l

5.88

280

1015

Childhood asthma (age<16)

135

446

2.43

19.35

1.1

1.42

1.44

g/l

0.24

124

402

Chronic periodontitis

152

682

2.26

19.33

1.3

1.1

1.58

1.51

g/l

1.19

136

620

Diseases of peritoneum

108

416

2.64

19.24

1.2

1.1

1.61

1.52

g/l

0.89

378

Other external causes of accidental injury

802

2794

1.44

19.18

1.1

1.50

1.49

g/l

0.21

725

2550

Abnormal findings on diagnostic imaging of other body structures

121

495

2.48

19.00

1.1

1.54

1.52

g/l

0.25

114

443

Other dorsopathies, not elsewhere classified

938

3553

1.40

19.00

1.1

1.47

1.50

g/l

1.45

845

3234

Gingivitis and periodontal diseases

817

2953

1.43

19.00

1.1

1.50

1.49

g/l

0.20

726

2679

Pain, not elsewhere classified

238

1268

1.89

18.89

1.1

1.52

1.47

g/l

0.81

219

1133

Malignant neoplasm of colon

130

551

2.39

18.87

1.2

1.1

1.60

1.55

g/l

0.70

124

487

Other systemic involvement of connective tissue (FG)

224

1168

1.92

18.60

1.0

1.1

1.54

1.50

g/l

0.71

206

1054

Hernia

839

4064

1.41

18.43

1.1

1.51

1.50

g/l

0.35

752

3679

Abnormal weight loss

352

2.75

18.32

1.1

1.55

1.53

g/l

0.22

319

Diseases of pulp and periapical tissues, including avohilmo

974

3679

1.38

18.26

1.1

1.50

g/l

0.09

869

3353

Ischaemic heart disease, wide definition

667

2856

1.47

18.26

1.1

1.58

1.51

g/l

3.25

601

2570

Paralytic ileus and intestinal obstruction

205

1051

1.97

18.26

1.1

1.54

1.52

g/l

0.34

182

940

Other disorders of urethra and urinary system

571

2863

1.50

18.01

1.1

1.51

1.50

g/l

0.09

513

2583

Vascular disorders of the intestines

196

3.37

17.92

1.0

1.1

1.63

1.55

g/l

0.77

176

Actinic keratosis

252

1319

1.83

17.80

1.1

1.50

1.57

g/l

2.12

234

1164

Dental pulpitis 4

972

3686

1.37

17.79

1.1

1.50

g/l

0.08

869

3359

279

1492

1.77

17.76

1.1

1.51

1.56

g/l

1.41

257

1320

Diseases of oral cavity, salivary glands and jaws

821

2988

1.41

17.76

1.1

1.51

1.49

g/l

0.85

743

2713

Problems related to lifestyle

116

481

2.45

17.74

1.1

1.59

1.49

g/l

1.69

432

Intestinal stricture

252

1397

1.82

17.67

1.1

1.54

1.53

g/l

0.23

226

1256

Tumor necrosis factor alpha inhibitors

153

715

2.17

17.65

1.1

1.43

1.48

g/l

1.02

138

643

Dental pulpitis 1

971

3688

1.37

17.63

1.1

1.50

g/l

0.06

868

3361

Other systemic involvement of connective tissue

232

1255

1.86

17.61

1.1

1.53

1.51

g/l

0.36

213

1123

Bacterial intestinal infections, IBD co-morbidities

162

774

2.12

17.61

1.1

1.64

1.52

g/l

2.51

145

698

Elevated erythrocyte sedimentation rate and abnormality of plasma viscosity

255

3.03

17.57

1.1

1.70

1.55

g/l

1.53

226

Other bacterial intestinal infections

158

750

2.13

17.47

1.1

1.64

1.51

g/l

2.72

142

674

Hypothyroidism, drug reimbursement

128

387

2.38

17.34

1.1

1.46

1.39

g/l

1.07

118

354

Intracranial trauma

519

2565

1.52

17.32

1.1

1.49

1.50

g/l

0.22

465

2332

Diseases of the musculoskeletal system and connective tissue

540

1778

1.53

17.27

1.1

1.49

1.48

g/l

0.13

486

1641

Accidents

788

2794

1.42

17.20

1.1

1.51

1.49

g/l

0.55

714

2550

Other diseases of hard tissues of teeth

572

2885

1.49

17.13

1.1

1.48

1.49

g/l

0.12

518

2621

Hernia of abdominal wall

385

2416

1.60

17.04

1.1

1.50

1.53

g/l

0.73

346

2188

Duodenal ulcer

371

2.62

17.01

1.1

1.65

1.52

g/l

1.64

328

Congenital malformations, deformations and chromosomal abnormalities

536

3461

1.49

16.99

1.1

1.49

1.48

g/l

0.20

495

3133

Benign neoplasm: Colon, unspecified

201

1051

1.93

16.98

1.2

1.1

1.57

1.55

g/l

0.27

173

937

Adalimumab

109

449

2.47

16.97

1.1

1.44

1.48

g/l

0.42

403

Other anxiety disorders

411

2318

1.58

16.87

1.1

1.47

g/l

0.00

367

2112

Weight loss

385

2.59

16.84

1.1

1.55

1.53

g/l

0.20

347

Ischemic heart diseases

669

2917

1.44

16.77

1.1

1.57

1.51

g/l

2.99

604

2624

Missing teeth due to accident, extraction or parodontitis

117

501

2.37

16.69

1.2

1.1

1.56

1.51

g/l

0.64

108

450

Dorsopathies

952

3576

1.36

16.57

1.1

1.48

1.50

g/l

0.59

857

3254

Disorders of lens

584

2508

1.48

16.48

1.1

1.56

1.52

g/l

1.79

514

2289

Skin changes due to chronic exposure to nonionizing radiation

257

1381

1.77

16.47

1.1

1.50

1.57

g/l

2.16

238

1218

Injuries to the thorax

368

2308

1.60

16.33

1.1

1.58

1.51

g/l

2.11

331

2074

Benign neoplasm: Caecum

362

2.61

16.30

1.1

1.55

1.53

g/l

0.14

313

Combinations of oral blood glucose lowering drugs

230

1276

1.82

16.15

1.1

1.56

1.53

g/l

0.69

216

1148

Genitourinary diseases

607

2081

1.47

16.00

1.1

1.51

1.49

g/l

0.64

556

1886

Sulfonylureas

242

1078

1.80

15.99

1.1

1.67

1.55

g/l

3.96

220

956

Agranulocytosis

111

476

2.37

15.81

1.1

1.62

1.50

g/l

2.16

103

428

Other and unspecified disorders of skin and subcutaneous tissue

261

2.89

15.73

1.0

1.1

1.66

1.53

g/l

1.45

234

Dysphagia

176

905

1.96

15.64

1.1

1.50

g/l

0.02

159

817

Benign neoplasm: Stomach

353

2.59

15.55

1.1

1.56

1.52

g/l

0.58

303

Diseases of arteries, arterioles and capillaries

512

2580

1.49

15.54

1.1

1.61

1.53

g/l

4.14

461

2340

Infections of the skin and subcutaneous tissue

506

3426

1.48

15.49

1.1

1.54

1.49

g/l

2.06

459

3108

Osteoporosis

185

926

1.92

15.37

1.1

1.60

1.54

g/l

0.85

160

821

Other diseases of anus and rectum

227

1276

1.79

15.21

1.1

1.53

1.52

g/l

0.21

213

1148

Candidiasis

127

586

2.19

15.19

1.0

1.1

1.50

1.51

g/l

0.13

109

534

Pacemaker

217

1171

1.81

15.13

1.1

1.62

1.55

g/l

1.46

204

1037

Benign neoplasm: Rectum, anus and anal canal

157

786

2.02

15.11

1.1

1.55

1.52

g/l

0.37

140

684

Benign neoplasm: Rectum

144

699

2.08

15.10

1.1

1.54

1.53

g/l

0.12

128

609

Psoriasis vulgaris

182

963

1.91

14.93

1.1

1.60

1.51

g/l

1.98

172

868

Parodontitis or operation codes

775

4183

1.37

14.90

1.1

1.54

1.50

g/l

1.86

692

3795

Sarcoidosis

134

637

2.13

14.88

1.1

1.53

1.51

g/l

0.28

127

575

Parodontitis

774

4181

1.37

14.88

1.1

1.54

1.50

g/l

1.88

691

3793

Vitamin deficiency, wide

169

3.32

14.83

1.1

1.54

1.49

g/l

0.37

153

Vitamin deficiency

169

3.32

14.83

1.1

1.54

1.49

g/l

0.37

153

Other or unspecified ileus, impaction or obstruction

142

690

2.08

14.81

1.1

1.55

1.52

g/l

0.45

128

609

Spondylopathies

686

2982

1.40

14.73

1.1

1.53

1.52

g/l

0.26

615

2706

Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperum or nerve system disorders, excluding more controls

240

1386

1.74

14.72

1.1

1.55

1.47

g/l

2.28

213

1268

Other joint disorders

813

3178

1.37

14.62

1.1

1.47

1.49

g/l

0.68

726

2897

External causes of morbidity and mortality

628

2205

1.43

14.60

1.1

1.51

1.49

g/l

0.75

565

2007

Excessive, frequent and irregular menstruation

323

1096

1.65

14.51

1.1

1.47

1.50

g/l

0.43

285

977

Ulcerative rectosigmoiditis

390

2.45

14.47

1.1

1.50

1.47

g/l

0.19

352

Ulcer of lower limb, not elsewhere classified

117

533

2.22

14.46

1.1

1.65

1.53

g/l

2.47

103

474

Psoriasis

260

1545

1.70

14.42

1.1

1.59

1.50

g/l

3.16

243

1399

Suggestive for eosinophilic asthma

385

2.45

14.38

1.0

1.1

1.43

1.54

g/l

1.70

347

Coronary atherosclerosis

548

2446

1.45

14.35

1.1

1.59

1.52

g/l

3.51

499

2201

Chronic periodontitis, including avohilmo

768

4185

1.36

14.34

1.1

1.54

1.50

g/l

1.76

685

3797

Osteopathies and chondropathies

444

2836

1.49

14.23

1.1

1.56

1.51

g/l

1.62

392

2560

Polycystic ovarian syndrome, consortium definition

553

2314

1.45

14.14

1.1

1.49

1.48

g/l

0.22

496

2091

DVT of lower extremities and pulmonary embolism

310

1929

1.61

14.11

1.1

1.52

1.53

g/l

0.10

290

1736

Benign neoplasm: Caecum

389

2.43

14.07

1.1

1.55

1.54

g/l

0.05

345

Dipeptidyl peptidase 4 (DPP-4) inhibitors

100

432

2.34

14.05

1.2

1.1

1.59

1.53

g/l

0.64

384

Injuries to the head

942

4668

1.32

13.84

1.1

1.52

1.49

g/l

1.05

844

4239

Cystitis

685

3034

1.38

13.73

1.1

1.50

g/l

0.12

623

2736

Conduction disorders

213

1000

1.78

13.73

1.1

1.55

1.51

g/l

0.88

192

890

Other CVD (FINNGEN)

279

2.51

13.67

1.1

1.59

1.47

g/l

1.36

248

Syncope and collapse

327

1839

1.58

13.65

1.1

1.57

1.50

g/l

2.52

298

1640

Benign neoplasm: Small intestine

124

3.63

13.59

1.1

1.0

1.45

1.52

g/l

0.51

109

Enlarged lymph nodes

139

695

2.02

13.49

1.1

1.52

1.49

g/l

0.35

125

615

Myocarditis

174

3.16

13.47

1.1

1.61

1.39

g/l

2.42

156

Concussion

425

2481

1.49

13.37

1.1

1.47

1.50

g/l

0.80

385

2258

Papulosquamous disorders

335

2161

1.56

13.32

1.1

1.57

1.50

g/l

2.74

310

1947

Other symptoms and signs involving the circulatory and respiratory systems

229

2.84

13.28

1.1

1.56

1.47

g/l

0.82

204

Pruritus

100

443

2.29

13.28

1.1

1.48

1.52

g/l

0.39

401

Secondary malignant neoplasm of other and unspecified sites, excluding all cancers (controls excluding all cancers)

175

951

1.86

13.25

1.2

1.1

1.65

1.52

g/l

2.74

161

835

Cerebrovascular diseases (FINNGEN)

255

1092

1.68

13.04

1.1

1.52

1.44

g/l

2.40

230

988

Ulcerative proctitis

278

2.64

12.95

1.1

1.49

1.48

g/l

0.08

248

Calcific aortic valvular stenosis, operated

189

1035

1.80

12.95

1.1

1.63

1.56

g/l

1.33

169

921

Calcific aortic valvular stenosis

189

1035

1.80

12.95

1.1

1.63

1.56

g/l

1.33

169

921

Diseases of the eye and adnexa

802

2995

1.35

12.95

1.1

1.52

1.48

g/l

1.76

732

2746

Atopic dermatitis, strict definition with reimbursement

268

1605

1.63

12.77

1.1

1.50

1.47

g/l

0.43

251

1467

Other complications of surgical and medical care, not elsewhere classified

413

2.31

12.76

1.1

1.53

1.50

g/l

0.39

378

Arthropathies

833

3188

1.33

12.75

1.1

1.49

g/l

0.00

751

2907

Vasomotor and allergic rhinitis

327

2089

1.55

12.69

1.1

1.41

1.50

g/l

4.93

290

1900

Senile cataract

500

2163

1.44

12.56

1.1

1.57

1.52

g/l

1.74

438

1974

Codes for special purposes

370

2471

1.51

12.53

1.1

1.51

1.49

g/l

0.52

329

2245

Benign neoplasm: Stomach

392

2.33

12.48

1.1

1.56

1.53

g/l

0.35

352

Calcific aortic valvular stenosis, diagnosis (helper)

187

1033

1.78

12.46

1.1

1.62

1.56

g/l

1.17

167

919

Operations 2 for CAVS

187

1033

1.78

12.46

1.1

1.62

1.56

g/l

1.17

167

919

Provisional assignment of new diseases of uncertain etiology

369

2467

1.50

12.43

1.1

1.51

1.49

g/l

0.48

328

2242

Presence of cardiac and vascular implants and grafts

316

1533

1.57

12.39

1.1

1.61

1.54

g/l

2.43

287

1369

Disorders of the thyroid gland

785

3868

1.33

12.38

1.1

1.49

1.51

g/l

0.97

709

3500

Dental pulpitis 4, only avohilmo

954

3837

1.30

12.36

1.1

1.49

1.50

g/l

0.24

861

3484

Intestinal malabsorption

189

2.97

12.36

1.1

1.58

1.48

g/l

1.10

171

Fissure and fistula of anal and rectal regions

205

1193

1.73

12.35

1.1

1.48

1.50

g/l

0.30

182

1075

Acute tubulo-interstitial nephritis

452

2783

1.45

12.34

1.1

1.59

1.49

g/l

4.28

411

2498

Calcific aortic valvular stenosis, including rheumatic fever

187

1036

1.78

12.31

1.1

1.62

1.56

g/l

1.19

167

922

Symptoms and signs involving the urinary system

604

3401

1.38

12.27

1.1

1.53

1.52

g/l

0.15

542

3080

Sicca syndrome [Sjögren]

340

2.42

12.22

1.0

1.1

1.48

1.50

g/l

0.25

301

Menorrhagia

288

988

1.62

12.21

1.1

1.50

g/l

0.08

255

875

Venous thromboembolism

401

2656

1.47

12.17

1.1

1.53

g/l

0.01

374

2388

Viral pneumonia

111

532

2.11

12.15

1.2

1.1

1.50

g/l

0.01

104

480

Parodontitis and operation codes

716

4170

1.34

12.14

1.1

1.54

1.51

g/l

1.32

642

3780

Coxibs

233

727

1.71

12.11

1.1

1.51

1.53

g/l

0.30

207

667

Other pleural conditions

373

2.33

12.04

1.1

1.70

1.52

g/l

1.91

332

Dental caries 1 and operation codes

745

2853

1.34

12.03

1.1

1.51

g/l

0.09

667

2573

Hypothyroidism, other/unspecified

730

3613

1.34

12.00

1.1

1.48

1.51

g/l

1.60

656

3265

Dental pulpitis 1, only avohilmo

953

3853

1.30

11.91

1.1

1.49

1.50

g/l

0.31

859

3499

Diseases of vocal cords and larynx+other diseases of upper respiratory tract, no elsewhere classified

436

2973

1.44

11.90

1.0

1.1

1.46

1.53

g/l

2.43

384

2710

Pulmonary embolism

211

1252

1.70

11.84

1.1

1.53

g/l

0.02

199

1118

Enterocolitis due to Clostridium difficile

382

2.30

11.84

1.1

1.66

1.54

g/l

1.45

344

Disorders of porphyrin and bilirubin metabolism

5.75

11.76

1.0

1.45

1.42

g/l

0.12

Dental caries 3 and operation codes

778

3010

1.33

11.76

1.1

1.51

1.50

g/l

0.23

699

2721

Benign neoplasm: Rectum

144

767

1.90

11.70

1.1

1.54

g/l

0.01

128

683

Other embolism and thrombosis

108

520

2.10

11.70

1.1

1.57

1.53

g/l

0.35

101

463

Volume depletion

298

2.48

11.69

1.0

1.1

1.82

1.51

g/l

4.93

264

Benign neoplasm: Sigmoid colon

136

712

1.93

11.64

1.1

1.55

1.52

g/l

0.33

124

617

Statin medication

666

2764

1.36

11.63

1.1

1.50

1.49

g/l

0.21

610

2493

Benign neoplasm: Rectum, anus and anal canal

157

861

1.84

11.63

1.1

1.55

g/l

0.05

140

767

Other arthritis (FG)

259

1629

1.60

11.57

1.1

1.53

1.50

g/l

0.54

240

1469

Bacterial pneumonia (organism specified)

324

1945

1.52

11.57

1.1

1.57

1.52

g/l

1.33

304

1745

Bacterial pneumoniae

304

1749

1.55

11.54

1.1

1.56

1.50

g/l

1.65

286

1569

Infections with a predominantly sexual mode of transmission

267

1691

1.59

11.54

1.1

1.47

g/l

0.05

236

1547

Coeliac disease

110

538

2.07

11.44

1.1

1.48

1.49

g/l

0.14

485

Adenocarcinoma and papilloma adenocarcinoma of rectum, excluding all cancers (controls excluding all cancers)

332

2.38

11.41

1.1

1.65

1.54

g/l

1.15

286

Other diseases of urinary system

843

3642

1.31

11.41

1.1

1.51

g/l

0.12

764

3301

Unspecified acute lower respiratory infection

133

697

1.93

11.37

1.1

1.58

1.52

g/l

0.95

120

630

Pulmonary heart disease

211

1267

1.68

11.34

1.1

1.53

g/l

0.01

199

1130

Psoriatic and enteropathic arthropathies

117

588

2.01

11.31

1.1

1.56

1.48

g/l

1.22

106

527

Seborrhoeic keratosis

167

943

1.79

11.24

1.1

1.51

1.53

g/l

0.34

157

837

Umbilical hernia

224

1374

1.64

11.12

1.1

1.52

g/l

0.02

200

1252

Spondyloarthritis

151

830

1.83

11.11

1.1

1.52

1.50

g/l

0.26

134

744

Special screening examination for infectious and parasitic diseases

214

958

1.68

11.10

1.1

1.42

1.45

g/l

0.52

186

881

Hyperlipidaemia, other/unspecified

273

1661

1.56

11.02

1.1

1.53

1.54

g/l

0.07

250

1495

Exposure to other specified factors

621

4359

1.34

10.94

1.1

1.50

1.49

g/l

0.04

557

3968

Elevated blood glucose level

327

2.36

10.90

1.0

1.1

1.47

1.51

g/l

0.43

295

Adenocarcinoma, papilloma adenocarcinoma and mucinous carcinomas of rectum, excluding all cancers (controls excluding all cancers)

346

2.31

10.85

1.1

1.65

1.54

g/l

1.17

300

Other intervertebral disc disorders

701

3244

1.33

10.82

1.1

1.48

1.51

g/l

1.31

628

2946

Convulsions, not elsewhere classified

188

1096

1.70

10.79

1.1

1.58

1.48

g/l

3.02

168

989

Hypothyreosis and Thyroxine purchase for inclusion criteria

743

3746

1.31

10.78

1.1

1.47

1.51

g/l

1.90

668

3387

Alcohol-induced chronic pancreatitis

348

2.31

10.78

1.1

1.57

1.52

g/l

0.55

317

Anaemia in chronic diseases classified elsewhere

3.78

10.77

1.1

1.78

1.46

g/l

2.14

Paroxysmal tachycardia

173

840

1.75

10.69

1.1

1.60

1.44

g/l

4.35

158

756

Ventral hernia

183

1077

1.71

10.67

1.1

1.47

1.53

g/l

1.47

166

970

Other blood glucose lowering drugs, excl. Insulins

122

635

1.94

10.66

1.1

1.58

1.54

g/l

0.63

117

559

Ethmoidectomy

121

629

1.94

10.64

1.1

1.44

1.52

g/l

1.25

108

569

Other abnormal uterine and vaginal bleeding

176

720

1.75

10.61

1.0

1.1

1.46

1.53

g/l

1.46

155

635

Personality disorders, excluding more controls

214

1315

1.64

10.57

1.1

1.52

1.47

g/l

1.23

183

1205

Other disorders of veins

292

1930

1.52

10.47

1.1

1.54

1.50

g/l

0.88

254

1739

327

2.33

10.46

1.1

1.74

1.58

g/l

2.14

295

Benign neoplasm: Ascending colon

469

2.09

10.45

1.1

1.50

1.54

g/l

0.42

412

Chronic periodontitis, complicated

437

2.13

10.41

1.2

1.1

1.61

1.54

g/l

0.81

394

Cutaneous abscess, furuncle and carbuncle

215

1329

1.63

10.39

1.1

1.55

1.49

g/l

1.19

194

1205

Other specified/unspecified arthritis

224

1402

1.61

10.28

1.1

1.53

1.50

g/l

0.34

207

1268

Unspecified urinary incontinence

311

2.34

10.25

1.1

1.51

1.53

g/l

0.16

274

Ovarian cyst

285

1070

1.55

10.17

1.1

1.46

1.50

g/l

0.81

260

953

All influenza

195

1183

1.66

10.15

1.1

1.51

1.50

g/l

0.16

179

1063

Xerosis cutis

4.95

10.10

1.0

1.2

1.55

1.53

g/l

0.08

Pollen allergy

168

975

1.72

9.94

1.1

1.41

1.46

g/l

1.01

143

894

Other and unspecified effects of external causes

232

1478

1.58

9.91

1.1

1.46

1.49

g/l

0.61

219

1341

Fracture of rib(s), sternum and thoracic spine

224

1416

1.59

9.89

1.1

1.61

1.52

g/l

2.22

205

1266

Idiopathic pulmonary fibrosis

249

2.48

9.86

1.1

1.59

1.58

g/l

0.03

227

Diseases of salivary glands

157

908

1.74

9.80

1.1

1.50

g/l

0.03

144

817

Type 1 diabetes

202

1247

1.63

9.78

1.1

1.53

1.47

g/l

1.23

182

1126

AV-block

112

528

1.94

9.72

1.1

1.61

1.53

g/l

1.24

102

470

Open wound of head

407

2866

1.40

9.71

1.1

1.56

1.50

g/l

2.23

364

2596

Atopic dermatitis

459

2849

1.38

9.68

1.1

1.50

1.47

g/l

1.05

419

2590

Hypothyroidism, strict autoimmune, 3 medication purchases required

665

3471

1.31

9.64

1.1

1.48

1.50

g/l

0.73

595

3139

Shoulder lesions

632

2934

1.32

9.63

1.1

1.51

1.52

g/l

0.09

570

2661

Propionic acid derivatives

247

784

1.59

9.63

1.1

1.49

1.52

g/l

0.56

220

720

Other arrhythmias

502

2833

1.36

9.60

1.1

1.52

1.49

g/l

0.79

452

2563

In situ neoplasms

234

1434

1.56

9.56

1.1

1.54

1.49

g/l

0.84

219

1268

Disorders of calcium metabolism

229

2.53

9.55

1.1

1.71

1.49

g/l

2.68

200

FESS (DNB20)

115

611

1.90

9.53

1.1

1.43

1.52

g/l

1.47

102

552

Other disorders of white blood cells

230

2.52

9.48

1.1

1.71

1.50

g/l

1.87

206

Intestinal adhesions without obstruction

297

2.32

9.47

1.1

1.61

1.50

g/l

1.30

264

Unspecific neurodegenerative disorder

1021

0.46

9.44

1.0

1.1

1.62

1.57

g/l

0.44

893

Generalized anxiety disorder

130

720

1.82

9.43

1.0

1.1

1.43

1.47

g/l

0.69

120

653

Injuries to the ankle and foot

575

3966

1.33

9.41

1.1

1.47

1.49

g/l

0.50

525

3604

Bacterial pneumonia, not elsewhere classified

277

1636

1.51

9.41

1.1

1.54

1.50

g/l

0.80

260

1464

Acetic acid derivatives and related substances

221

714

1.62

9.37

1.1

1.50

1.53

g/l

0.62

198

654

Injuries to the abdomen, lower back, lumbar spine and pelvis

286

1917

1.49

9.35

1.1

1.53

1.51

g/l

0.45

257

1724

Care involving dialysis

350

2.20

9.35

1.1

1.69

1.47

g/l

3.63

320

Pain and other conditions associated with female genital organs and menstrual cycle

154

860

1.73

9.33

1.1

1.43

1.50

g/l

1.50

144

772

Other female pelvic inflammatory diseases

127

703

1.82

9.24

1.1

1.49

1.50

g/l

0.08

116

635

Misadventures to patients during surgical and medical care

115

618

1.88

9.21

1.1

1.55

1.51

g/l

0.65

105

562

Phobic anxiety disorders

119

647

1.85

9.17

1.1

1.53

1.47

g/l

0.84

105

588

Rosacea

487

1.99

9.13

1.1

1.51

g/l

0.00

439

Drugs, medicaments and biological substances causing adverse effects in therapeutic use

373

2.14

9.13

1.2

1.1

1.51

1.50

g/l

0.13

342

Haemorrhoids and perianal venous thrombosis

198

1239

1.61

9.12

1.1

1.54

1.52

g/l

0.24

182

1109

Tobacco use

241

2.45

9.09

1.1

1.63

1.48

g/l

1.66

221

Other and unspecified rosacea

361

2.16

9.07

1.1

1.53

1.52

g/l

0.16

325

Atopic dermatitis, strict definition

252

1636

1.52

9.04

1.1

1.50

1.47

g/l

0.58

236

1495

Other and unspecified drugs and medicaments

355

2.17

9.03

1.2

1.1

1.50

1.52

g/l

0.22

321

Other viral diseases

251

1658

1.52

9.03

1.1

1.50

1.49

g/l

0.26

238

1515

Sulfasalazine

210

1337

1.58

9.03

1.1

1.50

1.49

g/l

0.07

188

1193

Benign neoplasm: Small intestine

160

2.81

9.03

1.1

1.45

1.55

g/l

0.87

143

Disorders of other endocrine glands

327

2248

1.44

8.93

1.1

1.51

1.49

g/l

0.22

301

2036

Rheumatism, unspecified

117

641

1.84

8.83

1.1

1.44

1.51

g/l

1.25

108

574

Glomerular diseases

146

854

1.72

8.81

1.1

1.60

1.51

g/l

1.79

134

773

Other/unspecified dorsalgia

289

1969

1.47

8.81

1.1

1.49

1.51

g/l

0.42

261

1788

Injuries to the knee and lower leg

982

4548

1.24

8.81

1.1

1.49

1.50

g/l

0.20

866

4140

Benign neoplasm: Sigmoid colon

136

780

1.76

8.80

1.1

1.55

1.54

g/l

0.06

124

697

Enteropathic arthropathies

104

3.26

8.70

1.1

1.55

1.43

g/l

0.94

Injury, poisoning and certain other consequences of external causes

482

1781

1.36

8.59

1.1

1.51

1.48

g/l

0.84

432

1616

Other headache syndromes

328

2312

1.42

8.59

1.1

1.44

1.51

g/l

2.66

303

2097

Paracetamol of NSAID medication

159

466

1.73

8.53

1.1

1.48

1.49

g/l

0.13

143

435

Bronchitis, not specified as acute or chronic

344

2.14

8.49

1.1

1.53

1.52

g/l

0.10

314

Angina pectoris

435

2157

1.37

8.44

1.1

1.56

1.53

g/l

1.15

396

1942

Chronic diseases of tonsils and adenoids

672

3320

1.28

8.38

1.1

1.44

1.51

g/l

4.15

611

3031

Other CVD

122

688

1.78

8.37

1.1

1.56

g/l

0.04

105

613

Other epidermal thickening

179

2.62

8.29

1.0

1.1

1.57

1.54

g/l

0.11

161

Dental operations

530

2048

1.33

8.29

1.1

1.52

1.51

g/l

0.21

473

1845

Inflammatory diseases of female pelvic organs

438

2442

1.36

8.25

1.1

1.47

1.48

g/l

0.40

398

2198

Urticaria and erythema

289

2008

1.45

8.22

1.1

1.50

1.49

g/l

0.16

267

1819

Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperium or nerve system disorders

240

1609

1.50

8.20

1.1

1.55

1.48

g/l

1.84

213

1467

Intrahepatic Cholestasis of Pregnancy (ICP)

285

2.24

8.14

1.0

1.1

1.41

1.45

g/l

0.36

261

Familial hypercholesterolemia

109

600

1.83

8.13

1.1

1.59

1.53

g/l

0.64

534

Sciatica+with lumbago

400

2791

1.37

8.13

1.1

1.49

1.51

g/l

0.44

364

2532

Other retinal disorders

442

2641

1.35

8.12

1.1

1.54

1.53

g/l

0.26

393

2374

Symptoms and signs involving speech and voice

241

1623

1.49

8.07

1.1

1.51

g/l

0.04

219

1469

109

602

1.83

8.06

1.1

1.59

1.49

g/l

1.42

100

532

Voice disturbances

199

1289

1.55

8.01

1.1

1.49

1.52

g/l

0.55

183

1165

Glomerular disorders in diseases classified elsewhere

532

1.88

8.00

1.1

1.61

1.52

g/l

1.31

482

Colonic or urogenital fistula

217

1433

1.52

8.00

1.1

1.48

1.51

g/l

0.58

191

1305

Anti-inflammatory and antirheumatic products, non-steroids

238

785

1.53

7.96

1.1

1.52

g/l

0.01

211

721

Heartburn

380

2.04

7.96

1.1

1.37

1.47

g/l

1.96

345

Fenamates

120

452

1.80

7.95

1.1

1.45

1.55

g/l

2.44

112

413

Panic disorder

123

707

1.75

7.95

1.1

1.44

1.48

g/l

0.44

107

642

Disorder of lipoprotein metabolism, unspecified

520

1.88

7.89

1.1

1.57

1.54

g/l

0.30

466

Heart failure and coronary heart disease

196

937

1.57

7.87

1.1

1.76

1.55

g/l

7.52

181

822

Basal cell carcinoma, excluding all cancers (controls excluding all cancers)

315

1534

1.42

7.79

1.1

1.52

1.51

g/l

0.11

284

1364

Intrahepatic Cholestasis of Pregnancy (ICP) , excluding more controls

291

2.19

7.76

1.0

1.1

1.41

1.43

g/l

0.13

264

Melanocytic naevi

214

1419

1.52

7.74

1.1

1.42

1.48

g/l

1.84

200

1261

Basal cell carcinoma, including avohilmo, excluding all cancers (controls excluding all cancers)

320

1561

1.42

7.72

1.1

1.53

1.51

g/l

0.30

287

1391

Intrahepatic Cholestasis of Pregnancy (ICP) , incl. ICD-8

351

2.07

7.72

1.0

1.1

1.41

1.48

g/l

0.64

316

Localized swelling, mass and lump of skin and subcutaneous tissue

236

1598

1.48

7.71

1.1

1.54

1.51

g/l

0.44

225

1443

Other malignant neoplasms of skin (=non-melanoma skin cancer), excluding all cancers (controls excluding all cancers)

329

1608

1.41

7.70

1.1

1.52

1.51

g/l

0.14

299

1430

Acute alcohol intoxication

195

1272

1.54

7.63

1.1

1.61

1.49

g/l

3.27

171

1158

Superficial injury of thorax

120

694

1.74

7.62

1.1

1.54

1.50

g/l

0.42

105

620

Cardiomyopathy

127

746

1.71

7.61

1.1

1.70

1.50

g/l

5.81

122

667

Cerebral cysts

255

2.27

7.61

1.1

1.56

1.51

g/l

0.31

233

Disorders of lacrimal system

302

2148

1.41

7.59

1.0

1.1

1.48

1.51

g/l

0.63

268

1932

Presence of other functional implants

379

1966

1.37

7.58

1.1

1.57

1.53

g/l

1.31

340

1753

Disorders of synovium and tendon

411

2761

1.35

7.57

1.1

1.45

1.50

g/l

1.88

362

2503

Peripheral artery disease

275

1541

1.44

7.54

1.1

1.68

1.55

g/l

5.07

245

1374

Acute gastritis

269

2.22

7.51

1.1

1.61

1.50

g/l

1.16

242

L01XE Protein kinase inhibitors

244

2.29

7.50

1.1

1.60

1.53

g/l

0.73

222

Hypertensive Heart Disease

148

739

1.65

7.43

1.1

1.63

1.55

g/l

1.80

132

657

Adjustment and management of implanted device

115

662

1.75

7.42

1.1

1.63

1.52

g/l

1.81

109

593

Cellulitis

169

1075

1.58

7.41

1.1

1.59

1.50

g/l

2.30

156

972

Fracture of lumbar spine and pelvis

138

834

1.66

7.40

1.1

1.66

1.53

g/l

1.95

122

738

Other diseases of blood and blood-forming organs

304

2.13

7.38

1.1

1.52

1.51

g/l

0.06

270

Bipolar affective disorders

156

976

1.61

7.34

1.1

1.46

1.49

g/l

0.40

140

889

Intrahepatic Cholestasis of Pregnancy (ICP) , incl. ICD-8, excluding more controls

358

2.03

7.34

1.0

1.1

1.41

1.45

g/l

0.39

321

Urticaria

235

1608

1.47

7.31

1.1

1.50

1.49

g/l

0.20

215

1454

Disorders of choroid and retina

593

3389

1.28

7.31

1.1

1.55

1.52

g/l

0.70

535

3053

Type 1 diabetes, wide definition, subgroup 1

160

1007

1.60

7.30

1.1

1.54

1.47

g/l

1.55

146

905

Disorders of eyelid, lacrimal system and orbit

640

3983

1.26

7.29

1.1

1.49

1.51

g/l

0.80

571

3603

Congenital malformation of biliary tract

8.50

7.26

1.0

1.51

1.31

g/l

—

Any dementia

957

0.51

7.24

1.1

1.61

1.57

g/l

0.39

839

Poisoning by drugs, medicaments and biological substances

198

1313

1.52

7.21

1.1

1.56

1.48

g/l

1.80

170

1192

Dental caries, including avohilmo

630

2533

1.27

7.20

1.1

1.53

1.50

g/l

1.12

560

2298

Alcohol abuse, main dg, excluding more controls

123

729

1.70

7.17

1.1

1.64

1.50

g/l

2.67

108

663

Intracranial injury

420

3067

1.33

7.16

1.1

1.49

1.50

g/l

0.05

370

2788

Lung diseases due to external agents

537

1.82

7.16

1.1

1.59

1.54

g/l

0.53

481

Dental caries 3

670

2716

1.26

7.15

1.1

1.52

1.50

g/l

0.83

594

2472

Persons with potential health hazards related to socioeconomic and psychosocial circumstances

221

1484

1.48

7.15

1.1

1.47

1.48

g/l

0.24

198

1361

Acute alcohol intoxication, ICD10

166

1062

1.57

7.13

1.1

1.63

1.50

g/l

3.19

144

968

Dental caries 1

630

2536

1.27

7.12

1.1

1.53

1.50

g/l

1.07

560

2301

Somatoform disorder

131

791

1.67

7.12

1.1

1.45

1.50

g/l

0.75

116

716

Persons encountering health services for specific procedures, not carried out

342

2.04

7.11

1.1

1.54

1.47

g/l

0.70

313

Adverse effects, not elsewhere classified

153

961

1.60

7.10

1.1

1.45

1.49

g/l

0.61

147

860

Disorders of sclera, cornea, iris and ciliary body

416

3148

1.33

7.09

1.1

1.53

1.50

g/l

0.70

380

2846

Care involving use of rehabilitation procedures

487

3571

1.30

7.08

1.1

1.51

1.49

g/l

0.58

439

3232

Irregular menses

342

2030

1.37

7.07

1.1

1.48

1.47

g/l

0.33

313

1840

Erosion of teeth, including avohilmo

160

981

1.58

7.07

1.1

1.47

g/l

0.07

143

895

Alcohol withdrawal state with delirium

357

2.02

7.06

1.1

1.73

1.53

g/l

3.45

322

Degeneration of nervous system due to alcohol

102

3.02

7.03

1.1

1.63

1.57

g/l

0.39

Hypertensive heart and/or renal disease

165

812

1.58

7.02

1.1

1.63

1.54

g/l

1.93

149

723

Malignant neoplasm of skin, excluding all cancers (controls excluding all cancers)

372

1880

1.36

6.98

1.1

1.49

1.50

g/l

0.36

340

1676

Disorders of skin appendages

373

2783

1.34

6.98

1.1

1.48

1.49

g/l

0.23

341

2522

Poisoning by medicine

180

1179

1.54

6.96

1.1

1.56

1.49

g/l

1.56

155

1074

Degeneration of the brain due to alcohol

103

2.99

6.92

1.1

1.63

1.55

g/l

0.48

Allergic rhinitis

254

1767

1.43

6.89

1.1

1.40

1.48

g/l

2.63

223

1617

Acute suppurative otitis media

214

1357

1.48

6.88

1.1

1.45

g/l

0.06

203

1235

N06DA Anticholinesterases

837

0.46

6.85

1.1

1.61

1.58

g/l

0.15

733

Use of anticholinesterases

837

0.46

6.85

1.1

1.61

1.58

g/l

0.15

733

Exclusions for E4_PCOS_BROAD

136

838

1.63

6.83

1.2

1.1

1.56

1.49

g/l

0.99

127

756

Infection due to other mycobacteria

4.35

6.79

1.1

1.46

1.48

g/l

0.09

Other problems related to primary support group, including family circumstances

547

1.78

6.77

1.1

1.48

1.45

g/l

0.38

499

Emotional disorders starting during childhood or adolecense, excluding more controls

146

2.58

6.74

1.2

1.1

1.45

1.42

g/l

0.26

128

Adenocarcinoma and papilloma adenocarcinoma of rectum

384

1.95

6.72

1.1

1.65

1.55

g/l

0.86

345

Non-selective monoamine reuptake inhibitors

278

1933

1.40

6.71

1.1

1.51

1.52

g/l

0.02

253

1755

Maternal care for other conditions predominantly related to pregnancy

156

986

1.57

6.67

1.1

1.41

1.48

g/l

1.23

143

903

Hyperkinetic disorders, excluding more controls

408

1.90

6.67

1.1

1.40

1.41

g/l

0.08

373

Diseases of the myoneural junction and muscle

528

1.80

6.66

1.1

1.56

1.53

g/l

0.29

471

Spondylopathies (FG)

119

715

1.68

6.63

1.1

1.50

1.47

g/l

0.37

107

646

Symptoms and signs involving cognition, perception, emotional state and behaviour

758

4336

1.23

6.63

1.1

1.51

g/l

0.07

659

3951

Excessive attrition of teeth

319

1254

1.39

6.61

1.1

1.48

1.47

g/l

0.21

291

1145

Dementia

1123

0.58

6.59

1.0

1.1

1.61

1.57

g/l

0.44

990

Laparoscopic right hemicolectomy

207

2.30

6.56

1.1

1.53

1.58

g/l

0.33

186

STROKE

429

2273

1.31

6.54

1.1

1.52

1.49

g/l

0.81

390

2043

Dementia, including avohilmo

106

1224

0.60

6.53

1.0

1.1

1.62

1.56

g/l

0.78

1079

Disorders of adult personality and behaviour

232

1621

1.44

6.53

1.1

1.51

1.48

g/l

0.58

198

1488

Hypotension

563

1.75

6.43

1.1

1.57

1.55

g/l

0.19

497

Faecal incontinence

254

2.14

6.41

1.1

1.55

1.53

g/l

0.16

225

In situ neoplasms

234

1643

1.43

6.41

1.1

1.54

1.52

g/l

0.18

219

1476

Other and unspecified nerve root and plexus disorders, also in other diseases

148

947

1.57

6.40

1.1

1.49

1.51

g/l

0.22

131

862

Transport accidents

351

2329

1.34

6.40

1.1

1.47

1.49

g/l

0.40

314

2133

Benign neoplasm: Ascending colon

558

1.75

6.36

1.1

1.50

1.55

g/l

0.60

502

Other diseases of lip and oral mucosa

118

716

1.66

6.35

1.1

1.57

1.51

g/l

0.87

109

640

Adenocarcinoma, papilloma adenocarcinoma and mucinous carcinomas of rectum

399

1.90

6.35

1.1

1.64

1.55

g/l

0.89

358

Malignant neoplasm of rectum, excluding all cancers (controls excluding all cancers)

456

1.83

6.34

1.2

1.1

1.62

1.53

g/l

1.14

401

Hard cardiovascular diseases

599

3073

1.25

6.29

1.1

1.58

1.51

g/l

3.44

541

2769

Haemangioma and lymphangioma, any site

365

1.94

6.29

1.2

1.1

1.38

1.46

g/l

0.95

318

Other enthesopathies

233

1641

1.43

6.29

1.1

1.45

1.51

g/l

1.60

213

1490

Dental pulpitis 2

559

2259

1.27

6.29

1.1

1.53

1.50

g/l

0.92

499

2052

Diseases of the ear and mastoid process

995

4222

1.19

6.26

1.1

1.49

1.50

g/l

0.41

895

3839

Other predominantly sexually transmitted diseases, not elsewhere classified

138

874

1.59

6.25

1.1

1.41

1.47

g/l

0.98

124

792

Occupational exposure to risk-factors

156

2.48

6.24

1.0

1.1

1.43

1.53

g/l

0.86

142

Migraine

363

2330

1.33

6.23

1.1

1.41

1.48

g/l

3.55

340

2116

DVT of lower extremities

123

759

1.63

6.20

1.1

1.52

1.53

g/l

0.07

114

676

Enthesopathies of lower limb, excluding foot

177

1188

1.50

6.16

1.1

1.49

1.51

g/l

0.26

161

1078

Endometriosis

247

1036

1.42

6.12

1.1

1.45

1.50

g/l

1.25

231

919

Crohn's disease (strict) with PSC

17.24

6.11

1.2

1.0

1.74

1.15

g/l

—

Suicide or other Intentional self-harm

199

1370

1.46

6.10

1.1

1.59

1.49

g/l

2.79

173

1245

Alcohol-induced acute pancreatitis

189

2.32

6.08

1.1

1.72

1.50

g/l

1.67

172

Persistent mood disorders

145

935

1.56

6.08

1.1

1.49

1.52

g/l

0.35

128

839

Fentanyl

321

1.98

6.05

1.1

1.74

1.51

g/l

2.50

281

Disorders of oesophagus in diseases classified elsewhere

3.40

6.04

1.1

1.55

1.50

g/l

0.18

Post-traumatic stress disorder

344

1.94

5.96

1.1

1.53

1.45

g/l

0.91

309

Viral infections characterized by skin and mucous membrane lesions

311

2317

1.35

5.96

1.1

1.50

g/l

0.00

290

2103

Extracorporeal dialysis

283

2.04

5.93

1.1

1.67

1.53

g/l

1.42

263

Unspecified fall

346

2602

1.32

5.91

1.1

1.51

1.50

g/l

0.17

306

2363

Cardiodefibrillation

235

1675

1.41

5.90

1.1

1.61

1.55

g/l

1.51

226

1488

Injuries to the wrist and hand

784

4715

1.21

5.89

1.1

1.50

g/l

0.06

700

4286

Internal derangement of knee

295

2181

1.35

5.88

1.1

1.49

1.50

g/l

0.15

254

1977

Thyroiditis, ILD-related definition

475

1.78

5.87

1.1

1.49

g/l

0.03

431

Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances

138

889

1.56

5.84

1.1

1.58

1.47

g/l

2.12

117

808

Other and unspecified myopathies

347

1.92

5.83

1.1

1.59

1.53

g/l

0.46

311

Other cataract

294

1680

1.36

5.82

1.1

1.54

1.52

g/l

0.41

265

1527

Vitamin B12 deficiency anaemia

375

1.88

5.82

1.1

1.53

g/l

0.04

333

Special screening examination for other diseases and disorders

326

1.95

5.81

1.1

1.45

1.51

g/l

0.71

294

Other disorders of lacrimal gland

240

1725

1.40

5.81

1.0

1.1

1.47

1.51

g/l

0.92

208

1556

Unspecified haematuria

279

1756

1.37

5.78

1.1

1.53

1.55

g/l

0.31

249

1571

Drug-induced osteoporosis with pathological fracture

4.00

5.75

1.1

1.66

1.50

g/l

0.88

Dental pulpitis 2, only avohilmo

566

2317

1.25

5.73

1.1

1.53

1.51

g/l

0.72

506

2102

Mixed and other personality disorders

399

1.85

5.73

1.1

1.50

1.46

g/l

0.39

366

Parodontitis or/and operation codes

532

2522

1.26

5.71

1.1

1.51

1.49

g/l

0.76

473

2294

Disturbances of skin sensation

207

1455

1.43

5.70

1.1

1.44

1.50

g/l

1.73

188

1315

Disorders of muscles

443

1.80

5.70

1.1

1.53

1.48

g/l

0.56

402

Lumbar disc prolapse

496

3136

1.26

5.67

1.1

1.46

1.51

g/l

2.17

447

2849

Primary_lymphoid and hematopoietic malignant neoplasms

148

975

1.52

5.65

1.1

1.62

1.52

g/l

1.66

139

854

Fracture of shoulder and upper arm

250

1817

1.38

5.64

1.1

1.62

1.50

g/l

3.95

222

1648

Osteomyelitis

276

2.02

5.58

1.1

1.60

1.52

g/l

0.65

251

Malignant neoplasm of rectum

389

1.84

5.54

1.1

1.64

1.55

g/l

1.13

348

Atherosclerosis, excluding cerebral and coronary sclerosis

241

1390

1.39

5.53

1.1

1.71

1.56

g/l

6.28

215

1237

Fall on same level involving ice and snow

412

3228

1.28

5.53

1.1

1.50

g/l

0.04

363

2920

Carpal tunnel syndrome

451

3222

1.27

5.50

1.1

1.48

1.51

g/l

0.83

396

2915

Seborrhoeic dermatitis

441

1.78

5.49

1.1

1.49

1.54

g/l

0.57

399

Aortic aneurysm

143

925

1.53

5.49

1.1

1.57

1.55

g/l

0.34

130

836

Supplementary factors related to causes of morbidity and mortality classified elsewhere

224

1610

1.40

5.45

1.1

1.55

1.50

g/l

1.14

201

1461

Injuries to the shoulder and upper arm

632

4352

1.22

5.43

1.1

1.56

1.50

g/l

2.35

562

3945

KRA_PSY_EATING, excluding more controls

271

2.00

5.41

1.1

1.50

1.46

g/l

0.29

251

Type 1 diabetes, wide definition

163

1108

1.48

5.36

1.1

1.54

1.47

g/l

1.28

149

999

Any dementia, excluding more controls

854

0.57

5.31

1.1

1.61

1.56

g/l

0.45

755

Congenital malformations of the circulatory system

116

712

1.59

5.30

1.1

1.48

g/l

0.08

108

645

Rotator cuff syndrome

458

2702

1.26

5.29

1.1

1.53

1.52

g/l

0.16

421

2452

Personality disorders

214

1535

1.40

5.29

1.1

1.52

1.48

g/l

0.72

183

1405

Lung cancer and mesothelioma

501

1.66

5.25

1.1

1.63

1.55

g/l

1.02

442

Melanocytic naevi

214

1537

1.40

5.25

1.1

1.42

1.50

g/l

3.03

200

1385

Fall on and from stairs and steps

177

1230

1.45

5.23

1.1

1.53

1.51

g/l

0.16

160

1104

Arthropathy in ulcerative colitis

3.43

5.21

1.2

1.0

1.55

1.42

g/l

0.66

Suppurative and unspecified otitis media

275

1822

1.34

5.17

1.1

1.47

g/l

0.08

261

1654

Barrett oesophagus

177

2.23

5.15

1.1

1.56

1.52

g/l

0.25

161

Viral and other specified intestinal infections

153

1014

1.48

5.10

1.1

1.52

1.43

g/l

1.77

144

915

Dental caries 3, only avohilmo

667

2816

1.21

5.08

1.1

1.51

1.50

g/l

0.23

588

2564

Fracture of foot, except ankle

183

1288

1.43

5.07

1.1

1.48

1.50

g/l

0.15

166

1166

Left ventricular outflow tract obstruction (LVOTO), broad definition

544

1.67

5.03

1.1

1.57

1.50

g/l

0.97

497

Spondylosis

383

2580

1.28

4.99

1.1

1.54

1.53

g/l

0.14

345

2348

Other and unspecified epidermal thickening

2.70

4.94

1.0

1.1

1.58

1.50

g/l

0.31

Other malignant neoplasms of skin (=non-melanoma skin cancer)

326

1981

1.30

4.92

1.1

1.52

1.55

g/l

0.72

292

1772

Basal cell carcinoma

333

2050

1.30

4.89

1.1

1.53

1.55

g/l

0.42

298

1832

All influenza (not pneumonia)

112

721

1.56

4.83

1.1

1.51

1.49

g/l

0.17

102

650

Sequelae of external causes of morbidity and mortality

167

1168

1.44

4.81

1.1

1.53

g/l

0.04

160

1040

Varicose veins of other sites

313

1.87

4.81

1.1

1.61

1.48

g/l

0.93

280

Other abnormal immunological findings in serum

3.21

4.79

1.1

1.0

1.47

1.50

g/l

0.17

Acquired haemolytic anaemia

2.83

4.74

1.1

1.69

1.55

g/l

1.01

Social phobias

387

1.77

4.74

1.0

1.1

1.52

1.43

g/l

0.89

354

Basal cell carcinoma, including avohilmo

341

2091

1.29

4.73

1.1

1.53

1.55

g/l

0.26

303

1872

Other peripheral vascular diseases

322

1.85

4.72

1.1

1.49

1.51

g/l

0.19

292

Superficial injury of head

154

1065

1.45

4.71

1.1

1.54

1.50

g/l

0.54

140

957

Persons with potential health hazards related to communicable diseases

292

2221

1.31

4.70

1.1

1.46

1.47

g/l

0.28

275

2027

Myocardial infarction

332

1850

1.29

4.66

1.1

1.67

1.53

g/l

6.03

298

1664

Other follicular disorders

331

1.83

4.65

1.0

1.1

1.55

1.48

g/l

0.85

300

Emotional disorders starting during childhood or adolescence

177

2.15

4.63

1.2

1.1

1.45

1.44

g/l

0.07

157

Other arthrosis

397

2256

1.26

4.63

1.1

1.49

1.52

g/l

0.71

344

2047

Other shoulder lesions

406

1.74

4.58

1.0

1.1

1.52

1.47

g/l

0.49

365

Benign neoplasm: Adrenal gland

269

1.91

4.55

1.0

1.1

1.55

1.49

g/l

0.60

230

Diseases of middle ear and mastoid

430

2837

1.24

4.53

1.1

1.47

1.48

g/l

0.13

397

2568

Multiple myeloma, Monoclonal gammopathy of undetermined significance (MGUS), excluding all cancers (controls excluding all cancers)

270

1.90

4.50

1.1

1.58

1.52

g/l

0.25

228

Thyrotoxicosis, other and/or unspecified

136

928

1.47

4.49

1.1

1.50

g/l

0.06

124

834

Burns and corrosions

108

703

1.55

4.48

1.1

1.58

1.49

g/l

1.01

636

Presence of other devices

120

798

1.51

4.47

1.1

1.50

1.53

g/l

0.37

114

719

Other specified/unspecified bacterial intestinal infections

271

1.90

4.46

1.2

1.1

1.58

1.53

g/l

0.28

249

Soft tissue disorders related to use, overuse and pressure

184

1329

1.39

4.44

1.1

1.48

1.51

g/l

0.67

166

1195

Corns and callosities

272

1.89

4.41

1.0

1.1

1.57

1.49

g/l

0.53

241

Oter anti-inflammatory and antirheumatic agents, non-steroids

144

543

1.48

4.40

1.1

1.54

1.57

g/l

0.45

127

501

Personal history of other diseases and conditions

485

1.65

4.38

1.1

1.53

1.46

g/l

0.75

440

Medical abortion

432

1888

1.25

4.36

1.1

1.53

1.48

g/l

1.95

386

1694

Nonorganic sleeping disorders, excluding more controls

129

877

1.48

4.35

1.1

1.56

1.47

g/l

1.46

114

806

Ankylosing spondylitis

451

1.68

4.33

1.1

1.52

1.48

g/l

0.40

404

Other melanin hyperpigmentation

2.83

4.31

1.1

1.51

1.53

g/l

0.11

Hypertrophic disorders of skin

232

1.96

4.31

1.2

1.1

1.65

1.47

g/l

1.47

210

Chronic tubulo-interstitial nephritis

132

2.30

4.30

1.0

1.1

1.66

1.48

g/l

1.18

118

Alcohol abuse, main dg

123

831

1.49

4.30

1.1

1.64

1.51

g/l

2.43

108

757

Fracture of lower leg, including ankle

401

3222

1.24

4.30

1.1

1.52

1.50

g/l

0.25

367

2924

Other coagulation defects

289

1.85

4.29

1.2

1.1

1.49

1.50

g/l

0.06

263

Dental pulpitis 3

410

1.61

4.26

1.0

1.1

1.44

1.41

g/l

0.43

375

Other diseases of oesophagus

326

1.79

4.25

1.1

1.55

1.50

g/l

0.32

289

Superficial injury of abdomen, lower back and pelvis

103

672

1.54

4.24

1.1

1.41

1.48

g/l

1.48

602

Haemangioma and lymphangioma, any site

416

1.70

4.23

1.2

1.1

1.38

1.50

g/l

1.66

376

Malignant neoplasm of pancreas, excluding all cancers (controls excluding all cancers)

269

1.87

4.22

1.1

1.82

1.53

g/l

2.42

230

Benign neoplasm of other and unspecified endocrine glands

517

1.62

4.18

1.1

1.51

1.50

g/l

0.07

454

Benign neoplasm of eye and adnexa

365

1.74

4.17

1.1

1.45

1.50

g/l

0.55

318

Herpesviral [herpes simplex] infections

533

1.61

4.17

1.0

1.1

1.51

1.50

g/l

0.06

482

Other extrapyramidal and movement disorders in other diseases

144

1009

1.43

4.17

1.1

1.47

1.53

g/l

1.37

129

909

Tubulo-interstitial nephritis, not specified as acute or chronic

249

1.90

4.16

1.1

1.63

1.51

g/l

0.80

226

Keratitis

252

1932

1.31

4.13

1.1

1.52

1.50

g/l

0.38

227

1746

Dental caries 2 and operation codes

592

3949

1.19

4.13

1.1

1.44

1.49

g/l

2.09

527

3590

Monoclonal gammopathy of undetermined significance (MGUS), excluding all cancers (controls excluding all cancers)

148

2.18

4.10

1.1

1.0

1.51

1.58

g/l

0.28

125

Other inflammation of eyelid

575

1.57

4.09

1.1

1.54

1.52

g/l

0.17

521

Disturbance of activity and attention

475

1.63

4.09

1.1

1.39

1.41

g/l

0.39

432

Spontaneous rupture of synovium and tendon

323

1.78

4.08

1.1

1.55

1.50

g/l

0.52

287

Use of memantine

601

0.51

4.07

1.0

1.1

1.65

1.61

g/l

0.31

521

Use of other anti-dementia drugs

601

0.51

4.07

1.0

1.1

1.65

1.61

g/l

0.31

521

Burns and corrosions of external body surface, specified by site

545

1.59

4.05

1.1

1.60

1.49

g/l

1.24

490

Diabetic retinopathy, excluding more controls

220

924

1.35

4.04

1.1

1.57

1.52

g/l

1.02

198

828

Sequelae with surgical and medical care as external cause

130

900

1.45

4.03

1.1

1.57

1.53

g/l

0.51

125

807

Behavioural and emotional disorders with onset usually occurring in childhood and adolescence

143

915

1.43

4.03

1.1

1.44

1.42

g/l

0.19

128

838

Olecranon bursitis

281

1.83

4.02

1.1

1.58

1.48

g/l

0.90

251

Symptoms and signs involving the nervous and musculoskeletal systems

393

3188

1.24

4.02

1.1

1.51

g/l

0.00

369

2872

Disorders of parathyroid gland

120

808

1.47

4.01

1.0

1.1

1.52

1.54

g/l

0.29

104

708

Adhesive capsulitis of shoulder

117

796

1.48

3.98

1.1

1.48

1.51

g/l

0.43

112

716

Thyrotoxicosis

169

1229

1.38

3.97

1.1

1.49

1.51

g/l

0.16

155

1103

Infectious mononucleosis

401

1.68

3.97

1.0

1.1

1.48

1.45

g/l

0.23

364

Open wound of lower leg

101

667

1.52

3.97

1.1

1.55

1.51

g/l

0.40

603

Major coronary heart disease event excluding revascularizations

432

2436

1.23

3.96

1.1

1.63

1.53

g/l

4.60

388

2199

Mental and behavioural disorders due to sedatives or hypnotics

334

1.75

3.96

1.1

1.61

1.46

g/l

1.98

298

Degeneration of macula and posterior pole

257

1634

1.30

3.95

1.1

1.53

1.55

g/l

0.38

225

1455

Disorders of tooth development and eruption

226

1.91

3.95

1.1

1.45

1.42

g/l

0.28

204

Nasal polyp

139

979

1.43

3.94

1.1

1.49

1.53

g/l

0.59

123

889

Rheumatoid arthritis

222

1529

1.32

3.93

1.1

1.53

1.51

g/l

0.32

198

1379

Laparoscopic left hemicolectomy

2.94

3.93

1.2

1.1

1.58

1.55

g/l

0.17

Phlebitis and thrombophlebitis (not including DVT)

140

988

1.42

3.92

1.1

1.55

1.52

g/l

0.49

131

884

Malignant neoplasm of skin

376

2285

1.24

3.91

1.1

1.51

1.55

g/l

1.13

337

2042

Polyarthrosis

125

828

1.45

3.91

1.0

1.1

1.60

1.52

g/l

1.07

108

743

Dental operations, only avohilmo

532

2265

1.21

3.90

1.1

1.51

1.52

g/l

0.12

473

2043

Postmenopausal bleeding

180

718

1.38

3.89

1.1

1.46

1.52

g/l

1.50

163

638

Other and unspecified coagulation defects

192

2.00

3.89

1.2

1.1

1.48

g/l

0.01

174

Benign neoplasm of mouth and pharynx

434

1.65

3.89

1.0

1.1

1.50

1.51

g/l

0.08

380

Fibroblastic disorders

150

1074

1.40

3.87

1.1

1.54

1.52

g/l

0.34

137

965

Peripheral arterial reconstruction

607

1.54

3.86

1.1

1.75

1.56

g/l

4.00

543

Dental caries 2

601

3997

1.18

3.86

1.1

1.44

1.49

g/l

2.23

536

3636

Palmar fascial fibromatosis [Dupuytren]

624

1.53

3.84

1.0

1.1

1.58

1.52

g/l

0.72

554

Abnormalities of gait and mobility

498

1.60

3.83

1.1

1.53

g/l

0.01

442

Amputation

367

1.70

3.83

1.1

1.63

1.56

g/l

0.57

329

Magnesium deficiency

12.65

3.81

1.0

1.64

1.46

g/l

—

Childhood allergy (age < 16)

104

571

1.51

3.81

1.1

1.41

g/l

0.02

521

Need for other prophylactic measures

250

1.86

3.81

1.1

1.50

1.51

g/l

0.02

224

Dentofacial anomalies [including malocclusion]

194

1436

1.34

3.80

1.1

1.45

1.47

g/l

0.35

179

1298

Vitreous haemorrhage

437

1.64

3.80

1.0

1.1

1.58

1.52

g/l

0.56

390

Trigger finger

101

674

1.51

3.80

1.1

1.46

1.50

g/l

0.38

607

Thoracic aortic aneurysm

611

1.53

3.77

1.0

1.1

1.52

1.53

g/l

0.09

551

Type of accident

196

1472

1.34

3.76

1.1

1.54

1.51

g/l

0.67

175

1329

Abscess of anal and rectal regions

392

1.67

3.76

1.1

1.44

1.48

g/l

0.37

354

Other necrotizing vasculopathies

266

1.82

3.74

1.1

1.59

1.53

g/l

0.30

238

Other specified diseases with participation of lymphoreticular and reticulohistiocytic tissue

7.06

3.74

1.3

1.1

1.69

1.34

g/l

—

Other obstetric conditions, not elsewhere classified

207

1011

1.33

3.71

1.1

1.42

1.46

g/l

0.87

199

925

Dental caries 1, only avohilmo

614

2659

1.18

3.68

1.1

1.52

1.51

g/l

0.33

545

2417

Dislocation, sprain and strain of joints and ligaments at ankle and foot level

273

2148

1.27

3.66

1.0

1.1

1.47

1.48

g/l

0.20

250

1957

Other symptoms and signs involving cognitive functions and awareness

275

2033

1.27

3.66

1.1

1.56

1.53

g/l

0.71

236

1839

Carcinoma in situ of skin of upper limb, including shoulder

2.90

3.65

1.0

1.55

1.56

g/l

0.08

Primary_lymphoid and hematopoietic malignant neoplasms

148

1070

1.39

3.64

1.1

1.62

1.53

g/l

1.41

139

956

Emotional disorders and disorders of social functioning with onset specific to childhood

201

1.93

3.64

1.2

1.1

1.45

1.43

g/l

0.14

180

Migraine with aura

161

1181

1.37

3.62

1.1

1.36

1.49

g/l

4.76

153

1072

Superficial injury of wrist and hand

140

1005

1.40

3.60

1.1

1.51

1.49

g/l

0.34

125

919

Polyuria

137

980

1.40

3.59

1.1

1.52

1.53

g/l

0.06

124

880

Degenerative diseases of the nervous system

867

0.64

3.58

1.1

1.60

1.58

g/l

0.14

760

Hyperparathyroidism

101

675

1.48

3.57

1.0

1.1

1.51

1.54

g/l

0.49

588

Major coronary heart disease event

473

2630

1.20

3.57

1.1

1.63

1.52

g/l

5.35

428

2369

Unintentional cut, puncture, perforation or haemorrhage during surgical and medical care

330

1.71

3.56

1.1

1.55

1.52

g/l

0.25

300

Viral pneumonia (unknown virus, not influenza)

301

1.74

3.52

1.1

1.51

1.49

g/l

0.10

276

Dental pulpitis 3, only avohilmo

373

1.57

3.52

1.1

1.47

1.42

g/l

0.61

342

Speech therapy

178

1333

1.34

3.52

1.1

1.47

1.52

g/l

0.99

160

1203

Lichen simplex chronicus and prurigo

279

1.77

3.51

1.1

1.50

1.52

g/l

0.07

252

Infective dermatitis

541

1.54

3.51

1.0

1.1

1.58

1.53

g/l

0.51

487

Superficial injury of ankle and foot

589

1.52

3.51

1.1

1.45

1.48

g/l

0.25

533

Use of pramipexole

135

968

1.40

3.51

1.1

1.54

1.53

g/l

0.14

116

859

Spinal stenosis

327

2067

1.24

3.50

1.1

1.56

1.54

g/l

0.30

288

1867

Deviated nasal septum

241

1886

1.28

3.44

1.1

1.45

1.54

g/l

3.14

215

1724

Carcinoma in situ of skin of upper limb, including shoulder

2.80

3.44

1.0

1.1

1.55

1.59

g/l

0.29

Calculus of kidney and ureter

196

1495

1.32

3.42

1.1

1.46

1.53

g/l

1.80

181

1349

Anogenital herpesviral [herpes simplex] infection

252

1.80

3.42

1.0

1.1

1.56

1.46

g/l

0.69

233

Epilepsy

209

1605

1.30

3.40

1.1

1.53

1.51

g/l

0.32

190

1461

Superficial injury of hip and thigh

570

1.51

3.37

1.1

1.50

1.52

g/l

0.16

510

Myocardial infarction, strict

297

1737

1.25

3.35

1.1

1.66

1.54

g/l

4.68

266

1559

Ankylosing spondylitis, ICD10

468

1.57

3.35

1.1

1.52

1.48

g/l

0.41

425

TMD related operations

119

843

1.42

3.34

1.1

1.37

1.49

g/l

3.56

106

764

Other maternal disorders predominantly related to pregnancy

398

2065

1.21

3.33

1.1

1.45

1.48

g/l

0.81

363

1864

Other disorders of patella

134

970

1.39

3.32

1.0

1.1

1.45

1.49

g/l

0.58

116

889

Hyperkinetic disorders

526

1.53

3.30

1.1

1.39

1.42

g/l

0.43

480

Specific personality disorders

173

1304

1.33

3.30

1.1

1.53

1.48

g/l

0.70

146

1193

Other and unspecified haemorrhagic conditions

2.83

3.27

1.3

1.1

1.42

1.43

g/l

0.04

Other disorders of glucose regulation and pancreatic internal secretion

369

1.64

3.27

1.1

1.58

1.50

g/l

0.60

336

Other maternal diseases classifiable elsewhere but complicating pregnancy, childbirth and the puerperium

196

970

1.32

3.25

1.1

1.41

1.46

g/l

1.16

187

885

Degenerative macular diseases

432

1.58

3.24

1.1

1.53

1.54

g/l

0.15

379

Emotionally unstable personality disorder

592

1.49

3.24

1.1

1.50

1.46

g/l

0.38

539

Carcinoma in situ of skin of scalp and neck

2.70

3.24

1.0

1.53

1.59

g/l

0.24

Adenomyosis (Endometriosis of uterus)

536

1.52

3.23

1.1

1.45

1.52

g/l

0.73

478

Sub-endpoint used in defining T1D endpoints

200

1518

1.30

3.22

1.1

1.54

1.49

g/l

0.81

180

1373

Seropositive rheumatoid arthritis

161

1203

1.34

3.21

1.1

1.55

1.51

g/l

0.74

140

1087

Other/unspecified enthesopathies of lower limb, excluding foot

325

1.67

3.21

1.1

1.45

1.48

g/l

0.28

294

Other and unspecified local infections of skin and subcutaneous tissue

411

1.59

3.18

1.1

1.54

1.49

g/l

0.43

374

Malignant melanoma, excluding all cancers (controls excluding all cancers)

660

1.46

3.18

1.1

1.42

1.52

g/l

2.59

583

Retention of urine

197

1282

1.30

3.17

1.1

1.57

1.55

g/l

0.34

178

1152

Arthrosis

551

2582

1.18

3.17

1.1

1.52

1.51

g/l

0.35

483

2346

Personal history of allergy to drugs, medicaments and biological substances

3.02

3.16

1.0

1.26

1.43

g/l

0.91

Acute pharyngitis

110

772

1.42

3.14

1.1

1.40

1.49

g/l

1.93

105

701

Injuries to the elbow and forearm

493

3788

1.18

3.14

1.1

1.51

1.50

g/l

0.31

437

3424

Dizziness and giddiness

518

3587

1.17

3.13

1.1

1.49

1.52

g/l

0.74

455

3253

Inflammatory diseases of prostate (prostatitis)

671

1.45

3.13

1.1

1.47

1.53

g/l

0.95

613

Behavioural syndromes associated with physiological disturbances and physical factors

220

1726

1.28

3.12

1.1

1.53

1.48

g/l

0.98

197

1578

Aortic valve malfunction, age under 60 years

501

1.53

3.11

1.1

1.57

1.51

g/l

0.69

456

Stenosis and insufficiency of lacrimal passages

359

1.63

3.10

1.0

1.1

1.52

1.53

g/l

0.08

328

Polymyalgia rheumatica

438

1.56

3.08

1.0

1.1

1.63

1.56

g/l

0.55

385

Cerebral palsy and other paralytic syndromes

510

1.52

3.08

1.1

1.60

1.49

g/l

1.45

456

Diseases of external ear

219

1723

1.27

3.06

1.1

1.52

1.51

g/l

0.12

199

1553

Vaginitis/vulvovaginitis/vulvitis/abscess of vulva

101

707

1.43

3.05

1.1

1.46

1.48

g/l

0.24

641

Visual disturbances and blindness

335

2765

1.21

3.03

1.1

1.49

1.51

g/l

0.30

302

2507

Developmental endpoint to exclude non autoimmune-cases from E4_HYTHY_AI_STRICT

224

1770

1.27

3.03

1.1

1.49

1.51

g/l

0.19

211

1594

Urolithiasis

205

1603

1.28

3.02

1.1

1.45

1.53

g/l

2.00

188

1443

Cystic kidney disease

141

2.01

2.97

1.0

1.1

1.61

1.49

g/l

0.77

128

Delirium, not induced by alcohol and other psychoactive substances

387

1.58

2.94

1.1

1.55

g/l

0.01

342

Contact with heat and hot substances

265

1.71

2.93

1.1

1.57

1.49

g/l

0.57

241

Demyelinating diseases of the central nervous system

404

1.57

2.93

1.1

1.48

1.49

g/l

0.11

368

Diabetic neuropathy

652

1.44

2.93

1.1

1.59

1.53

g/l

0.84

599

Preparation and fitting of bite rail to mouth

672

1.44

2.93

1.1

1.37

1.49

g/l

2.67

609

Other and unspecified tonsillitis

251

1709

1.25

2.92

1.1

1.44

1.49

g/l

1.18

225

1553

Pre-eclampsia or eclampsia

144

1079

1.34

2.91

1.1

1.46

1.49

g/l

0.35

131

975

Nonsuppurative otitis media

152

990

1.33

2.89

1.1

1.47

g/l

0.08

140

895

Amyloidosis, other/unspecified

2.97

2.87

1.1

1.96

1.55

g/l

1.83

Restless leg syndrome

511

1.50

2.86

1.1

1.48

1.51

g/l

0.36

457

Nonorganic sleeping disorders

129

954

1.36

2.85

1.1

1.56

1.49

g/l

1.11

114

860

Other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

423

1.55

2.85

1.1

1.52

g/l

0.03

380

Toxic effects of substances chiefly nonmedicinal as to source

561

1.47

2.83

1.1

1.53

1.50

g/l

0.26

506

Procreative management

251

1706

1.24

2.83

1.1

1.45

1.48

g/l

0.40

228

1550

Striking against or struck by other objects

237

1904

1.25

2.80

1.1

1.48

g/l

0.06

217

1729

Disorders of vitreous body

307

2485

1.21

2.75

1.0

1.1

1.50

1.52

g/l

0.42

274

2224

Benign neoplasm of mouth and pharynx

475

1.50

2.75

1.0

1.1

1.50

1.51

g/l

0.13

429

Sleep disorders

147

1116

1.32

2.74

1.1

1.56

1.49

g/l

1.27

129

1014

Cervical disc disorders

246

1991

1.24

2.74

1.1

1.52

g/l

0.08

226

1813

Other and unspecified urticaria

129

961

1.35

2.74

1.1

1.51

1.50

g/l

0.17

116

866

Other noninflammatory disorders of vagina

278

1.66

2.73

1.1

1.57

1.54

g/l

0.26

244

Tonsillectomy and adenotomy

442

2622

1.18

2.73

1.1

1.42

1.47

g/l

2.13

406

2396

Methotrexate

574

1.45

2.72

1.1

1.56

1.51

g/l

0.63

506

Benign neoplasm of eye and adnexa

412

1.54

2.71

1.1

1.45

1.52

g/l

0.78

369

Suppurative and necrotic conditions of lower respiratory tract

241

1.72

2.71

1.1

1.68

1.54

g/l

1.10

221

Endometriosis of ovary

105

756

1.39

2.71

1.1

1.51

1.50

g/l

0.08

100

676

Subjective visual disturbances

154

1179

1.31

2.71

1.0

1.1

1.43

1.52

g/l

1.96

138

1048

Meniscus derangement

413

2396

1.18

2.70

1.1

1.51

g/l

0.02

377

2174

Benign neoplasm: Choroid

197

1.79

2.68

1.0

1.1

1.50

1.51

g/l

0.03

170

Cervicalgia

136

1025

1.33

2.68

1.1

1.43

1.52

g/l

2.12

125

932

Secondary uncertain malignant neoplasm

527

1.47

2.67

1.1

1.69

1.53

g/l

1.85

468

Car occupant injured in other and unspecified transport accidents

130

974

1.34

2.67

1.1

1.48

1.50

g/l

0.21

118

872

Other retinal artery occlusion

2.36

2.66

1.3

1.1

1.55

1.54

g/l

0.07

Other local infections of skin and subcutaneous tissue

448

1.50

2.62

1.1

1.54

1.49

g/l

0.39

406

Open wound of forearm

424

1.52

2.61

1.1

1.59

1.51

g/l

0.69

379

Rheumatoid arthritis, including avohilmo

243

1976

1.23

2.61

1.1

1.53

1.51

g/l

0.21

219

1786

Congenital absence, atresia and stenosis of large intestine

7.73

2.60

1.0

1.69

1.31

g/l

—

Superficial injury of lower leg

161

1248

1.29

2.60

1.1

1.50

1.51

g/l

0.19

143

1135

Lichen planus

548

1.45

2.57

1.1

1.52

1.53

g/l

0.01

487

Female infertility

200

977

1.27

2.57

1.1

1.41

1.48

g/l

2.08

183

873

Benign neoplasm: Adrenal gland

323

1.59

2.55

1.0

1.1

1.55

1.53

g/l

0.21

289

Eating disorder

346

1.57

2.55

1.1

1.50

1.45

g/l

0.42

318

Other localized connective tissue disorders

2.53

2.54

1.0

1.1

1.48

1.47

g/l

0.02

Benign neoplasm of other and unspecified endocrine glands

583

1.43

2.54

1.1

1.51

g/l

0.01

523

Undefined dementia

239

0.38

2.53

1.0

1.1

1.68

1.63

g/l

—

210

Unspecified dementia

234

0.38

2.52

1.0

1.1

1.68

1.63

g/l

—

205

Impingement syndrome of shoulder

170

1333

1.28

2.52

1.1

1.47

1.52

g/l

0.90

151

1205

Disorders of conjunctiva

593

4359

1.14

2.52

1.1

1.51

1.48

g/l

0.82

538

3949

Female infertility, associated with anovulation

293

1.61

2.50

1.1

1.38

1.46

g/l

0.77

260

Hyperhidrosis

2.12

2.49

1.1

1.38

1.45

g/l

0.30

Other benign neoplasms of skin

213

1684

1.24

2.49

1.0

1.1

1.47

1.49

g/l

0.46

184

1497

Disorders of vitreous body and globe

312

2548

1.20

2.49

1.1

1.50

1.53

g/l

0.51

278

2282

Hydronephrosis

437

1.49

2.49

1.2

1.1

1.56

1.50

g/l

0.70

387

Peripheral artery operations in Hilmo

454

1.48

2.46

1.1

1.59

1.56

g/l

0.28

406

Stomatitis and related lesions

350

1.55

2.45

1.1

1.51

1.47

g/l

0.28

312

Other noninflammatory disorders of vulva and perineum

342

1.56

2.45

1.1

1.49

1.53

g/l

0.40

296

Pneumonitis due to solids and liquids

295

1.60

2.45

1.1

1.68

1.55

g/l

1.32

270

Oxicams

142

614

1.32

2.44

1.0

1.1

1.45

1.56

g/l

3.00

128

562

Assault

101

740

1.37

2.43

1.1

1.59

1.45

g/l

2.63

678

MS-disease / Multiple Sclerosis

335

1.56

2.43

1.0

1.1

1.48

1.49

g/l

0.08

304

Pyothorax

174

1.80

2.43

1.1

1.69

1.54

g/l

0.97

160

Diseases of male genital organs

435

1886

1.17

2.41

1.1

1.48

1.51

g/l

1.03

390

1731

Migraine without aura

130

991

1.32

2.40

1.1

1.37

1.48

g/l

3.52

120

900

Benign neoplasm of bone and articular cartilage

344

1.55

2.40

1.1

1.44

1.48

g/l

0.41

298

Carcinoma in situ of skin of lower limb, including hip

2.78

2.38

1.1

1.0

1.43

1.56

g/l

0.65

Other disorders of eye and adnexa

641

1.39

2.38

1.1

1.56

1.49

g/l

1.10

575

Certain conditions originating in the perinatal period

347

1.51

2.38

1.1

1.47

1.42

g/l

0.51

318

Exclusions for E4_PCOS_CONSORTIUM

505

2754

1.15

2.38

1.1

1.49

1.48

g/l

0.21

457

2493

Allergic urticaria

353

1.54

2.37

1.1

1.57

1.47

g/l

1.05

317

Schizophrenia

915

0.69

2.35

1.1

1.56

1.49

g/l

0.81

834

Other bursopathies

567

1.42

2.35

1.0

1.1

1.51

1.49

g/l

0.16

508

Varicose veins

388

2510

1.17

2.33

1.1

1.55

1.50

g/l

1.68

351

2253

Unstable angina pectoris

212

1425

1.24

2.32

1.1

1.57

1.54

g/l

0.38

193

1261

Lesion of ulnar nerve

670

1.38

2.31

1.1

1.53

1.52

g/l

0.06

608

Traumatic subdural haemorrhage

445

1.46

2.31

1.1

1.56

1.55

g/l

0.02

395

Parodontitis, under 40 years

445

1.47

2.30

1.0

1.1

1.45

1.41

g/l

0.36

402

Chronic Coagulation defects

2.14

2.30

1.2

1.1

1.33

1.42

g/l

0.34

Congenital malformations and deformations of the musculoskeletal system

427

1.48

2.29

1.1

1.49

1.45

g/l

0.38

387

Carcinoma in situ of skin of scalp and neck

2.25

2.29

1.0

1.1

1.53

1.65

g/l

0.54

Other and unspecified noninflammatory disorders of ovary, fallopian tube and broad ligament

2.04

2.27

1.1

1.40

1.52

g/l

1.06

severe traumatic brain injury, does not include concussion

122

931

1.31

2.26

1.1

1.57

1.53

g/l

0.61

105

836

Other specified and unspecified personality disorders

464

1.45

2.25

1.1

1.55

1.47

g/l

0.82

418

Other sleep disorders

489

1.44

2.24

1.1

1.58

1.52

g/l

0.55

441

Diabetes mellitus in pregnancy

208

1093

1.24

2.23

1.1

1.42

1.47

g/l

0.96

195

1012

Insomnia

105

786

1.34

2.23

1.0

1.1

1.54

1.49

g/l

0.73

705

Postprocedural endocrine and metabolic disorders, not elsewhere classified

499

1.43

2.21

1.1

1.48

1.50

g/l

0.09

450

Parodontitis, under 40 years, or operation codes

450

1.45

2.19

1.0

1.1

1.45

1.41

g/l

0.37

407

Excessive vomiting in pregnancy

320

1.54

2.19

1.1

1.40

1.50

g/l

1.74

289

Visual disturbances

306

2594

1.18

2.18

1.1

1.48

1.51

g/l

0.54

277

2348

Haemorrhage in early pregnancy

173

1353

1.25

2.18

1.1

1.45

1.49

g/l

0.82

157

1222

Pre-eclampsia or poor fetal growth

188

1518

1.24

2.17

1.1

1.45

1.48

g/l

0.57

174

1379

Other keratitis

526

1.41

2.17

1.0

1.1

1.63

1.50

g/l

1.31

474

Pedestrian injured in collision with car, pick-up truck or van

2.04

2.17

1.0

1.1

1.45

g/l

0.02

Monoamine oxidase A inhibitors

526

1.41

2.17

1.1

1.52

1.54

g/l

0.17

472

Recurring oral aphthae, including avohilmo

603

1.38

2.14

1.0

1.1

1.49

1.51

g/l

0.18

541

Perineal laceration during delivery

621

0.66

2.14

1.0

1.1

1.51

1.46

g/l

0.36

572

Pre-eclampsia

129

1001

1.29

2.14

1.1

1.45

1.49

g/l

0.68

118

904

Acute nasopharyngitis (common cold)

702

1.35

2.13

1.1

1.51

g/l

0.00

634

Iridocyclitis

146

1152

1.27

2.12

1.0

1.1

1.56

1.51

g/l

0.78

137

1043

Zoster [herpes zoster]

741

1.34

2.12

1.1

1.55

g/l

0.01

660

Lack of expected normal physiological development

2.13

2.12

1.0

1.46

1.40

g/l

0.29

Combined immunodeficiencies

2.75

2.12

1.5

1.1

1.49

1.39

g/l

—

Benign neoplasm of ovary

690

1.35

2.11

1.1

1.54

1.47

g/l

0.83

615

Oral leukoplakia and related diseases, including avohilmo

388

1.48

2.11

1.0

1.1

1.61

1.52

g/l

0.64

345

Dysplasia of cervi uteri

147

895

1.27

2.11

1.1

1.45

1.49

g/l

0.64

135

800

Female infertility, cervigal, vaginal, other or unspecified origin

177

952

1.25

2.09

1.1

1.42

1.49

g/l

1.58

160

851

613

1.36

2.08

1.1

1.56

1.58

g/l

0.32

537

Infarction of spleen

5.10

2.08

1.0

1.4

1.53

1.52

g/l

—

Eustachian salpingitis and obstruction

398

1.47

2.07

1.2

1.1

1.40

1.45

g/l

0.51

366

Pain in thoracic spine

745

1.33

2.06

1.1

1.51

1.52

g/l

0.14

674

Myocardial infarction, without ST-elevation

208

1579

1.22

2.05

1.1

1.68

1.55

g/l

3.31

183

1407

Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)

516

1.40

2.03

1.1

1.65

1.51

g/l

1.80

450

Thyrotoxicosis with diffuse goitre

635

1.36

2.03

1.1

1.49

1.50

g/l

0.02

577

Otitis externa

137

1080

1.27

2.02

1.1

1.50

1.51

g/l

0.05

124

975

Diseases of appendix

549

4447

1.13

2.02

1.1

1.45

1.50

g/l

2.61

501

4032

Lichen ruber planus, wide definition including periferal and oral lichen planus

129

1010

1.28

2.01

1.1

1.48

1.52

g/l

0.79

118

901

Psychotic depression

239

1.60

2.01

1.1

1.48

1.53

g/l

0.29

214

Dislocation, sprain and strain of joints and ligaments at wrist and hand level

198

1628

1.22

2.00

1.1

1.47

1.48

g/l

0.13

169

1495

Seropositive rheumatoid arthritis, wide

161

1295

1.25

2.00

1.1

1.55

1.53

g/l

0.31

140

1167

Insulin, fast-acting (human)

714

1.34

2.00

1.0

1.1

1.55

1.47

g/l

0.97

648

Molar incisor enamel hypoplasia

109

1.90

2.00

1.0

1.53

1.42

g/l

0.77

103

Contact with machinery

586

1.37

2.00

1.1

1.50

1.52

g/l

0.23

532

Malignant neoplasm of breast

223

1931

0.83

1.99

1.1

1.55

1.49

g/l

1.64

200

1732

Transient global amnesia

376

0.56

1.98

1.2

1.1

1.41

1.55

g/l

2.13

333

Malignant neoplasm of prostate

164

1280

0.81

1.95

1.1

1.55

1.58

g/l

0.44

146

1164

Appendicitis, broad definition

544

4431

1.12

1.94

1.1

1.45

1.50

g/l

2.48

497

4018

Other/unspecified seropositive rheumatoid arthritis (ICD-10)

156

1257

1.24

1.93

1.1

1.54

1.52

g/l

0.23

135

1132

Other disorders of bone

131

1035

1.27

1.92

1.1

1.50

1.51

g/l

0.07

115

943

125

868

1.28

1.92

1.1

1.57

1.56

g/l

0.07

107

771

Leisure time condition

108

833

1.30

1.91

1.1

1.53

1.51

g/l

0.30

740

Retinal detachments and breaks

202

1674

1.21

1.91

1.1

1.56

1.53

g/l

0.46

189

1506

Parkinson's disease

581

0.65

1.90

1.0

1.1

1.47

1.56

g/l

1.28

518

Other diseases of jaws

299

1.51

1.90

1.0

1.1

1.49

g/l

0.01

269

Single delivery by caesarean section

128

579

1.28

1.88

1.1

1.41

1.51

g/l

1.86

121

526

Amyloidosis

2.33

1.88

1.1

1.96

1.52

g/l

2.01

Conjunctivitis

529

4109

1.12

1.88

1.0

1.1

1.51

1.48

g/l

1.34

481

3723

Other otitis externa (chronic)

292

1.52

1.87

1.1

1.55

1.51

g/l

0.36

263

Glomerulonephritis

474

1.40

1.87

1.1

1.56

1.51

g/l

0.48

428

Blood alcohol or alcohol intoxication level

107

1.89

1.87

1.1

1.59

1.43

g/l

0.92

Peritonsillar abscess

143

1146

1.25

1.87

1.1

1.47

1.50

g/l

0.58

125

1048

Other/unspecified seropositive rheumatoid arthritis

158

1281

1.24

1.86

1.1

1.55

1.52

g/l

0.34

137

1154

Carcinoma in situ of other and unspecified digestive organs

2.00

1.86

1.1

1.0

1.51

1.54

g/l

0.13

Organic, including symptomatic, mental disorders

181

1586

0.82

1.85

1.1

1.57

1.55

g/l

0.31

160

1409

Hydrocele

560

1.36

1.85

1.1

1.49

1.51

g/l

0.14

511

Other disorders of bladder

526

1.37

1.85

1.0

1.1

1.50

1.53

g/l

0.42

476

Chondropathies

102

785

1.30

1.85

1.1

1.52

1.50

g/l

0.24

706

Hypoplasia of dental enamel , including avohilmo

1.91

1.85

1.1

1.0

1.52

1.41

g/l

0.73

Fitting and adjustment of other devices

178

1359

1.22

1.84

1.0

1.1

1.52

g/l

0.05

156

1206

Lichen planus, including avohilmo

109

848

1.29

1.82

1.1

1.50

1.52

g/l

0.31

757

Gonarthrosis

462

2340

1.13

1.82

1.1

1.53

1.52

g/l

0.18

400

2131

Malignant melanoma

622

1.34

1.82

1.1

1.43

1.55

g/l

3.28

553

Pregnancy hypertension

260

1995

1.18

1.81

1.1

1.46

1.47

g/l

0.20

240

1805

Other and unspecified acute skin changes due to ultraviolet radiation

1.93

1.81

1.1

1.66

1.58

g/l

0.36

Intracerebral haemorrhage

444

1.40

1.79

1.1

1.62

1.55

g/l

0.54

393

Dental caries 2, only avohilmo

560

3960

1.12

1.79

1.1

1.43

1.49

g/l

3.06

498

3599

Temporomandibular joint disorders

712

1.31

1.76

1.1

1.44

1.48

g/l

0.48

637

Cardiac murmurs and other cardiac sounds

342

1.45

1.75

1.1

1.51

1.46

g/l

0.32

309

Disorders of continuity of bone

439

1.40

1.73

1.0

1.1

1.58

1.48

g/l

1.10

395

Anomalies of dental arch relationship, including avohilmo

127

910

1.26

1.73

1.1

1.46

1.48

g/l

0.10

112

823

Extrapyramidal and movement disorders

208

1749

1.19

1.71

1.1

1.49

1.53

g/l

1.06

180

1576

Carcinoma in situ of skin of lower limb, including hip

2.31

1.71

1.1

1.43

1.56

g/l

0.66

Sequelae of injuries, of poisoning and of other consequences of external causes

156

1277

1.22

1.71

1.1

1.51

g/l

0.08

143

1159

Follicular cysts of skin and subcutaneous tissue

115

910

1.27

1.70

1.1

1.45

1.50

g/l

0.69

105

822

Allergic colitis

2.07

1.70

1.1

1.0

1.48

1.41

g/l

0.42

Inguinal hernia

411

2446

1.13

1.70

1.1

1.53

1.51

g/l

0.30

376

2218

Tooth eruption problems

640

1.32

1.70

1.1

1.51

1.44

g/l

0.86

582

Dislocation, sprain and strain of joints and ligaments of elbow

291

1.49

1.70

1.0

1.1

1.54

1.50

g/l

0.38

261

Migraine without aura and triptan purchases

101

787

1.29

1.69

1.1

1.38

1.50

g/l

3.18

715

Appendectomy

467

4013

1.12

1.69

1.1

1.44

1.49

g/l

2.04

429

3643

Allergic contact dermatitis

648

1.32

1.68

1.2

1.1

1.50

g/l

0.01

583

Malignant neoplasm of breast, HER2-negative

218

1891

0.85

1.67

1.1

1.55

1.49

g/l

1.68

196

1693

Melanoma in situ

119

1.78

1.66

1.1

1.0

1.47

1.54

g/l

0.62

103

Pregnancy with abortive outcome

412

1900

1.14

1.66

1.1

1.51

1.48

g/l

1.10

366

1706

Molar incisor enamel hypoplasia, with caries

2.62

1.66

1.1

1.0

1.56

1.41

g/l

—

Lateral epicondylitis

702

1.30

1.65

1.0

1.1

1.49

1.50

g/l

0.15

637

D07AA Corticosteroids, weak (group I)

101

789

1.28

1.65

1.1

1.56

1.47

g/l

1.15

712

Mixed specific developmental disorders

111

1.78

1.64

1.0

1.1

1.46

1.40

g/l

0.38

102

Endometriosis ASRM stages 3,4

134

1085

1.24

1.64

1.1

1.50

1.49

g/l

0.07

126

974

Other benign neoplasms of uterus

135

1.71

1.62

1.0

1.1

1.58

1.54

g/l

0.21

110

Graves disease, strict definition

445

1.38

1.62

1.1

1.48

g/l

0.01

396

Coronary revascularization (ANGIO or CABG)

266

1596

1.16

1.61

1.1

1.66

1.54

g/l

4.31

246

1427

Acute appendicitis, no complications

403

3569

1.13

1.61

1.1

1.45

1.50

g/l

1.88

372

3244

Use of disulfiram, acamprosate or naltrexone

506

1.35

1.60

1.1

1.54

1.49

g/l

0.65

461

Complications of internal orthopaedic prosthetic devices, implants and grafts

115

918

1.26

1.60

1.1

1.58

1.54

g/l

0.48

817

Eating disorders

454

1.37

1.60

1.1

1.51

1.47

g/l

0.38

415

Other endocrine disorders

237

1.51

1.59

1.1

1.44

1.46

g/l

0.08

218

Single spontaneous delivery

174

1111

0.83

1.57

1.1

1.47

1.53

g/l

1.57

151

978

Speech disturbances, not elsewhere classified

330

1.43

1.56

1.1

1.60

1.55

g/l

0.52

298

Effects of foreign body entering through natural orifice

164

1365

1.20

1.55

1.0

1.1

1.46

1.50

g/l

0.66

153

1242

Respiratory conditions due to other external agents

1.99

1.55

1.1

1.50

1.57

g/l

0.53

Injury of eye and orbit

754

1.28

1.54

1.0

1.1

1.52

1.49

g/l

0.44

683

Bacterial, viral and other infectious agents

467

1.36

1.53

1.2

1.1

1.44

1.47

g/l

0.18

428

Transitory disorders of carbohydrate metabolism specific to fetus and newborn

2.05

1.53

1.0

1.36

1.41

g/l

0.16

Salpingitis and oophoritis

106

844

1.26

1.52

1.0

1.1

1.48

1.50

g/l

0.18

760

Transitory endocrine and metabolic disorders specific to fetus and newborn

2.04

1.52

1.0

1.36

1.41

g/l

0.16

malignant neoplasm of male genital organs

178

1346

0.84

1.52

1.1

1.54

1.57

g/l

0.47

158

1225

Injury of muscle and tendon at wrist and hand level

703

1.28

1.52

1.1

1.50

1.51

g/l

0.14

639

Pregnancy, childbirth and the puerperium

108

709

0.80

1.52

1.0

1.1

1.48

1.54

g/l

0.83

627

Other disorders of kidney and ureter

563

1.32

1.51

1.1

1.54

1.52

g/l

0.18

506

Assault by bodily force

400

1.38

1.51

1.1

1.59

1.44

g/l

1.36

361

Abnormal findings on examination of other body fluids, substances and tissues, without diagnosis

372

2692

1.13

1.50

1.1

1.46

1.49

g/l

0.92

342

2426

Desensitization to allergens

242

1.50

1.0

1.1

1.39

1.44

g/l

0.50

220

Fracture of skull and facial bones

137

1125

1.22

1.49

1.1

1.53

1.49

g/l

0.53

121

1026

Deforming dorsopathies

175

1471

1.19

1.49

1.1

1.52

1.51

g/l

0.16

152

1336

Dystonia

234

1.50

1.49

1.1

1.52

1.49

g/l

0.13

213

Anterior Iridocyclitis

126

1026

1.23

1.49

1.1

1.57

1.51

g/l

0.91

117

925

Acute appendicitis

505

4305

1.11

1.49

1.1

1.45

1.50

g/l

2.62

461

3912

Delivery

177

1115

0.84

1.49

1.1

1.46

1.53

g/l

1.93

152

981

Fracture at wrist and hand level

231

1988

1.16

1.48

1.1

1.49

g/l

0.06

211

1812

Polyarthritis, unspecified

155

1.62

1.47

1.0

1.1

1.50

1.45

g/l

0.19

143

Other salmonella infections

155

1.62

1.47

1.2

1.1

1.46

1.48

g/l

0.10

140

Benign neoplasm of ovary

733

1.27

1.47

1.1

1.54

1.51

g/l

0.32

656

Parkinson's disease, including avohilmo

605

0.71

1.46

1.0

1.1

1.50

1.56

g/l

0.75

539

Sleep disorders, other/unspecified

132

1.68

1.46

1.2

1.1

1.74

1.46

g/l

1.13

116

Other disorders of penis

541

1.32

1.45

1.2

1.1

1.44

1.49

g/l

0.51

495

Chronic respiratory disease originating in the perinatal period

3.24

1.45

1.0

1.39

1.28

g/l

—

Disorders of psychological development

549

1.30

1.45

1.1

1.44

1.43

g/l

0.08

501

Oedema, proteinuria and hypertensive disorders in pregnancy, childbirth and the puerperium

287

2198

1.14

1.44

1.1

1.46

1.47

g/l

0.25

266

1982

Open wound of wrist and hand

301

2621

1.14

1.44

1.1

1.48

1.50

g/l

0.38

271

2398

Acquired absence of organs, not elsewhere classified

2.34

1.44

1.1

1.67

1.55

g/l

—

Other disorders of prostate

152

0.46

1.43

1.0

1.1

1.50

1.58

g/l

—

142

Medial epicondylitis

172

1.58

1.43

1.1

1.42

1.48

g/l

0.39

153

Injury of muscle and tendon at shoulder and upper arm level

224

1931

1.16

1.43

1.1

1.55

1.53

g/l

0.25

200

1756

Other and unspecified types of non-Hodgkin lymphoma, hilmo, excluding all cancers

133

1.66

1.43

1.1

1.0

1.57

1.53

g/l

0.18

114

Benign neoplasm of bone and articular cartilage

388

1.37

1.41

1.1

1.44

1.49

g/l

0.54

354

Benign leiomyoma with endometriosis

631

1.29

1.41

1.1

1.51

1.48

g/l

0.20

561

Delivery, wide proxy

138

889

0.82

1.41

1.1

1.46

1.53

g/l

1.40

119

783

Mature T/NK-cell lymphomas, hilmo, excluding all cancers

2.20

1.41

1.1

1.0

1.68

1.48

g/l

—

Malignant neoplasm of breast, HER-positive

137

1626

0.83

1.40

1.0

1.1

1.57

1.50

g/l

1.25

123

1449

Other and specified injuries of hip and thigh

1.91

1.39

1.1

1.72

1.52

g/l

0.78

Contusion of toe(s) without damage to nail

1.79

1.39

1.3

1.1

1.31

1.43

g/l

0.59

Gonarthrosis [arthrosis of knee](FG)

527

2813

1.10

1.39

1.1

1.54

1.51

g/l

0.98

459

2548

Other benign neoplasms of uterus

142

1.63

1.38

1.0

1.58

1.54

g/l

0.22

122

Abscess of tendon sheath

2.65

1.37

1.0

1.57

1.46

g/l

—

Other condition

687

1.27

1.37

1.1

1.53

1.50

g/l

0.29

619

Other infective otitis externa

272

1.44

1.37

1.1

1.50

1.52

g/l

0.15

247

Noninflammatory disorders of female genital tract

256

1117

1.15

1.37

1.1

1.45

1.50

g/l

1.20

238

997

Seronegative rheumatoid arthritis

511

1.32

1.37

1.0

1.1

1.49

1.50

g/l

0.03

459

Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)

555

1.30

1.37

1.0

1.1

1.41

1.53

g/l

2.60

487

Artrosis, including avohilmo

647

3253

1.09

1.36

1.1

1.51

g/l

0.08

575

2963

Other hearing loss

130

1056

1.21

1.35

1.1

1.47

1.55

g/l

1.30

112

951

Atrophic disorders of skin

600

1.29

1.35

1.2

1.1

1.47

1.49

g/l

0.26

539

Postmenopausal atrophic vaginitis

146

730

1.21

1.35

1.1

1.46

1.52

g/l

1.35

132

650

Kyphosis

2.15

1.34

1.1

1.0

1.34

1.45

g/l

—

Diplopia

584

1.29

1.33

1.1

1.52

g/l

0.02

525

Artificial joint re-operation

266

1.44

1.32

1.1

1.58

1.57

g/l

0.12

236

Unspecified privation

497

1.31

1.32

1.1

1.53

1.50

g/l

0.33

448

Carbimazole or st.post thyroidectomy, condition for graves disease

123

1015

1.21

1.32

1.1

1.48

1.50

g/l

0.29

113

912

Acute and subacute iridocyclitis

116

952

1.22

1.31

1.0

1.1

1.59

1.51

g/l

1.22

108

864

Malignant neoplasm of bronchus and lung, excluding all cancers (controls excluding all cancers)

650

1.25

1.30

1.1

1.63

1.54

g/l

1.06

568

Cervicobrachial syndrome

140

1172

1.20

1.29

1.0

1.1

1.46

1.51

g/l

1.22

133

1064

Parkinson's disease, strict definition

520

0.71

1.29

1.0

1.1

1.47

1.56

g/l

1.22

463

Benign neoplasm: Skin of other and unspecified parts of face

395

1.35

1.28

1.1

1.43

1.51

g/l

0.71

343

Polyarteritis nodosa and related conditions

2.10

1.28

1.2

1.1

1.70

1.43

g/l

—

Other contact dermatitis

361

1.36

1.28

1.1

1.49

g/l

0.01

325

Postprocedural disorders of nervous system

344

1.37

1.28

1.1

1.41

1.46

g/l

0.34

314

All dysplastic lesions of the cervix uteri, vagina or vulva

166

1404

1.18

1.27

1.1

1.46

1.48

g/l

0.24

154

1277

Other disorders of eyelid

239

2022

1.14

1.25

1.1

1.49

1.54

g/l

0.88

213

1814

Flat foot [pes planus] (acquired)

423

1.33

1.25

1.1

1.49

1.50

g/l

0.02

380

Polycythaemia vera

115

1.66

1.25

1.1

1.0

1.50

1.55

g/l

0.18

Tinnitus

141

1186

1.19

1.25

1.0

1.1

1.51

g/l

0.01

126

1073

Allergic conjunctivitis

377

3342

1.11

1.25

1.0

1.1

1.50

1.48

g/l

0.50

340

3032

Hypertrophy of breast in women and men

124

1031

1.21

1.25

1.0

1.1

1.43

1.49

g/l

1.36

109

930

Malignant neoplasm of oesophagus, excluding all cancers (controls excluding all cancers)

119

0.42

1.24

1.0

1.1

1.59

1.54

g/l

—

101

Malignant neoplasm of cervix uteri, excluding all cancers (controls excluding all cancers)

1.87

1.24

1.1

1.61

1.47

g/l

0.33

Diabetic nephropathy, excluding more controls

104

708

1.23

1.24

1.1

1.69

1.53

g/l

3.06

634

Endometriosis of pelvic peritoneum

741

1.24

1.1

1.40

1.50

g/l

3.12

661

Evidence of alcohol involvement determined by level of intoxication

2.02

1.24

1.1

1.0

1.48

1.38

g/l

—

Intentional self-harm by sharp object

100

1.71

1.24

1.1

1.70

1.43

g/l

1.32

Erythema multiforme

1.78

1.23

1.0

1.55

1.46

g/l

0.31

Other benign neoplasms of skin

213

1855

1.15

1.23

1.0

1.1

1.47

1.52

g/l

1.40

184

1674

Contraceptive management

313

1960

1.12

1.22

1.1

1.46

1.49

g/l

0.82

284

1785

Other disorders of conjunctiva

628

1.26

1.21

1.1

1.49

1.53

g/l

0.38

562

therapeutic use

1.73

1.21

1.0

1.1

1.63

1.51

g/l

—

HSIL lesion of the cervix uteri, vagina or vulva

111

916

1.21

1.1

1.48

1.47

g/l

0.10

100

836

Benign neoplasm: Choroid

246

1.43

1.21

1.0

1.1

1.50

1.54

g/l

0.22

220

Pilonidal cyst

487

1.30

1.21

1.1

1.53

1.45

g/l

0.84

445

Other (seronegative) rheumatoid arthritis, wide

105

862

1.22

1.21

1.0

1.1

1.50

1.53

g/l

0.34

769

Dislocation, sprain and strain of joints and ligaments at neck level

754

1.24

1.20

1.0

1.1

1.43

1.48

g/l

0.63

674

Radiculopathy

736

1.24

1.20

1.1

1.51

1.53

g/l

0.30

663

Other and unspecified injuries of lower leg

331

1.36

1.20

1.1

1.46

1.47

g/l

0.04

304

Toxic effect of ethanol

205

1.47

1.20

1.1

1.54

1.47

g/l

0.53

189

Use of eye-antiallergens (taken as indicator of allergic/atopic conjunctivitis)

360

3188

1.11

1.20

1.0

1.1

1.49

1.47

g/l

0.45

325

2888

Hypertrophy of breast

103

845

1.22

1.20

1.0

1.1

1.43

1.48

g/l

1.08

763

Maternal care for known or suspected abnormality of pelvic organs

152

889

1.18

1.19

1.1

1.42

1.48

g/l

1.43

144

805

Congenital malformations of uterus and cervix

1.89

1.18

1.0

1.1

1.78

1.44

g/l

1.22

Corneal ulcer

112

929

1.21

1.17

1.1

1.52

1.50

g/l

0.17

840

Diabetic retinopathy

250

1391

1.14

1.16

1.1

1.56

1.55

g/l

0.17

225

1257

Gestational diabetes (for exclusion)

217

1342

1.15

1.1

1.42

1.46

g/l

1.11

201

1231

Gonarthrosis, primary, with knee surgery

262

2410

0.89

1.15

1.1

1.55

1.54

g/l

0.19

224

2167

Non-follicular lymphoma, hilmo, excluding all cancers

343

1.35

1.14

1.0

1.1

1.70

1.52

g/l

2.06

294

HSIL lesion of the cervix uteri

101

833

1.22

1.13

1.1

1.47

g/l

0.02

762

Bitten or struck by other mammals

519

1.28

1.13

1.1

1.44

1.48

g/l

0.43

471

Other symptoms and signs involving the nervous and musculoskeletal systems

262

2330

1.13

1.12

1.1

1.48

1.51

g/l

0.37

246

2094

Other neurological diseases

442

3245

1.10

1.12

1.1

1.51

1.53

g/l

0.66

398

2917

Mature T/NK-cell lymphomas, hilmo

1.98

1.12

1.1

1.68

1.55

g/l

—

Pedestrian injured in transport accident

310

1.36

1.12

1.0

1.1

1.47

1.49

g/l

0.13

279

Benign lipomatous neoplasm of skin and subcutaneous tissue of trunk

582

1.26

1.12

1.1

1.42

1.50

g/l

0.77

510

Focal brain injury

276

1.38

1.11

1.1

1.52

1.50

g/l

0.14

250

Congenital malformations of genital organs

439

1.29

1.09

1.0

1.1

1.50

1.45

g/l

0.33

395

Diffuse large B-cell lymphoma, excluding all cancers (controls excluding all cancers)

144

1.54

1.09

1.0

1.78

1.52

g/l

1.27

125

Diffuse large B-cell lymphoma, helper endpoint

144

1.54

1.09

1.0

1.78

1.52

g/l

1.27

125

Other infectious diseases

329

1.34

1.08

1.2

1.1

1.70

1.53

g/l

1.73

300

Premature rupture of membranes

122

755

1.19

1.07

1.0

1.1

1.43

1.50

g/l

1.24

111

687

Other disorders of ear

641

3967

1.08

1.06

1.1

1.51

1.52

g/l

0.24

565

3607

Carcinoma in situ of other and unspecified digestive organs

105

1.63

1.06

1.1

1.51

1.55

g/l

0.18

Other osteochondropathies

366

1.32

1.05

1.1

1.52

1.50

g/l

0.19

339

Use of levodopa decarboxylase inhibitor

476

0.73

1.04

1.1

1.49

1.56

g/l

0.73

425

Contact with and exposure to communicable diseases

207

1818

1.14

1.04

1.1

1.44

1.46

g/l

0.49

196

1667

Coronary angioplasty

200

1349

1.14

1.03

1.1

1.63

1.54

g/l

2.19

184

1196

Macular pucker

571

1.25

1.03

1.2

1.1

1.56

1.55

g/l

0.08

508

Other/unspecified synovitis and tenosynovitis

509

1.26

1.02

1.0

1.1

1.47

1.49

g/l

0.16

454

Cerebrovascular diseases

453

2983

1.09

1.01

1.1

1.56

1.53

g/l

0.59

407

2693

Other crystal arthropathies

1.89

1.00

1.0

1.1

1.67

1.52

g/l

—

Crystal arthropathies, rheuma endpoint

1.89

1.00

1.0

1.1

1.67

1.51

g/l

—

Non-small cell lung cancer, excluding all cancers (controls excluding all cancers)

514

1.25

1.00

1.1

1.62

1.54

g/l

0.74

453

Medicines for HER+ breast cancer

152

1704

0.87

0.99

1.1

1.56

1.50

g/l

1.05

138

1519

Polyp of the female genital tract

182

926

1.15

0.98

1.1

1.43

1.50

g/l

1.92

167

823

Temporomandibular joint disorders, including avohilmo

262

2351

1.11

0.97

1.1

1.40

1.49

g/l

4.25

237

2127

Coxarthrosis, primary, with hip surgery

196

2099

0.88

0.97

1.1

1.57

1.54

g/l

0.47

175

1878

Toxic effect of carbon monoxide

1.75

0.97

1.1

1.0

1.65

1.49

g/l

0.45

Fracture of forearm

341

2909

1.10

0.97

1.0

1.1

1.50

1.49

g/l

0.09

305

2623

Other/unspecified enthesopathies, not elsewhere classified

363

1.30

0.95

1.1

1.41

1.49

g/l

0.76

327

Other specified congenital malformation syndromes affecting multiple systems

1.70

0.95

1.0

1.50

1.41

g/l

0.45

Injuries to the neck

138

1192

1.16

0.95

1.0

1.1

1.45

1.50

g/l

0.84

126

1077

Ganglion

127

1091

1.17

0.94

1.1

1.41

1.49

g/l

2.77

107

984

Nontoxic multinodular goitre

833

1.19

0.94

1.1

1.46

1.53

g/l

1.30

751

Pathological resorption of teeth

125

1.53

0.94

1.2

1.1

1.59

1.51

g/l

0.28

113

Dermatitis due to ingested food

144

1.48

0.94

1.1

1.0

1.41

1.44

g/l

0.16

133

Other specified/unspecified disorders of synovium and tendon +Other specified/unspecified bursopathies

217

1.39

0.93

1.1

1.46

1.47

g/l

0.06

195

Crushed, pushed or stepped on by crowd or human stampede

347

1.30

0.93

1.1

1.55

1.46

g/l

0.62

312

Measles

1.75

0.93

1.0

1.35

1.48

g/l

—

Mouth breathing

270

2437

1.11

0.93

1.1

1.47

1.51

g/l

1.40

244

2216

Dislocation, sprain and strain of joints and ligaments of knee

430

3686

1.08

0.92

1.1

1.44

1.49

g/l

2.12

379

3366

Thyroiditis

296

1.32

0.91

1.1

1.58

1.52

g/l

0.36

261

Benign leiomyoma with endometriosis

672

1.21

0.90

1.1

1.51

1.52

g/l

0.08

593

Myocardial infarction, with ST-elevation

718

1.20

0.90

1.0

1.1

1.68

1.54

g/l

2.17

648

Trochanteric bursitis

564

1.23

0.89

1.0

1.1

1.43

1.51

g/l

1.05

508

Coxarthrosis

306

1887

1.10

0.89

1.1

1.55

1.53

g/l

0.28

276

1703

All dysplastic lesions of the cervix uteri

140

1216

1.15

0.89

1.1

1.43

1.47

g/l

0.68

131

1105

Other disorders of choroid

1.92

0.89

1.0

1.54

1.43

g/l

—

Motorcycle rider injured in noncollision transport accidents

154

0.58

0.88

1.1

1.66

1.45

g/l

—

135

Gestational [pregnancy-induced] hypertension

145

1264

1.15

0.88

1.1

1.43

1.47

g/l

0.69

135

1143

Benign neoplasm: Larynx

111

1.54

0.88

1.4

1.0

1.56

1.53

g/l

0.07

Mental disorders, not otherwise specified

395

1.27

0.87

1.1

1.54

1.49

g/l

0.48

360

Polycystic ovarian syndrome, broad definition

449

1.25

0.87

1.1

1.37

1.46

g/l

1.01

410

Blepharochalasis

152

1334

1.14

0.86

1.1

1.47

1.54

g/l

1.04

133

1206

Evidence of alcohol involvement determined by blood alcohol level

1.73

0.86

1.0

1.1

1.68

1.46

g/l

0.85

Other spirochaetal diseases

149

1307

1.14

0.86

1.1

1.50

1.51

g/l

0.14

134

1169

Inflammatory disease of uterus

622

1.21

0.85

1.2

1.1

1.44

1.48

g/l

0.53

563

Endocrine disorders, other/unspecified

1.68

0.85

1.1

1.38

1.44

g/l

0.22

Malignant neoplasm of other connective and soft tissue

1.64

0.85

1.3

1.1

1.61

1.50

g/l

0.75

Intracranial and intraspinal abscess and granuloma

1.79

0.84

1.4

1.1

1.40

1.47

g/l

—

Malignant neoplasm of respiratory system and intrathoracic organs, excluding all cancers (controls excluding all cancers)

107

768

1.17

0.84

1.1

1.64

1.54

g/l

1.49

668

Antenatal screening

111

728

0.86

0.84

1.1

1.35

1.49

g/l

3.00

103

672

Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)

207

1509

0.89

0.84

1.1

1.53

1.46

g/l

1.87

188

1352

Malignant neoplasm of breast, HER2-negative, excluding all cancers (controls excluding all cancers)

207

1509

0.89

0.84

1.1

1.53

1.46

g/l

1.87

188

1352

Acute lymphadenitis

274

1.32

0.84

1.0

1.1

1.47

1.45

g/l

0.06

249

Other meningitis

1.77

0.84

1.0

1.1

1.41

1.46

g/l

—

Other disorders of cornea

416

1.25

0.83

1.0

1.1

1.46

1.49

g/l

0.28

375

Lyme disease

147

1292

1.14

0.83

1.1

1.50

1.51

g/l

0.08

132

1157

Dental caries 2 and operation codes, only avohilmo

518

2999

1.07

0.83

1.1

1.44

1.50

g/l

2.90

457

2740

Nontraumatic intracranial haemmorrhage

799

1.18

0.82

1.1

1.59

1.54

g/l

0.59

710

Exclusion endpoint for clefts

1.58

0.81

1.0

1.53

1.44

g/l

0.45

Labour and delivery complicated by intrapartum haemorrhage, not elsewhere classified

213

0.65

0.81

1.0

1.1

1.37

1.51

g/l

0.82

190

Abdominal aortic aneurysm (AAA)

326

1.28

0.80

1.2

1.1

1.65

1.57

g/l

0.60

287

Focal epilepsy, strict definition

107

922

1.16

0.80

1.1

1.50

1.51

g/l

0.08

100

826

Infections of genitourinary tract in pregnancy

365

1.26

0.79

1.0

1.1

1.54

1.50

g/l

0.49

330

Deep bite

469

1.22

0.79

1.1

1.53

1.48

g/l

0.44

424

Leiomyoma of uterus

283

1454

1.10

0.78

1.1

1.45

g/l

0.03

255

1305

Congenital malformations of ovaries, fallopian tubes and broad ligaments

216

1.35

0.78

1.0

1.1

1.41

1.46

g/l

0.26

199

Spontaneous abortion

274

1700

1.10

0.78

1.1

1.46

g/l

0.14

249

1529

Benign neoplasm of meninges

395

0.76

0.78

1.1

1.64

1.53

g/l

0.57

352

Transient synovitis

0.00

0.78

0.0

1.0

—

1.39

—

Redundant prepuce, phimosis and paraphimosis

141

1238

1.14

0.77

1.1

1.44

1.48

g/l

0.73

128

1132

Carcinoma in situ of colon

1.71

0.76

1.1

1.0

1.60

1.52

g/l

—

Schizophrenia or delusion

166

1857

0.89

0.76

1.1

1.52

1.48

g/l

0.70

145

1686

Oral lichen ruber planus, hypothyreosis or thyroxin

1.71

0.75

1.0

1.1

1.53

1.49

g/l

—

Perforation of tympanic membrane

440

1.23

0.75

1.1

1.61

1.51

g/l

0.78

393

Benign neoplasm: Skin of other and unspecified parts of face

431

1.23

0.75

1.1

1.43

1.53

g/l

1.03

392

Benign lipomatous neoplasm

157

1397

1.13

0.75

1.1

1.44

1.49

g/l

0.58

140

1248

Glucosamine medication

224

1968

0.91

0.74

1.0

1.1

1.56

1.54

g/l

0.26

196

1759

Benign neoplasm: Pituitary gland, craniopharyngeal duct

201

1.35

0.74

1.2

1.1

1.44

1.47

g/l

0.08

181

Preterm labour and delivery

152

1353

1.12

0.73

1.1

1.45

1.48

g/l

0.43

137

1221

Parkinson's disease, excluding more controls

468

0.79

0.73

1.0

1.1

1.47

1.56

g/l

1.22

420

Ductal carcinoma of pancreas, excluding all cancers (controls excluding all cancers)

2.02

0.73

1.0

1.89

1.51

g/l

—

Benign neoplasm: Short bones of lower limb

1.81

0.73

1.0

1.26

1.46

g/l

—

Other and unspecified intracranial injuries

125

1.45

0.73

1.1

1.57

1.49

g/l

0.35

114

407

1.23

0.71

1.1

1.46

1.47

g/l

0.05

374

Emergency coronary revascularization (for ACS)

286

1889

1.09

0.71

1.1

1.66

1.56

g/l

3.49

264

1684

Chronic crepitant synovitis/bursitis of hand and wrist/periarthritis of wrist

1.59

0.71

1.0

1.30

1.46

g/l

—

Schizophrenia, schizotypal and delusional disorders

167

1859

0.90

0.71

1.1

1.52

1.48

g/l

0.71

145

1688

Postpartum hemorraghe, parous women as controls

139

1079

1.13

0.71

1.1

1.40

1.45

g/l

1.22

122

1000

HSIL lesion of the vagina

1.72

0.70

1.1

1.0

1.80

1.46

g/l

—

Malignant neoplasm of breast, ER-positive, excluding all cancers (controls excluding all cancers)

137

1251

0.89

0.70

1.0

1.1

1.57

1.47

g/l

2.27

123

1114

Retinal breaks without detachment

730

1.17

0.69

1.1

1.54

1.52

g/l

0.21

653

Other disorders of breast

518

1.20

0.69

1.0

1.1

1.48

1.49

g/l

0.12

463

Conductive and sensorineural hearing loss

507

3301

1.06

0.69

1.1

1.51

1.53

g/l

0.33

443

2994

Melanoma in situ

152

1.39

0.69

1.1

1.47

1.58

g/l

1.00

135

Mental and behavioural disorders due to use of other stimulants, including caffeine

144

1.40

0.68

1.0

1.1

1.56

1.42

g/l

1.22

126

Postpartum hemorraghe, all women as controls

139

1233

1.12

0.67

1.1

1.40

1.47

g/l

2.16

122

1128

Coronary artery bypass grafting

134

905

1.13

0.67

1.1

1.69

1.56

g/l

2.83

122

797

Status post-ami

148

0.66

0.67

1.0

1.1

1.75

1.60

g/l

0.56

131

Spondylopathies in diseases classified elsewhere

1.64

0.67

1.0

1.59

1.52

g/l

—

Calcaneal spur

1.64

0.67

1.1

1.0

1.32

1.46

g/l

—

Adenocarcinoma and papillary adenocarcinoma of stomach

0.52

0.66

1.0

1.1

1.67

1.60

g/l

—

Malignant neoplasm of floor of mouth, excluding all cancers (controls excluding all cancers)

1.80

0.66

1.0

1.1

1.66

1.49

g/l

—

Other and unspecified disorders of vitreous body

225

2049

1.09

0.66

1.0

1.1

1.49

1.52

g/l

0.47

204

1842

Sexual dysfunction

1.58

0.65

1.0

1.1

1.38

1.47

g/l

0.36

Benign neoplasm: Short bones of lower limb

1.60

0.65

1.0

1.26

1.45

g/l

—

Spondylolisthesis/Spondylolysis

103

903

1.14

0.65

1.0

1.1

1.57

1.52

g/l

0.57

819

Pulmonary oedema

1.60

0.65

1.1

1.92

1.60

g/l

—

Abnormal findings in secretions and smears from cervix uteri vagina vulva

286

2079

1.08

0.64

1.1

1.42

1.47

g/l

1.54

269

1873

Supervision of high-risk pregnancy

128

688

1.13

0.62

1.1

1.39

1.49

g/l

2.66

115

638

Nystagmus and other irregular eye movements

1.64

0.62

1.0

1.63

1.36

g/l

—

Persons encountering health services in circumstances related to reproduction

429

2733

1.06

0.62

1.1

1.43

1.49

g/l

2.69

390

2480

Achalasia of cardia

1.61

0.61

1.3

1.1

1.72

1.51

g/l

—

Sensorineural hearing loss

469

3097

1.06

0.60

1.1

1.51

1.53

g/l

0.61

409

2813

IgA nephropathy (IgA glomerulonephritis)

122

1.40

0.60

1.2

1.1

1.49

g/l

0.00

108

Exclusion endpoint for supernumerary teeth

1.52

0.58

1.0

1.52

1.31

g/l

—

Sequelae of injuries of lower limb

455

1.19

0.58

1.1

1.44

1.49

g/l

0.51

408

Acute laryngitis and tracheitis

621

1.16

0.58

1.1

1.38

1.47

g/l

1.61

560

Coxarthrosis [arthrosis of hip](FG)

321

2169

1.07

0.57

1.1

1.55

1.52

g/l

0.68

287

1949

Other and unspecified trigeminal disorders

1.49

0.57

1.1

1.33

1.44

g/l

—

Diabetic nephropathy

104

911

1.13

0.57

1.1

1.69

1.53

g/l

3.11

825

Other/unspecified rheumatoid arthritis

493

1.18

0.57

1.1

1.54

1.55

g/l

0.07

441

Non-small cell lung cancer

586

1.16

0.57

1.1

1.62

1.55

g/l

0.68

521

Triptan medication for migraine, single purchase ok

557

3584

1.05

0.56

1.1

1.41

1.49

g/l

5.96

516

3229

Migraine, single triptan purchase ok & required. ICD-code if available is included

557

3584

1.05

0.56

1.1

1.41

1.49

g/l

5.96

516

3229

Renal tubulo-interstitial disorders in diseases classified elsewhere

1.63

0.56

1.2

1.1

1.43

1.51

g/l

—

Localized skin eruption due to drugs and medicaments

1.63

0.55

1.2

1.1

1.66

1.40

g/l

—

Other and unspecified types of non-Hodgkin lymphoma, hilmo

168

1.31

0.55

1.1

1.57

1.56

g/l

0.03

150

Post-traumatic wound infection, not elsewhere classified

116

1.39

0.54

1.0

1.1

1.53

1.49

g/l

0.16

105

Disorders of synovium and tendon in diseases classified elsewhere

1.42

0.54

1.0

1.1

1.33

1.50

g/l

1.80

Lichen sclerosus et atrophicus

376

1.20

0.54

1.2

1.1

1.52

1.51

g/l

0.13

333

Von Willebrand disease

1.54

0.53

1.0

1.39

1.36

g/l

—

Pneumoconiosis due to asbestos and other mineral fibres

1.46

0.53

1.0

1.1

1.57

1.69

g/l

—

Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)

131

869

0.90

0.52

1.1

1.54

1.56

g/l

0.20

119

782

Primary gonarthrosis, bilateral

248

2329

0.93

0.52

1.1

1.57

1.53

g/l

0.95

209

2099

Abscess of external ear

1.44

0.52

1.2

1.1

1.48

1.41

g/l

—

Open wound of shoulder and upper arm

100

1.41

0.52

1.0

1.1

1.38

1.47

g/l

0.62

Conjunctivitis (acute, non atopic)

167

1526

1.09

0.52

1.1

1.52

1.49

g/l

0.47

154

1383

Endometriosis ASRM stages 1,2

866

1.12

0.50

1.1

1.40

1.48

g/l

2.24

782

Acute otitis externa, noninfective

1.50

0.50

1.0

1.1

1.66

1.48

g/l

—

Burns and corrosions confined to eye and internal organs

127

1.34

0.49

1.0

1.1

1.43

1.47

g/l

0.08

115

Kela-code for severe mental illness

206

2219

0.93

0.49

1.1

1.48

1.49

g/l

0.06

182

2020

Sudden idiopathic hearing loss

445

1.17

0.49

1.1

1.49

1.51

g/l

0.21

398

Carcinoma in situ, bladder

144

0.69

0.49

1.1

1.34

1.61

g/l

—

133

Focal epilepsy

112

1010

1.11

0.49

1.1

1.50

1.51

g/l

0.08

104

905

Crossbite

293

1.20

0.49

1.1

1.51

1.45

g/l

0.43

267

Malignant neoplasm of other connective and soft tissue, excluding all cancers (controls excluding all cancers)

145

1.31

0.49

1.2

1.0

1.55

1.52

g/l

0.14

129

Other and unspecified iridocyclitis

172

1.28

0.48

1.0

1.1

1.51

1.48

g/l

0.15

154

Problems related to social environment

1.40

0.48

1.1

1.30

1.48

g/l

2.22

Obstructed labour due to maternal pelvic abnormality

775

1.12

0.48

1.1

1.52

1.49

g/l

0.25

706

Congenital deformities of feet

102

1.38

0.47

1.1

1.38

1.42

g/l

0.18

Malignant neoplasm of tonsil, excluding all cancers (controls excluding all cancers)

1.48

0.47

1.0

1.1

1.55

1.54

g/l

—

Tuberculosis, wide

263

1.22

0.47

1.1

1.55

1.57

g/l

0.10

236

Other disorders of optic disc

1.47

0.47

1.0

1.1

1.47

1.42

g/l

—

Ischaemic Stroke, excluding all haemorrhages

271

2180

0.94

0.46

1.1

1.55

g/l

0.06

242

1961

Dental caries 3 and operation codes, only avohilmo

234

1096

1.07

0.46

1.1

1.49

g/l

0.02

205

1000

Patellar tendinitis

1.39

0.46

1.2

1.1

1.61

1.44

g/l

0.71

Chalazion

542

1.15

0.46

1.0

1.1

1.49

1.51

g/l

0.11

494

Superficial injury of shoulder and upper arm

514

1.15

0.46

1.0

1.1

1.54

1.49

g/l

0.45

461

Adenocarcinoma and papillary adenocarcinoma of stomach, excluding all cancers (controls excluding all cancers)

0.59

0.45

1.0

1.67

1.55

g/l

—

Ptosis of eyelid

431

1.16

0.45

1.1

1.48

1.55

g/l

0.53

390

Benign lipomatous neoplasm of skin and subcutaneous tissue of trunk

647

1.13

0.45

1.1

1.42

1.51

g/l

1.02

581

Disorders of ocular muscles, binocular movement, accommodation and refraction

291

2723

1.06

0.44

1.1

1.48

1.49

g/l

0.13

259

2474

Nontoxic goitre/thyroid nodule

154

1421

1.08

0.44

1.1

1.49

1.52

g/l

0.54

143

1279

Injuries to unspecified part of trunk, limb or body region

432

1.16

0.44

1.1

1.52

1.51

g/l

0.06

390

Triptan medication for migraine, min. 3 purchases

362

2712

1.05

0.44

1.1

1.40

1.48

g/l

4.10

338

2455

Papilloedema, unspecified

1.42

0.43

1.1

1.38

1.43

g/l

0.68

L02BG Aromatase inhibitors

121

1322

0.91

0.43

1.1

1.55

1.50

g/l

0.66

110

1173

Injury of intra-abdominal organs

113

1.33

0.43

1.3

1.1

1.52

1.43

g/l

0.40

102

Non-follicular lymphoma

396

1.16

0.42

1.0

1.1

1.70

1.54

g/l

1.74

351

Embedded and impacted teeth

153

1202

1.08

0.42

1.1

1.50

1.44

g/l

1.00

140

1094

Benign neoplasm: Skin of eyelid, including canthus

603

1.13

0.42

1.1

1.52

1.51

g/l

0.06

524

Donors of organs and tissues

1.41

0.42

1.0

1.1

1.70

1.43

g/l

—

Benign neoplasm of meninges

360

0.83

0.42

1.1

1.64

1.52

g/l

0.66

311

Benign neoplasm: Skin of upper limb, including shoulder

1.43

0.42

1.1

1.0

1.51

1.46

g/l

—

Lymphoid leukaemia

185

1.25

0.42

1.0

1.49

1.52

g/l

0.06

161

Other and unspecified injuries of abdomen, lower back and pelvis

1.38

0.41

1.0

1.1

1.40

1.45

g/l

—

Injuries to the hip and thigh

243

2093

1.06

0.41

1.1

1.56

1.52

g/l

0.82

219

1883

Artificial joint operation, meniscal resection

609

3899

1.04

0.41

1.1

1.51

1.52

g/l

0.36

535

3529

Assault by sharp object

1.40

0.41

1.0

1.1

1.65

1.45

g/l

0.65

Early lumbar disc prolapse, operated

558

1.13

0.40

1.1

1.41

1.46

g/l

0.58

510

Unspecified visual impairment (binocular)

1.34

0.40

1.0

1.1

1.61

1.44

g/l

—

Achilles tendinitis

511

1.14

0.40

1.1

1.49

1.50

g/l

0.08

462

Universal erythroderma, KELA reimbursement

1.32

0.39

1.0

1.72

1.50

g/l

—

Postpartum haemorrhage

139

1118

1.08

0.39

1.1

1.40

1.47

g/l

1.92

122

1021

Adenocarcinoma and Papillary adenocarcinoma of kidney, excluding all cancers (controls excluding all cancers)

1.43

0.39

1.0

1.73

1.55

g/l

—

Maternal care for known or suspected malpresentation of fetus

657

1.10

0.39

1.1

1.39

1.48

g/l

1.51

594

Burn and corrosion confined to eye and adnexa

115

1.31

0.39

1.0

1.1

1.45

1.46

g/l

—

105

Vestibular neuronitis

400

1.15

0.39

1.1

1.47

1.50

g/l

0.22

358

Complications predominantly related to the puerperium

141

1307

1.08

0.38

1.1

1.44

1.48

g/l

0.56

130

1184

Clefts and syndromes for tooth agenesis exclusion, including avohilmo

160

1.25

0.38

1.0

1.47

1.43

g/l

0.26

146

Other abnormal products of conception

189

1179

1.07

0.37

1.1

1.42

1.44

g/l

0.28

176

1079

Foreign body in ear

1.33

0.37

1.0

1.1

1.42

1.44

g/l

—

Strabismus

151

1404

1.07

0.37

1.1

1.50

1.49

g/l

0.02

136

1275

Crowding of teeth, including avohilmo

328

0.85

0.37

1.2

1.1

1.43

1.45

g/l

0.11

299

Gonarthrosis,primary

545

3556

0.96

0.36

1.1

1.53

1.52

g/l

0.17

474

3230

Parkinson's disease, strict definition, excluding more controls

420

0.86

0.36

1.0

1.1

1.47

1.56

g/l

1.20

376

Synovial hypertrophy, not elsewhere classified

1.44

0.35

1.2

1.0

1.50

1.40

g/l

—

Other fall from one level to another

125

1158

1.08

0.35

1.1

1.53

1.50

g/l

0.30

111

1047

Other and unspecified corneal deformities and disorders

135

1.26

0.35

1.1

1.45

1.50

g/l

0.24

123

Melanoma in situ of trunk

1.40

0.35

1.0

1.63

1.50

g/l

—

Obstructed labour due to malposition and malpresentation of fetus

108

1103

0.92

0.35

1.1

1.43

1.46

g/l

0.38

101

1015

Memory loss

348

1.15

0.34

1.1

1.48

1.55

g/l

0.47

309

Aneurysms, operations, SAH

732

0.90

0.34

1.1

1.48

1.52

g/l

0.47

657

Systemic atrophies primarily affecting the central nervous system

167

0.78

0.34

1.2

1.1

1.63

1.51

g/l

0.86

151

Focal epilepsy, mode (most common among epilepsy diagnosis)

881

1.09

0.34

1.1

1.47

1.51

g/l

0.56

784

Tuberculosis, IBD comorbidity

255

1.18

0.34

1.1

1.57

g/l

0.01

231

Malignant neoplasm of oropharynx, excluding all cancers (controls excluding all cancers)

1.35

0.34

1.0

1.54

g/l

0.03

Spermatocele

368

1.14

0.33

1.1

1.53

1.54

g/l

0.03

335

Testicular hypofunction

191

1.21

0.33

1.1

1.38

1.46

g/l

0.71

172

Foreign body on external eye

854

1.09

0.33

1.0

1.1

1.47

1.50

g/l

0.24

780

malignant neoplasm of male genital organs, excluding all cancers (controls excluding all cancers)

145

947

0.93

0.32

1.1

1.53

1.55

g/l

0.18

131

852

Retinal haemorrhage

1.36

0.32

1.1

1.30

1.49

g/l

—

Myocardial infarction, unclassifiable

720

1.09

0.32

1.1

1.67

1.56

g/l

1.55

644

Benign neoplasm: Larynx

137

1.24

0.32

1.4

1.1

1.56

1.54

g/l

0.04

124

Congenital malformations of the nervous system

1.33

0.32

1.0

1.65

1.37

g/l

1.14

Struck by thrown, projected or falling objec

239

1.17

0.31

1.0

1.1

1.57

1.47

g/l

0.73

217

Marginal zone B-cell lymphoma, excluding all cancers (controls excluding all cancers)

1.35

0.31

1.0

1.74

1.51

g/l

—

Perichondritis of external ear

1.35

0.31

1.0

1.1

1.52

1.51

g/l

—

Malignant neoplasm of brain, excluding all cancers (controls excluding all cancers)

186

0.80

0.31

1.1

1.46

1.45

g/l

0.04

165

Cerebral palsy

1.34

0.30

1.0

1.1

1.49

1.37

g/l

—

Covid-19 suspected case

121

1130

1.07

0.30

1.1

1.54

1.48

g/l

0.67

103

1029

Hereditary corneal dystrophies

111

1.26

0.30

1.0

1.1

1.43

1.55

g/l

—

102

Superficial injury of forearm

448

1.12

0.29

1.0

1.1

1.55

1.48

g/l

0.51

404

Sequelae of other accidents

1.25

0.29

1.0

1.48

1.46

g/l

—

Injury of other and unspecified intrathoracic organs

303

0.86

0.29

1.0

1.1

1.56

1.49

g/l

0.32

277

Diffuse large B-cell lymphoma

185

1.19

0.29

1.0

1.1

1.78

1.56

g/l

1.02

165

Malignant neoplasm of other and unspecified parts of tongue

1.23

0.29

1.0

1.1

1.55

1.52

g/l

—

Other noninflammatory disorders of uterus, except cervix

664

0.92

0.28

1.1

1.57

1.53

g/l

0.43

587

Benign lipomatous neoplasm of skin and subcutaneous tissue of limbs

326

1.14

0.28

1.1

1.37

1.49

g/l

1.00

284

Other, unspecified and serous retinal detachments

121

1.24

0.28

1.1

1.52

1.55

g/l

0.11

106

Supervision of normal pregnancy

116

710

0.93

0.28

1.1

1.38

1.49

g/l

2.32

106

657

malignant neoplasm of female genital organs, excluding all cancers (controls excluding all cancers)

659

1.09

0.27

1.2

1.1

1.62

1.48

g/l

1.84

582

Other menopausal disorders

135

827

0.94

0.27

1.1

1.47

1.50

g/l

0.36

120

739

Leiomyoma of uterus

365

2002

1.04

0.27

1.1

1.45

1.49

g/l

1.03

329

1800

Undescended testicle

1.21

0.27

1.0

1.40

1.39

g/l

—

Peroneal tendinitis

1.21

0.27

1.0

1.1

1.53

1.47

g/l

—

Postpartum haemorrhage due to anatomy

423

1.11

0.27

1.0

1.1

1.37

1.42

g/l

0.72

393

Disorders of vestibular function (Vertigo)

252

2399

1.04

0.26

1.1

1.47

1.52

g/l

1.98

226

2164

Impacted cerumen

404

1.12

0.26

1.0

1.1

1.47

1.54

g/l

0.55

370

Carcinoma in situ of other and unspecified sites

113

1.24

0.26

1.1

1.0

1.42

1.57

g/l

0.85

Injury of muscle and tendon at lower leg level

781

0.92

0.26

1.1

1.49

1.52

g/l

0.31

708

Operations for atrial fibrillation

0.69

0.26

1.0

1.1

1.68

1.58

g/l

—

Unspecified mental disorder

240

2503

0.96

0.26

1.1

1.50

1.49

g/l

0.13

209

2277

Brain glioblastoma and astrocytoma

0.66

0.26

1.0

1.1

1.41

1.48

g/l

—

Adhesive middle ear disease

1.25

0.25

1.1

1.43

1.46

g/l

—

Intussusception

1.25

0.25

1.4

1.0

1.45

1.42

g/l

—

Testicular dysfunction

216

1.16

0.25

1.1

1.39

1.47

g/l

0.62

194

Ulcer of vagina/vulva

1.22

0.25

1.1

1.45

g/l

—

Correction of physiology of bite - very demanding therapy visit

114

1.23

0.25

1.1

1.53

1.45

g/l

0.22

106

Other disorders of the musculoskeletal system and connective tissue

675

1.08

0.25

1.1

1.58

1.52

g/l

0.57

608

Other and unspecified injuries of thorax

1.20

0.25

1.1

1.67

1.44

g/l

—

Neovascular glaucoma

159

0.82

0.24

1.0

1.1

1.63

1.55

g/l

0.45

145

Presbycusis

395

1.11

0.24

1.1

1.45

1.60

g/l

2.05

353

Iridocyclitis in diseases classified elsewhere

1.17

0.24

1.1

1.57

1.51

g/l

—

Malignant neoplasm of breast, HER-negative

869

0.93

0.24

1.1

1.52

1.51

g/l

0.18

775

Cervicocranial syndrome

486

0.90

0.24

1.0

1.1

1.42

1.52

g/l

1.03

439

Malignant neoplasm of eye, brain and central nervous system

189

1.17

0.24

1.1

1.50

1.48

g/l

0.17

171

Glaucoma suspect

176

1680

1.05

0.23

1.1

1.53

g/l

0.11

162

1524

Other degenerative diseases of the nervous system

128

918

1.06

0.23

1.1

1.53

1.55

g/l

0.16

113

823

Lesion of sciatic nerve

136

0.81

0.23

1.0

1.1

1.60

g/l

0.00

120

Mental and behavioural disorders of puerperium, not classified elsewhere

1.29

0.23

1.2

1.1

1.66

1.37

g/l

—

Coxarthrosis, primary

297

2667

0.97

0.23

1.1

1.54

g/l

0.01

264

2390

Malignant neoplasm of tongue

0.77

0.22

1.0

1.1

1.55

g/l

—

Mental and behavioural disorders associated with the puerperium

1.25

0.22

1.2

1.1

1.66

1.37

g/l

—

Attention to artificial openings

153

1.18

0.22

1.1

1.60

1.53

g/l

0.32

144

Long labour

117

1079

0.95

0.22

1.1

1.55

1.46

g/l

1.45

107

983

Benign neoplasm: Vagina

1.22

0.22

1.0

1.62

1.46

g/l

—

Non-Hodgkin lymphoma, all

135

0.81

0.22

1.0

1.1

1.73

1.62

g/l

0.49

123

Malignant neoplasm of bronchus and lung

618

1.08

0.22

1.1

1.63

1.56

g/l

0.59

547

Other perinatal haematological disorders

0.00

0.21

0.0

1.0

—

1.47

—

Unknown and unspecified causes of morbidity

286

1.12

0.21

1.1

1.62

1.47

g/l

1.57

252

Complications of labour and delivery

375

2029

1.03

0.21

1.1

1.46

1.48

g/l

0.53

336

1831

Malignant neoplasm of thymus, excluding all cancers (controls excluding all cancers)

0.00

0.21

0.0

1.0

—

1.52

—

Follicular lymphoma, hilmo

188

0.85

0.21

1.0

1.1

1.68

1.54

g/l

0.51

170

Type 1 diabetes, strict definition

418

0.91

0.21

1.1

1.40

1.41

g/l

0.04

377

Hyperaldosteronism

102

0.78

0.21

1.0

1.1

1.49

1.53

g/l

—

Suppurative otitis media, unspecified

102

0.78

0.21

1.1

1.44

1.47

g/l

—

Delayed milestone in childhood

1.22

0.21

1.0

1.51

1.40

g/l

0.47

Myeloid leukaemia

105

0.76

0.21

1.1

1.49

1.51

g/l

—

Serous carcinoma of ovary

105

0.76

0.21

1.4

1.0

1.69

1.52

g/l

—

Other specific arthropathies, wide

1.24

0.21

1.0

1.64

1.48

g/l

0.56

Benign neoplasm: Skin of upper limb, including shoulder

1.25

0.20

1.1

1.51

1.49

g/l

—

Hereditary retinal dystrophy

1.23

0.20

1.0

1.73

1.43

g/l

—

Use of amantadine

1.23

0.20

1.0

1.1

1.32

1.50

g/l

—

Disorders of optic nerve and visual pathways

432

1.09

0.20

1.1

1.46

1.50

g/l

0.35

390

Mantle cell lymphoma, excluding all cancers (controls excluding all cancers)

1.20

0.20

1.0

1.65

1.51

g/l

—

Benign neoplasm: Pituitary gland, craniopharyngeal duct

241

1.12

0.19

1.2

1.1

1.44

1.49

g/l

0.18

219

Glaucoma secondary to other eye disorders

164

0.85

0.18

1.0

1.1

1.61

1.55

g/l

0.29

149

Disorders of speech understanding and production

192

0.87

0.18

1.1

1.39

1.45

g/l

0.38

173

Other and unspecified injuries of shoulder and upper arm

132

0.83

0.18

1.1

1.34

1.48

g/l

0.44

117

Diabetic retinopathy, strict definition

119

997

1.05

0.18

1.0

1.1

1.63

1.54

g/l

1.33

103

902

Puerperal sepsis

600

1.07

0.17

1.1

1.50

1.48

g/l

0.15

545

Benign neoplasm: Short bones of upper limb

1.11

0.17

1.0

1.39

1.44

g/l

—

Other bursitis of knee

0.74

0.17

1.0

1.60

1.50

g/l

—

Abnormal spermatozoa

543

1.07

0.17

1.1

1.57

1.55

g/l

0.08

492

Malignant neoplasm of tonsil

1.18

0.16

1.0

1.1

1.52

1.57

g/l

—

Myopia

631

1.06

0.16

1.1

1.49

1.47

g/l

0.18

563

Single delivery by forceps and vacuum extractor

477

0.94

0.16

1.0

1.1

1.48

1.51

g/l

0.15

430

Ankyloglossia

1.14

0.16

1.0

1.32

1.40

g/l

—

Parapsoriasis

0.78

0.15

1.2

1.1

1.49

1.45

g/l

—

Other hammer toe(s) (acquired)

703

1.05

0.15

1.1

1.47

1.53

g/l

0.88

637

Other and unspecified erythematous conditions

119

0.84

0.15

1.0

1.40

1.50

g/l

—

109

Occupant of special all-terrain or other motor vehicle designed primarily for off-road use, injured in transport accident

1.14

0.15

1.0

1.1

1.38

1.48

g/l

—

Abrasion of teeth

153

1085

1.04

0.15

1.1

1.46

1.48

g/l

0.22

139

989

Pedal cyclist injured in other and unspecified transport accidents

546

1.06

0.15

1.1

1.44

1.50

g/l

0.68

488

Other lesions of median nerve

1.09

0.14

1.1

1.58

1.56

g/l

—

Melanocytic naevi of upper limb, including shoulder

0.79

0.14

1.0

1.1

1.45

1.46

g/l

—

Melanocytic naevi of upper limb, including shoulder

0.79

0.14

1.0

1.45

1.46

g/l

—

Procedures for purposes other than remedying health state

1.18

0.14

1.0

1.40

1.45

g/l

0.22

Malignant neoplasm of brain

139

0.86

0.14

1.2

1.1

1.54

1.49

g/l

0.16

128

Myeloid leukaemia

0.83

0.13

1.1

1.0

1.49

1.50

g/l

—

Stroke, excluding SAH

322

2340

1.02

0.13

1.1

1.55

1.54

g/l

0.15

285

2111

Serous carcinoma of ovary, excluding all cancers (controls excluding all cancers)

100

0.80

0.13

1.4

1.1

1.69

1.49

g/l

—

Ectopic pregnancy

882

1.04

0.13

1.1

1.46

1.47

g/l

0.02

805

Injury of unspecified body region

315

1.08

0.13

1.1

1.52

g/l

0.00

283

Mandibular retrognathia AND surgery (BSSRO)

109

0.82

0.13

1.1

1.33

1.44

g/l

—

101

Impacted teeth

868

1.04

0.12

1.1

1.47

1.44

g/l

0.28

785

Carcinoma in situ of breast, intraductal

324

0.93

0.12

1.1

1.44

1.51

g/l

0.43

284

Female genital prolapse

153

856

1.03

0.12

1.1

1.46

1.51

g/l

0.86

137

765

Unspecified lump in breast

678

1.05

0.12

1.1

1.51

g/l

0.02

605

Stroke, including SAH

346

2512

1.02

0.12

1.1

1.55

1.54

g/l

0.21

308

2267

Seropositive rheumatoid arthritis, strict definition

708

1.05

0.12

1.1

1.54

1.52

g/l

0.08

637

Sequelae of injuries of head

261

0.92

0.11

1.2

1.1

1.63

1.48

g/l

1.17

238

Congenital malformations of eye, ear, face and neck

302

0.93

0.11

1.0

1.1

1.45

1.47

g/l

0.13

269

Carcinoma in situ of breast, intraductal

322

0.93

0.11

1.1

1.44

1.48

g/l

0.26

277

Labour and delivery complicated by fetal stress [distress]

114

785

0.97

0.10

1.1

1.45

g/l

0.03

104

722

Other strabismus

120

1161

1.03

0.10

1.1

1.49

g/l

0.00

109

1053

Separation of retinal layers (serosa)

202

1.09

0.10

1.1

1.66

1.49

g/l

1.27

181

Other secondary coxarthrosis

144

1.11

0.10

1.1

1.53

1.52

g/l

0.01

129

Maternal care related to the fetus and amniotic cavity and possible delivery problems

255

1531

0.98

0.10

1.1

1.39

1.48

g/l

3.97

239

1382

Malignant neoplasm of breast, ER-negative, excluding all cancers (controls excluding all cancers)

911

1.03

0.10

1.1

1.52

1.47

g/l

0.68

807

Other bursitis of elbow

1.11

0.10

1.2

1.0

1.49

1.53

g/l

—

Pedal cyclist injured in collision with other pedal cycle or other nonmotor vehicle

1.11

0.10

1.0

1.49

1.40

g/l

—

Sequelae of cerebrovascular disease

152

1301

1.03

0.09

1.1

1.61

1.55

g/l

1.25

132

1156

Major anomalies of jaw size

135

1.11

0.09

1.0

1.1

1.50

1.45

g/l

0.20

123

Disorders of breast

264

2403

1.02

0.09

1.0

1.1

1.49

g/l

0.08

238

2164

Fourth [trochlear] nerve palsy

1.15

0.09

1.0

1.1

1.50

1.52

g/l

—

Morphin

1.06

0.09

1.2

1.1

1.55

1.47

g/l

—

Glaucoma

284

2451

1.02

0.09

1.1

1.54

1.53

g/l

0.21

254

2202

Exposure to smoke, fire and flames

116

1.12

0.09

1.0

1.1

1.44

1.45

g/l

0.07

101

Bicuspidal aortic valve syndrome

184

1.09

0.09

1.0

1.1

1.52

1.47

g/l

0.17

168

Dependence on enabling machines and devices, not elsewhere classified

1.11

0.09

1.0

1.68

1.49

g/l

—

Early lumbar disc prolapse operation

616

1.04

0.09

1.1

1.41

1.45

g/l

0.49

565

malignant neoplasm of female genital organs

532

0.96

0.08

1.1

1.58

1.52

g/l

0.64

459

Brain glioblastoma and astrocytoma, excluding all cancers (controls excluding all cancers)

0.79

0.08

1.0

1.41

1.49

g/l

—

Benign lipomatous neoplasm

157

1537

1.02

0.08

1.1

1.44

1.52

g/l

1.37

140

1389

Primary coxarthrosis, bilateral

125

1220

1.02

0.08

1.0

1.1

1.52

1.54

g/l

0.20

111

1089

Causalgia

0.78

0.08

1.0

1.1

1.49

1.45

g/l

—

Malignant neoplasm of respiratory system and intrathoracic organs

741

0.97

0.08

1.1

1.64

1.56

g/l

0.83

661

Vascular dementia (subcortical)

0.77

0.08

1.0

1.1

1.57

1.70

g/l

—

Guillain-Barre syndrome

1.09

0.08

1.0

1.1

2.11

1.48

g/l

—

Medical treatment for female infertility

105

1020

1.03

0.08

1.1

1.35

1.47

g/l

3.13

943

Retained placenta and membranes, without haemorrhage

582

0.96

0.08

1.1

1.54

1.49

g/l

0.33

529

Benign neoplasm: Skin of eyelid, including canthus

657

1.04

0.08

1.1

1.52

1.54

g/l

0.11

586

Benign neoplasm: Short bones of upper limb

1.05

0.08

1.0

1.1

1.39

1.45

g/l

—

Heterophoria

352

1.05

0.08

1.1

1.59

1.48

g/l

0.62

317

Malignant neoplasm of larynx, excluding all cancers (controls excluding all cancers)

1.03

0.08

1.3

1.0

1.66

1.59

g/l

—

Malignant melanoma of skin

480

1.04

0.08

1.0

1.1

1.42

1.54

g/l

2.07

425

Hyperplasia of prostate

215

1205

1.02

0.07

1.1

1.54

1.57

g/l

0.30

192

1117

Muscle strain

137

1.10

0.07

1.1

1.46

1.49

g/l

0.17

124

Malignant neoplasm of oropharynx

1.07

0.07

1.0

1.1

1.52

1.57

g/l

—

Acute appendicitis, with complications

102

1046

0.97

0.07

1.1

1.45

1.52

g/l

1.15

957

Diseases of inner ear

297

2869

1.01

0.07

1.1

1.47

1.52

g/l

1.92

266

2577

Corneal scars and opacities

112

0.89

0.07

1.2

1.1

1.50

1.54

g/l

—

103

Torticollis

0.87

0.07

1.1

1.23

1.43

g/l

—

Viral conjunctivitis

0.86

0.07

1.0

1.34

1.44

g/l

—

Dislocation, sprain and strain of joints and ligaments of shoulder girdle

165

1620

1.02

0.07

1.1

1.52

1.50

g/l

0.35

152

1469

Retinoschisis and retinal cysts

1.05

0.07

1.1

1.66

1.51

g/l

—

Other arterial embolism and thrombosis

1.03

0.07

1.0

1.68

1.56

g/l

—

Dental caries 1 and operation codes, only avohilmo

193

954

1.02

0.06

1.1

1.50

g/l

0.03

171

868

Traumatic amputation of wrist and hand

226

1.06

0.06

1.2

1.1

1.57

1.52

g/l

0.19

208

Transient ischemic attack

264

2159

1.01

0.06

1.1

1.49

1.55

g/l

1.66

240

1940

Schizophrenia or delusion, excluding more controls

166

1619

1.02

0.06

1.1

1.52

1.47

g/l

1.07

145

1484

Burn and corrosion of trunk

138

1.09

0.06

1.3

1.1

1.53

1.48

g/l

0.17

126

Malignant cancer of tonsil and base of tongue, excluding all cancers (controls excluding all cancers)

1.11

0.06

1.0

1.1

1.61

1.52

g/l

0.46

Benign paroxysmal vertigo

133

1354

0.98

0.06

1.1

1.47

1.53

g/l

1.02

121

1216

Autonomic disorders

1.11

0.05

1.0

1.1

1.61

1.52

g/l

—

Postpartum haemorrhage due to retained placenta

597

0.97

0.05

1.1

1.41

1.45

g/l

0.42

561

Carcinoma in situ of other and unspecified sites

151

0.93

0.05

1.1

1.42

1.61

g/l

1.20

137

Benign mammary dysplasia

556

0.97

0.05

1.1

1.57

1.52

g/l

0.38

490

Pedal cyclist injured in noncollision transport accidents

555

0.97

0.04

1.1

1.39

1.48

g/l

1.16

500

Other erythematous conditions

140

0.93

0.04

1.0

1.1

1.40

1.51

g/l

0.74

127

Lymphoid leukaemia

219

1.05

0.04

1.0

1.1

1.49

1.55

g/l

0.13

200

Distal bite

138

0.94

0.03

1.2

1.0

1.38

1.45

g/l

0.50

128

Acute alcohol intoxication ICD-9

149

0.94

0.03

1.0

1.1

1.54

1.50

g/l

0.11

136

Follicular lymphoma

151

1.06

0.03

1.0

1.68

1.49

g/l

0.77

127

Carcinoma in situ, bladder

108

0.93

0.03

1.1

1.0

1.34

1.57

g/l

—

Type 1 diabetes, definitions combined

498

1.02

0.02

1.1

1.40

1.43

g/l

0.16

448

Acute and transient psychotic disorders

610

0.98

0.02

1.1

1.47

1.48

g/l

0.06

551

Disorders of refraction and accommodation

146

1466

0.99

0.02

1.1

1.46

1.49

g/l

0.47

129

1337

Benign lipomatous neoplasm of skin and subcutaneous tissue of limbs

362

1.02

0.01

1.1

1.37

1.50

g/l

1.17

324

Other and unspecified nonorganic psychotic disorders

109

1099

0.99

0.01

1.1

1.52

1.46

g/l

0.84

1000

Fracture of femur

100

906

1.01

0.01

1.1

1.64

1.54

g/l

1.68

798

Hallux rigidus

653

1.01

0.01

1.1

1.46

1.52

g/l

0.44

591

Other specified/unspecified disorders of bone/cartilage

124

1.05

0.00

1.0

1.1

1.51

1.48

g/l

0.11

113

Complications of the puerperium, not elsewhere classified

154

1.04

0.00

1.1

1.33

1.43

g/l

0.43

144

False labour

166

1038

1.00

0.00

1.1

1.34

1.48

g/l

4.19

156

950

Wet age-related macular degeneration

497

0.99

0.00

1.1

1.57

1.59

g/l

0.08

432

LeFortI or BSSRO operation

184

1.03

0.00

1.1

1.41

1.44

g/l

0.17

167

Maternal care for other known or suspected fetal problems

118

756

1.00

0.00

1.1

1.42

1.48

g/l

0.93

111

688

Primary open-angle glaucoma, strict

101

1008

1.00

0.00

1.1

1.52

1.55

g/l

0.35

900

Examination and encounter for administrative purposes

145

1.03

0.00

1.1

1.0

1.46

1.52

g/l

0.29

128

Other peripheral vertigo

378

1.01

0.00

1.1

1.33

1.53

g/l

5.10

342

Urethral stricture

254

0.98

0.00

1.0

1.1

1.72

1.54

g/l

0.60

235

Other mental disorders due to brain damage and dysfunction and to physical disease

438

1.00

0.00

1.1

1.56

1.55

g/l

0.04

388

Other maltreatment syndromes

164

0.98

0.00

1.1

1.56

1.43

g/l

0.74

149

Mandibular retrognathia

300

1.00

0.00

1.0

1.1

1.43

1.46

g/l

0.20

273

Burns and corrosions of multiple and unspecified body regions

112

0.98

0.00

1.1

1.67

1.47

g/l

1.24

102

Type 1 diabetes, strict (exclude DM2)

497

1.00

0.00

1.1

1.40

1.42

g/l

0.16

449

Primary open-angle glaucoma

122

1190

1.00

0.00

1.1

1.53

1.56

g/l

0.42

106

1061

Other congenital malformations of face and neck

129

1.01

0.00

1.1

1.45

1.44

g/l

0.05

117

Pedal cyclist injured in transport accident

116

1159

1.00

0.00

1.1

1.44

1.50

g/l

0.91

103

1050

Pedestrian injured in collision with pedal cycle

147

1.02

0.00

1.0

1.1

1.42

1.47

g/l

0.18

131

Bilateral sagittal split ramus osteotomy operation

153

0.98

0.00

1.1

1.44

1.45

g/l

0.04

139

Type 1 diabetes, strict definition, subgroup 1

364

0.99

0.00

1.1

1.41

1.38

g/l

0.12

327

Short stature, not elsewhere classified

108

0.95

0.00

1.1

1.0

1.37

1.39

g/l

0.10

100

Hallux valgus (acquired)

184

1334

1.00

0.00

1.0

1.1

1.51

g/l

0.02

158

1199

Tuberculosis of nervous system

0.00

0.0

1.0

—

1.34

—

Malignant neoplasm of thymus

0.00

0.0

1.1

—

1.55

—

Crushing injuries involving multiple body regions

0.00

0.0

1.0

—

1.35

—

Open wound of thorax

1.00

0.00

1.3

1.1

1.43

1.45

g/l

—

Erythema in diseases classified elsewhere

0.00

0.0

1.0

—

1.29

—

Other lack of coordination

1.01

0.00

1.1

1.84

1.45

g/l

—

Phakomatoses, not elsewhere classified

0.93

0.00

1.4

1.0

1.58

1.35

g/l

—

hereditary angioödema type 3

0.00

0.0

1.0

—

1.18

—

Benign neoplasm: other/unspecified salivary gland

0.90

0.00

1.0

1.1

1.59

1.51

g/l

—

Café au lait spots

0.00

0.0

1.0

—

1.37

—

Benign lipomatous neoplasm of intrathoracic organs

0.00

0.0

1.0

—

1.33

—

Noonan syndrome

0.00

0.0

1.0

—

1.14

—

Progressive vascular leukoencephalopathy

0.89

0.00

1.3

1.1

1.43

1.69

g/l

—

Sleep terrors [night terrors]

0.00

0.0

1.0

—

1.22

—

Wegener granulomatosis

0.89

0.00

1.0

1.1

1.54

1.50

g/l

—

Rickettsioses

0.00

0.0

1.0

—

1.41

—

Rhabdomyosarcoma, excluding all cancers (controls excluding all cancers)

0.00

0.0

1.0

—

1.42

—

Intracranial laceration and haemorrhage due to birth injury

0.00

0.0

1.0

—

1.43

—

Other sideroblastic anaemias

0.00

0.0

1.0

—

1.41

—

Venous complications and haemorrhoids in pregnancy

0.87

0.00

1.2

1.1

1.52

1.47

g/l

—

Profound mental retardation

0.00

0.0

1.0

—

1.28

—

Superficial injury of neck

1.01

0.00

1.1

1.39

1.42

g/l

—

Disorders of endocrine glands in diseases classified elsewhere

0.00

0.0

1.0

—

1.23

—

Other specified/unspecified disorders of middle ear and mastoid

0.00

0.0

1.0

—

1.34

—

Ankylosing hyperostosis [Forestier]

1.00

0.00

1.0

1.1

1.56

1.54

g/l

—

Other trisomies and partial trisomies of the autosomes, not elsewhere classified

0.00

0.0

1.0

—

1.27

—

Dysplastic lesion of the vagina of unknown severity

0.00

0.0

1.0

—

1.46

—

Crushing injury of forearm

0.00

0.0

1.0

—

1.37

—

Defect, injury or illness of face

0.00

0.0

1.0

—

1.33

—

Benign neoplasm: other/unspecified salivary gland

0.96

0.00

1.0

1.59

1.51

g/l

—

≡ Risteys

FG R12 + FR

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma

Coding

Definition

OMOP mapping QC

Cohort

Year of birth distribution

Age at first measurement

Age at last measurement

Age at start of registry

Duration from first to last measurement

Statistics

Number of measurements over the years

Number of measurements per person

Distribution of lab values

Value range per person

LabWAS